data_2nch_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nch _Structure_validation_residue.Date_analyzed 2017-03-31 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.739 -0.467 . . . . 73.55 109.739 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 3' ' ' LYS . 11.2 p -74.5 -36.26 41.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.308 0.575 . . . . 71.32 109.683 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 2' ' ' VAL . 73.1 mmtt -97.06 70.69 2.41 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.871 -0.789 . . . . 74.24 108.871 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.06 -70.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 55.52 110.101 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.39 -41.13 41.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.633 . . . . 73.41 110.413 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -105.4 169.44 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.807 -0.633 . . . . 75.15 110.475 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.4 m 70.03 18.68 7.08 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.013 0.821 . . . . 75.15 111.308 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -69.86 -28.08 65.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.181 0.515 . . . . 74.4 109.771 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -68.1 94.25 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.397 -0.819 . . . . 74.13 109.145 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 60' ' ' GLU . 8.2 tt -137.93 141.4 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.774 -0.648 . . . . 70.4 110.903 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -107.43 143.75 35.33 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.126 -0.694 . . . . 73.31 109.126 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.02 123.24 46.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.973 0.416 . . . . 71.12 110.826 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 83.6 t -110.89 135.85 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.9 -0.591 . . . . 75.21 110.732 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.52 113.69 26.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.697 -0.483 . . . . 75.02 109.697 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.88 -154.12 6.16 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.771 -0.728 . . . . 51.23 111.816 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 56' ' ' ARG . . . -149.02 143.49 26.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.876 0.338 . . . . 71.25 110.422 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.583 ' HA ' HG12 ' A' ' 28' ' ' VAL . 8.4 p -68.0 143.03 15.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.56 -0.291 . . . . 74.55 110.402 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.616 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 11.9 t -107.24 -33.9 7.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.886 -0.325 . . . . 73.25 110.939 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -165.35 158.46 16.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.618 -0.265 . . . . 73.55 110.292 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.654 HD21 HD13 ' A' ' 53' ' ' ILE . 2.5 pt? -118.54 154.29 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 73.11 110.133 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.528 ' HB2' ' HB3' ' A' ' 25' ' ' GLU . 9.4 mp -116.93 157.24 46.93 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 72.34 110.293 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.26 6.85 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.517 2.811 . . . . 74.42 113.0 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.16 24.73 10.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.097 -0.501 . . . . 75.55 109.941 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.06 27.78 15.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.562 -0.745 . . . . 73.33 110.036 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.528 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 35.1 tt0 -99.12 136.52 38.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.142 -0.935 . . . . 75.13 110.521 -174.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.05 111.57 17.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.287 -0.634 . . . . 74.14 109.287 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' O ' HG23 ' A' ' 18' ' ' THR . 17.0 mtp180 -101.14 123.86 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.434 -0.58 . . . . 74.03 109.434 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.719 HG13 HG23 ' A' ' 57' ' ' VAL . 13.3 m -110.04 155.8 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.97 -0.559 . . . . 75.3 110.694 -173.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.616 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -112.72 127.3 56.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.321 0.582 . . . . 75.23 110.307 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 53.7 tp -76.53 148.74 36.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.545 -0.752 . . . . 74.23 109.105 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.08 -11.06 17.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.857 0.36 . . . . 62.11 111.504 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.557 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 11.4 t30 -93.79 24.44 4.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.292 0.567 . . . . 64.42 109.724 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 63.14 46.46 4.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.501 -0.772 . . . . 73.25 111.293 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.38 119.39 22.67 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.732 -0.605 . . . . 74.34 111.001 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -91.71 126.48 36.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.67 -0.492 . . . . 75.44 109.67 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.7 158.21 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.965 0.412 . . . . 74.31 110.973 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 72.5 mt -89.71 141.68 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 75.34 110.429 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 68.8 m -139.72 146.77 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.191 0.519 . . . . 60.02 110.531 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -139.93 167.83 21.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.781 -0.645 . . . . 72.32 109.401 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 m -84.75 118.07 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.343 0.592 . . . . 72.34 110.367 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.1 m -155.37 59.27 0.64 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 43.11 110.167 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.63 -154.4 8.1 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.443 -0.884 . . . . 63.13 112.562 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.73 -17.02 12.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.45 0.7 . . . . 74.42 111.45 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG12 ' HB ' ' A' ' 49' ' ' ILE . 18.7 t -49.78 -32.25 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 122.952 0.501 . . . . 73.03 111.477 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 2.5 tmt_? -71.28 -41.59 69.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 72.41 110.146 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 46' ' ' ARG . 11.9 mmt180 -80.21 -44.61 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 72.02 111.434 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.4 t -78.16 -23.83 47.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.33 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 59.21 87.55 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.618 0.723 . . . . 74.24 111.237 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.556 ' HB ' HG12 ' A' ' 44' ' ' VAL . 43.1 mm -104.31 145.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.324 -0.853 . . . . 74.43 110.28 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -99.77 113.78 26.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 74.32 110.675 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -91.62 122.47 43.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.9 -0.407 . . . . 74.14 109.9 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -125.04 148.54 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.662 0.268 . . . . 63.43 110.676 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.654 HD13 HD21 ' A' ' 20' ' ' LEU . 60.0 mt -77.91 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.865 -0.42 . . . . 75.55 109.865 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.08 -14.84 40.29 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.612 -0.804 . . . . 75.13 111.904 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -102.63 157.33 17.01 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 42.14 109.204 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.645 ' HD3' ' HB3' ' A' ' 16' ' ' ALA . 26.2 mmt180 -75.3 158.78 32.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.766 -0.457 . . . . 74.51 109.766 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.719 HG23 HG13 ' A' ' 28' ' ' VAL . 34.3 m -135.17 153.87 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.812 0.339 . . . . 75.45 110.969 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -107.39 115.84 30.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.907 -0.775 . . . . 71.24 108.907 173.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.478 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 47.4 t -97.85 109.1 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.161 -0.472 . . . . 75.54 110.115 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HB3' HD22 ' A' ' 10' ' ' LEU . 32.5 mt-10 -101.7 108.58 20.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.088 -0.505 . . . . 74.52 109.643 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -145.05 160.44 41.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 74.34 111.075 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.612 ' H ' ' HB2' ' A' ' 67' ' ' ASN . 47.7 t -100.0 144.24 29.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 74.35 109.309 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.0 mm -78.55 -17.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 111.793 0.294 . . . . 72.45 111.793 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -65.89 -84.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.865 0.691 . . . . 75.23 112.865 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -148.45 -55.34 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.158 0.429 . . . . 74.11 112.158 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' HG2' ' H ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -48.77 -58.56 4.6 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.676 0.61 . . . . 73.01 112.093 -176.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.612 ' HB2' ' H ' ' A' ' 62' ' ' SER . 2.3 m-20 -100.68 25.83 7.43 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.405 -0.184 . . . . 71.32 110.888 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.28 -43.88 20.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.981 0.363 . . . . 63.44 111.981 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.583 ' HD2' ' H ' ' A' ' 69' ' ' LYS . 7.3 mptt -77.52 -33.7 54.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.992 0.425 . . . . 71.35 110.418 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -134.78 149.7 50.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 73.44 110.612 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.96 175.36 15.66 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.281 -0.962 . . . . 71.14 112.106 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -93.16 109.34 20.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.484 -0.561 . . . . 71.21 109.484 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 11.9 tt -99.32 126.95 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.161 -0.472 . . . . 73.33 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.751 HG21 ' H ' ' A' ' 75' ' ' ARG . 5.2 tt -118.2 -66.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.101 -0.5 . . . . 73.05 110.684 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.751 ' H ' HG21 ' A' ' 74' ' ' ILE . 0.3 OUTLIER 174.91 175.51 0.19 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.646 -0.872 . . . . 75.23 108.646 176.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.565 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 31.8 tpt180 -69.41 120.9 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.964 0.411 . . . . 75.34 109.956 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.6 pt? -73.72 177.57 5.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.903 -0.59 . . . . 74.34 109.962 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 122.38 20.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.214 -0.662 . . . . 63.24 109.214 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.464 ' C ' ' HG1' ' A' ' 80' ' ' THR . . . -81.49 44.65 3.11 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.943 -0.572 . . . . 75.22 113.505 -169.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.464 ' HG1' ' C ' ' A' ' 79' ' ' GLY . 18.5 p 46.33 51.19 11.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.384 0.612 . . . . 71.11 112.038 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 p -89.54 15.52 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 74.25 111.38 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.82 5.79 46.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.209 -0.451 . . . . 75.13 111.002 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -65.92 -53.06 44.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 75.13 110.721 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -155.69 -80.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.396 -0.335 . . . . 61.12 111.781 176.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.674 ' H ' HG22 ' A' ' 84' ' ' THR . 41.1 pt 40.24 39.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.716 0.806 . . . . 71.32 111.961 -173.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 m 64.69 79.91 0.24 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.396 -0.82 . . . . 74.11 110.672 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.377 -0.821 . . . . 73.24 109.946 -179.534 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HG2' HG21 ' A' ' 2' ' ' VAL . 26.9 ttt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.59 0.233 . . . . 72.24 110.749 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.427 HG21 ' HG2' ' A' ' 1' ' ' MET . 55.5 t -133.0 99.78 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.669 0.271 . . . . 74.44 110.945 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -143.15 111.28 6.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 73.1 110.306 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.459 ' HA ' HH22 ' A' ' 66' ' ' ARG . 31.9 t70 -149.86 -61.06 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.096 -0.642 . . . . 72.44 112.376 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.465 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -68.56 -31.39 70.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.803 0.335 . . . . 73.11 110.708 -173.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -92.59 14.26 17.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 72.14 111.164 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.565 ' HB3' ' HE2' ' A' ' 64' ' ' TYR . 14.5 m -76.58 95.73 3.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.226 -0.657 . . . . 62.45 109.226 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.84 1.27 57.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 71.52 111.286 -173.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -92.57 79.13 4.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.0 -0.741 . . . . 61.11 109.0 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.586 ' HA ' HG12 ' A' ' 63' ' ' ILE . 2.0 pt? -150.14 -177.04 5.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.713 -0.676 . . . . 75.53 110.019 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -142.74 124.04 14.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 74.43 110.572 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.28 139.19 30.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.17 -0.678 . . . . 72.52 109.17 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.6 161.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 74.43 111.147 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -91.86 128.78 37.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.465 -0.568 . . . . 62.4 109.465 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.73 176.96 19.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.715 -0.755 . . . . 73.11 112.125 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.55 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.249 -0.278 . . . . 71.04 110.249 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.62 ' HA ' HG11 ' A' ' 28' ' ' VAL . 5.6 p -70.06 112.58 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.433 0.635 . . . . 75.22 110.231 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -98.23 -24.78 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.751 -0.659 . . . . 52.41 110.308 -176.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -166.95 163.2 16.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.031 -0.531 . . . . 74.32 110.287 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -136.35 155.24 50.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.545 -0.539 . . . . 61.4 109.545 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 23' ' ' ALA . 7.1 mp -103.53 151.16 38.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.473 -0.566 . . . . 74.01 109.473 177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.02 38.24 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.875 2.383 . . . . 73.44 112.406 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -139.83 28.06 2.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.728 -0.669 . . . . 74.04 110.13 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.67 20.58 12.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.577 -0.738 . . . . 71.12 111.581 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.46 135.18 45.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -118.58 139.89 50.76 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.596 -0.89 . . . . 74.45 108.596 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -124.45 107.2 10.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.864 0.84 . . . . 75.52 110.968 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.62 HG11 ' HA ' ' A' ' 17' ' ' VAL . 13.7 m -96.56 148.24 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.458 -1.246 . . . . 74.1 109.114 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -116.28 140.35 49.42 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.88 -0.728 . . . . 73.13 110.388 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.513 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 48.8 tp -80.9 145.67 31.19 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.471 -0.937 . . . . 74.4 108.471 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.91 -8.75 51.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.798 0.332 . . . . 74.13 111.03 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.513 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 61.7 t30 -89.11 14.83 9.86 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.633 0.73 . . . . 72.22 109.536 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 68.15 52.19 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.159 -0.928 . . . . 73.41 112.764 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -129.8 141.25 50.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 72.43 109.434 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.54 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.116 0.484 . . . . 75.15 110.737 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 pt -132.26 154.85 40.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.803 -0.635 . . . . 75.42 110.513 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 2.5 mp -88.92 134.41 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.799 -0.637 . . . . 74.11 109.589 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 62.0 m -122.95 140.74 52.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.468 . . . . 73.24 110.036 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -151.57 149.49 29.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.413 -0.958 . . . . 70.43 108.413 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -70.76 118.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.403 0.621 . . . . 74.33 110.663 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 m -153.22 53.53 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 74.5 109.864 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.96 -159.59 12.12 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 71.11 112.577 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -59.17 -22.09 60.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.784 0.434 . . . . 75.21 111.277 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.804 HG22 ' HB ' ' A' ' 49' ' ' ILE . 5.6 p -53.25 -35.01 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.171 -0.468 . . . . 71.34 111.335 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -68.94 -38.62 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.475 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -81.97 -28.79 32.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.42 111.409 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -86.59 -5.57 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.699 -0.228 . . . . 75.14 111.252 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.8 mttt 60.61 37.91 19.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.971 0.415 . . . . 73.44 110.86 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.804 ' HB ' HG22 ' A' ' 44' ' ' VAL . 47.5 mm -66.0 133.68 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.291 0.567 . . . . 74.34 111.535 -175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 ttt85 -88.99 105.45 17.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.477 -0.783 . . . . 75.3 110.888 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 74' ' ' ILE . 51.9 mt -85.89 123.63 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.047 -0.524 . . . . 75.21 109.98 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.603 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -118.63 151.84 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.851 0.358 . . . . 75.43 111.062 -175.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -78.48 141.88 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 74.41 110.974 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.428 ' H ' HG13 ' A' ' 17' ' ' VAL . . . 89.68 9.2 66.7 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.028 -0.606 . . . . 71.13 112.637 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.93 151.53 27.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.698 0.285 . . . . 72.45 110.36 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.7 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 17.5 mmm180 -77.63 145.48 36.72 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 75' ' ' ARG . 30.2 m -132.68 154.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.855 0.36 . . . . 75.2 111.2 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 tp -106.64 106.65 17.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.673 -0.862 . . . . 73.44 108.673 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.39 127.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.453 0.644 . . . . 72.41 111.195 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -102.9 111.22 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.177 -0.92 . . . . 72.4 109.669 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.544 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -133.87 158.6 43.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.001 0.429 . . . . 75.21 111.004 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 18.7 m -100.26 143.35 30.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.971 -0.559 . . . . 72.41 110.759 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.586 HG12 ' HA ' ' A' ' 10' ' ' LEU . 18.9 mm -77.97 3.37 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.282 0.563 . . . . 74.42 111.267 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.565 ' HE2' ' HB3' ' A' ' 7' ' ' SER . 87.8 m-85 -78.72 -91.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.322 0.49 . . . . 75.15 112.322 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.07 -69.25 0.23 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.812 0.671 . . . . 73.42 112.812 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -55.88 -44.81 78.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.674 0.273 . . . . 74.21 111.129 -175.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 61' ' ' MET . 84.2 m-20 -99.24 21.94 11.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.537 -0.301 . . . . 74.01 111.197 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.35 -18.32 22.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.468 0.651 . . . . 71.4 109.55 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -102.08 -45.34 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.198 -0.91 . . . . 74.22 109.873 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 12.5 ptmm? -106.83 137.65 44.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.434 -0.803 . . . . 73.33 110.841 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.79 169.81 13.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.666 -0.778 . . . . 73.03 111.963 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' NH2' ' HA ' ' A' ' 5' ' ' GLU . 60.1 mtt180 -92.87 109.35 20.79 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.523 -0.547 . . . . 73.23 109.523 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 14.5 tt -102.39 143.74 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 73.4 110.793 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.707 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.4 tt -140.8 -65.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.626 . . . . 71.32 110.261 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.707 ' H ' HG23 ' A' ' 74' ' ' ILE . 9.5 mtp180 176.13 173.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.615 1.166 . . . . 75.32 108.118 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -87.05 132.6 33.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.215 -0.661 . . . . 73.05 109.215 173.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' N ' ' HD3' ' A' ' 76' ' ' ARG . 52.1 tp -62.56 145.69 53.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.751 -0.463 . . . . 72.22 109.751 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.62 ' HD3' ' H ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -47.86 124.88 7.97 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.689 0.618 . . . . 73.11 111.075 -176.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.48 161.36 51.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.4 -0.818 . . . . 72.14 113.125 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.8 t -105.35 150.25 25.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.924 -0.398 . . . . 75.35 109.924 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -100.81 6.2 43.72 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.398 0.518 . . . . 74.15 112.398 -171.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 16.7 p-10 -78.62 -45.56 21.3 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.923 -0.399 . . . . 75.51 109.923 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 63.33 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 75.31 112.518 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -96.09 -34.68 11.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.99 -0.55 . . . . 75.51 111.402 -171.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.478 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 35.2 pt -113.46 160.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.277 -0.419 . . . . 71.02 111.165 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.5 m -74.25 -55.68 5.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 62.1 109.592 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? . . . . . 0 C--O 1.245 0.862 0 N-CA-C 108.685 -0.857 . . . . 75.2 108.685 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 110.123 -0.325 . . . . 73.34 110.123 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 t 50.36 80.03 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.818 -0.628 . . . . 74.14 111.989 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 39.2 mmtm -138.27 101.76 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.59 . . . . 74.14 109.579 176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -119.57 -57.1 2.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 72.52 111.042 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.27 -42.77 73.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.415 0.626 . . . . 75.24 109.957 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.92 100.91 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.577 -0.897 . . . . 74.54 108.577 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.3 m -85.96 -7.91 58.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.656 -0.702 . . . . 75.13 112.694 -169.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.73 -162.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.317 0.386 . . . . 72.34 110.495 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -84.43 106.29 15.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 63.21 110.005 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.4 pt? -137.81 151.33 48.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.038 -0.528 . . . . 73.24 110.184 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -105.57 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.164 0.507 . . . . 73.2 110.029 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' HB3' HD13 ' A' ' 58' ' ' LEU . 9.3 mt-10 -92.46 104.08 16.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.679 -0.691 . . . . 74.23 109.603 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.5 149.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.955 -0.566 . . . . 75.42 111.148 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.66 133.98 53.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.925 -0.58 . . . . 73.22 110.614 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.72 163.55 32.7 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 74.2 111.475 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 56' ' ' ARG . . . -86.51 128.46 34.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.862 0.363 . . . . 70.23 110.998 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 4.6 p -75.06 124.85 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 75.25 110.245 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.1 t -104.0 -30.52 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.289 -0.414 . . . . 64.12 111.656 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.03 168.42 26.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.557 -0.292 . . . . 72.53 110.741 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.775 HD22 HD13 ' A' ' 53' ' ' ILE . 2.4 pt? -143.28 155.46 44.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.921 -0.581 . . . . 74.31 109.751 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 19.4 tp -107.65 142.81 25.98 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.442 -0.947 . . . . 74.34 108.442 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.529 ' HD2' HD13 ' A' ' 21' ' ' LEU . 42.1 Cg_endo -67.51 36.22 0.16 Allowed 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 123.219 2.613 . . . . 74.42 113.377 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -133.84 28.0 3.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 73.01 109.428 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.33 24.02 10.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.264 -0.88 . . . . 74.41 111.261 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 40.5 tt0 -100.66 136.52 40.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.867 -0.606 . . . . 74.33 110.132 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.671 ' HB2' ' HB2' ' A' ' 38' ' ' CYS . 72.1 m-85 -121.83 147.52 45.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.83 -0.804 . . . . 74.42 108.83 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -128.7 112.18 13.95 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.375 -0.53 . . . . 74.23 111.123 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.7 m -101.71 151.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.281 -0.872 . . . . 72.53 109.073 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.21 131.48 56.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.969 -0.692 . . . . 74.1 109.711 175.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.3 tp -85.91 156.99 20.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.481 -0.781 . . . . 71.02 109.221 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.7 -1.13 8.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.354 0.597 . . . . 70.44 110.889 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -88.12 12.45 13.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 72.51 109.49 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 69.0 31.74 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.477 -0.783 . . . . 61.0 111.281 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.35 140.01 50.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.441 -0.345 . . . . 74.0 110.826 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -93.65 143.35 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.52 -0.309 . . . . 75.41 110.206 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.0 mt -118.82 133.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.409 -0.36 . . . . 70.44 110.335 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 64.5 mt -77.21 113.48 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.239 0.542 . . . . 70.43 110.304 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.671 ' HB2' ' HB2' ' A' ' 26' ' ' PHE . 28.3 m -108.67 143.5 37.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.108 -0.496 . . . . 72.25 110.204 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -148.95 156.23 41.98 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.96 -0.755 . . . . 74.54 108.96 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.81 132.21 33.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.722 -0.473 . . . . 75.13 109.722 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -117.99 -166.07 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.892 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -93.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.237 -0.892 . . . . 64.22 114.933 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -49.16 -39.58 29.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.578 0.584 . . . . 71.04 112.578 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.663 HG12 ' HB ' ' A' ' 49' ' ' ILE . 57.1 t -58.21 -40.66 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.899 0.381 . . . . 70.45 110.883 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -67.35 -39.73 85.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 72.25 110.644 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 1.8 mpt_? -76.4 -32.92 58.81 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.146 -0.221 . . . . 75.15 111.396 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -80.97 -9.99 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 72.52 110.847 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 66.55 37.51 4.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.679 -0.691 . . . . 74.34 111.239 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.741 HG21 HG13 ' A' ' 74' ' ' ILE . 50.0 mm -74.4 143.28 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.77 -0.65 . . . . 75.02 109.721 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -116.3 119.91 37.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.371 -0.377 . . . . 75.43 111.222 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 51' ' ' ILE . 4.0 mp -86.84 116.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.941 -0.572 . . . . 74.33 109.48 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.677 HD11 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -105.91 147.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.917 0.389 . . . . 75.32 110.968 -177.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.775 HD13 HD22 ' A' ' 20' ' ' LEU . 60.7 mt -78.73 130.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.496 . . . . 72.0 110.354 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.73 -18.53 11.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.55 -0.833 . . . . 75.15 112.521 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.02 155.52 17.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 71.22 109.755 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.794 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -96.92 109.98 22.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.32 -0.993 . . . . 75.31 108.32 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.598 HG23 HD11 ' A' ' 73' ' ' ILE . 26.7 m -116.61 174.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 75.04 112.233 -163.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' A' ' 12' ' ' GLU . 44.4 tp -106.3 124.62 49.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.258 -0.883 . . . . 74.43 110.344 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 5.2 p -119.27 120.6 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.704 -0.68 . . . . 73.11 109.408 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 28.5 mt-10 -98.54 109.47 22.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.807 -0.633 . . . . 75.41 110.222 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -125.35 153.06 43.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.174 -0.466 . . . . 74.01 111.105 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.633 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 47.2 t -100.02 143.96 29.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 73.33 110.711 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 63' ' ' ILE . 27.0 mm -79.54 3.2 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.271 -0.422 . . . . 74.42 111.581 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -73.81 -93.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.012 -0.43 . . . . 73.5 111.855 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -149.95 -67.51 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.337 0.495 . . . . 60.02 112.337 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.406 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.93 -39.45 89.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.896 0.332 . . . . 74.31 111.896 -174.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 62' ' ' SER . 74.1 m-20 -98.75 20.11 13.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.569 -0.287 . . . . 72.43 110.345 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.96 -38.83 11.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.245 -0.434 . . . . 73.24 111.145 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 12.2 mptt -77.55 -44.75 27.52 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.209 0.528 . . . . 72.23 109.891 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -126.88 139.91 52.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 64.42 110.799 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.39 14.4 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.617 -0.72 . . . . 74.33 111.665 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HG3' ' HB2' ' A' ' 60' ' ' GLU . 13.3 ptt180 -91.5 109.17 20.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.391 0.615 . . . . 75.3 110.342 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 57' ' ' VAL . 13.4 tt -96.42 131.49 43.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.35 -0.841 . . . . 71.02 109.494 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.741 HG13 HG21 ' A' ' 49' ' ' ILE . 5.4 tt -116.38 -68.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.559 -0.457 . . . . 75.24 111.832 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.669 ' H ' HG21 ' A' ' 74' ' ' ILE . 19.4 ttt180 174.42 172.99 0.2 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.166 -0.679 . . . . 72.53 109.166 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.743 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 27.5 tpt180 -78.85 127.54 32.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.8 -0.444 . . . . 74.34 109.8 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.5 pt? -61.85 123.56 18.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.315 -0.624 . . . . 73.45 109.315 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.63 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -78.41 161.05 27.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.905 -0.405 . . . . 73.21 109.905 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -65.69 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.797 -0.716 . . . . 75.05 111.735 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m 62.75 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.375 0.67 . . . . 75.3 111.84 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 p -91.33 75.72 6.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 55.13 111.299 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -76.98 -48.46 17.94 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.97 -0.559 . . . . 62.13 110.059 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' C ' ' HG1' ' A' ' 84' ' ' THR . 96.5 mtt180 61.23 -94.25 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.266 -0.879 . . . . 64.14 110.137 -172.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 83' ' ' ARG . 86.2 m -163.56 -45.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.561 -0.904 . . . . 74.22 108.561 178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.8 pt 50.54 20.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.973 1.309 . . . . 72.31 113.524 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -134.96 153.03 52.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.007 -0.368 . . . . 75.24 110.007 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.861 -0.59 . . . . 71.11 110.313 -179.428 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 25.1 ttt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.408 -0.59 . . . . 64.11 109.408 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.42 -46.65 96.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.014 0.435 . . . . 74.13 110.386 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.25 74.93 7.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.928 -0.767 . . . . 73.11 108.928 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 1' ' ' MET . 12.4 t70 -105.22 -54.37 2.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 72.13 110.361 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.95 -25.92 67.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.162 -0.926 . . . . 71.23 111.701 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HD2' ' HA ' ' A' ' 6' ' ' LYS . 9.7 tptm -97.49 -0.65 45.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.001 0.371 . . . . 72.35 112.001 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.3 p -104.64 94.74 5.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.831 0.348 . . . . 72.22 110.762 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -135.98 -29.31 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 74.01 110.865 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -95.79 92.89 6.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.988 0.423 . . . . 74.01 110.102 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 60' ' ' GLU . 2.2 pt? -150.81 168.92 22.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.273 -0.421 . . . . 71.15 110.948 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' HB2' HD13 ' A' ' 63' ' ' ILE . 32.7 t80 -106.2 130.53 54.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.474 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.15 127.23 53.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.845 -0.616 . . . . 64.11 110.87 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.403 HG22 HG13 ' A' ' 59' ' ' VAL . 3.6 m -141.79 177.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.968 0.413 . . . . 72.34 111.432 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.95 173.41 7.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 75.13 111.331 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.69 174.3 46.92 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.763 -0.935 . . . . 43.44 110.763 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.88 123.62 29.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.187 0.494 . . . . 62.44 110.554 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.825 ' HA ' HG13 ' A' ' 28' ' ' VAL . 7.5 p -72.01 134.09 30.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 72.2 110.963 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -103.8 -47.56 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.025 -0.534 . . . . 75.23 110.981 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.18 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 63.24 110.608 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 53' ' ' ILE . 2.5 pt? -135.15 155.74 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 75.53 110.847 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 19.0 tp -118.78 139.57 27.34 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.39 -0.967 . . . . 75.12 108.39 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.66 4.67 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.308 2.672 . . . . 75.04 113.889 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -92.39 28.5 1.94 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.341 -0.244 . . . . 64.25 110.341 177.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.56 27.39 17.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.501 0.667 . . . . 72.34 110.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 33.1 tt0 -112.88 136.6 52.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.121 -0.945 . . . . 72.4 110.134 -172.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.794 ' HB2' ' HB2' ' A' ' 38' ' ' CYS . 99.0 m-85 -125.91 162.56 24.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.438 -0.346 . . . . 75.31 110.169 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -137.09 112.96 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.266 0.555 . . . . 72.24 110.844 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.825 HG13 ' HA ' ' A' ' 17' ' ' VAL . 3.7 m -118.28 155.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 71.15 109.25 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.675 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -117.71 130.26 56.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.294 0.568 . . . . 74.34 110.722 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.74 144.92 50.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.089 -1.078 . . . . 72.52 108.089 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.65 1.09 3.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.819 0.342 . . . . 73.31 111.542 -175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -108.45 34.69 3.51 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.392 0.615 . . . . 74.51 109.869 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 66.9 38.5 3.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.184 0.809 . . . . 74.13 113.184 171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -128.99 118.71 23.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.366 -0.533 . . . . 72.24 111.253 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 44.4 mt-10 -104.22 127.44 51.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.528 -0.545 . . . . 74.11 109.528 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.39 147.99 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.974 0.416 . . . . 65.25 111.335 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.63 112.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.862 -0.608 . . . . 64.43 109.368 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.794 ' HB2' ' HB2' ' A' ' 26' ' ' PHE . 15.7 m -98.4 141.56 31.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.264 -0.425 . . . . 74.13 110.778 -174.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -151.26 127.76 10.74 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.341 -0.615 . . . . 72.21 109.341 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 m -72.15 117.53 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.17 0.509 . . . . 75.31 110.912 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 m -160.67 55.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 53.2 110.146 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' HA3' ' HD3' ' A' ' 72' ' ' ARG . . . -164.74 -135.74 1.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.767 -1.206 . . . . 62.14 113.389 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.09 -18.22 60.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.427 0.691 . . . . 74.02 111.626 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.554 HG22 ' HB ' ' A' ' 74' ' ' ILE . 12.1 t -54.3 -38.85 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 72.32 110.461 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 4.3 tmt_? -70.7 -28.55 64.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.57 -0.741 . . . . 74.22 110.647 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.41 -53.35 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.188 0.518 . . . . 72.41 110.856 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 t -90.89 -9.16 47.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.747 -0.66 . . . . 72.21 111.866 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 55.44 46.52 23.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.273 0.358 . . . . 75.43 111.346 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.777 HD11 HD11 ' A' ' 74' ' ' ILE . 44.2 mt -83.04 139.54 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.998 0.428 . . . . 74.04 110.593 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.62 125.64 34.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.899 -0.592 . . . . 75.12 111.122 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.25 125.72 44.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.095 -0.502 . . . . 73.41 109.653 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -128.57 148.52 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.684 0.278 . . . . 72.45 110.825 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 20' ' ' LEU . 61.3 mt -74.39 139.39 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 72.33 110.744 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.62 -15.67 52.73 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.832 -0.699 . . . . 71.44 111.794 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.87 175.31 6.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.584 -0.524 . . . . 70.25 109.584 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.595 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 13.9 mmm180 -92.38 154.02 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.65 ' HB ' HG23 ' A' ' 73' ' ' ILE . 35.1 m -127.0 152.89 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.048 0.451 . . . . 74.34 110.92 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.9 tp -107.65 122.34 46.51 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 72.4 108.517 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.638 ' HB ' HG13 ' A' ' 73' ' ' ILE . 2.2 p -116.78 121.6 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.252 0.549 . . . . 71.14 111.317 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.553 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 8.3 pt-20 -109.25 114.2 27.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.226 -0.897 . . . . 71.52 109.864 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 3.7 ppp? -123.44 159.2 29.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.831 0.348 . . . . 74.24 110.766 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 16.0 m -99.11 130.39 45.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.735 0.302 . . . . 74.44 110.952 -174.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.436 HD13 ' HB2' ' A' ' 11' ' ' PHE . 46.7 mm -69.35 -19.08 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.923 -0.58 . . . . 74.13 111.156 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -60.38 -88.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.54 0.57 . . . . 71.25 112.54 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -150.26 -68.75 0.19 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.799 0.666 . . . . 75.35 112.799 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.817 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.23 -48.13 68.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.994 -0.548 . . . . 75.13 112.382 -172.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 6.3 m-20 -99.46 26.94 5.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.712 0.264 . . . . 61.42 111.712 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.79 -44.07 43.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.639 0.257 . . . . 73.25 111.065 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -89.94 -14.55 33.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.83 0.348 . . . . 74.13 111.262 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -143.73 134.54 25.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.203 0.525 . . . . 72.02 111.267 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.47 -175.92 14.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.652 -0.704 . . . . 72.31 111.952 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HD3' ' HA3' ' A' ' 42' ' ' GLY . 76.5 mtt180 -92.44 108.54 20.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.657 -0.498 . . . . 71.14 109.657 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.65 HG23 ' HB ' ' A' ' 57' ' ' VAL . 2.8 mp -99.19 124.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.388 -0.597 . . . . 72.12 109.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.777 HD11 HD11 ' A' ' 49' ' ' ILE . 9.0 tt -118.46 -70.28 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.032 -0.667 . . . . 72.51 112.504 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.725 ' H ' HG21 ' A' ' 74' ' ' ILE . 4.4 tmt_? 173.3 148.11 0.06 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.865 -0.42 . . . . 72.24 109.865 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.549 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -149.67 147.84 28.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.134 -0.321 . . . . 72.34 110.134 171.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 78' ' ' LYS . 20.5 tp -52.18 149.48 5.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.934 -0.576 . . . . 72.41 111.119 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 10.7 mptt -63.53 179.45 0.46 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.218 0.532 . . . . 74.45 110.998 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.07 -176.92 35.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.618 -0.801 . . . . 64.15 111.542 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -128.56 152.67 48.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.888 0.344 . . . . 74.33 110.374 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m 66.15 179.8 0.2 Allowed 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.736 0.648 . . . . 64.52 111.541 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.522 ' O ' HG12 ' A' ' 85' ' ' ILE . 1.4 m-20 -92.48 -2.19 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 74.41 110.497 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 64.72 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 71.13 111.636 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -136.73 -8.05 1.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.897 0.332 . . . . 71.53 111.897 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 82' ' ' ASP . 29.1 pt -77.44 82.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.683 0.754 . . . . 53.03 111.53 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.3 m -94.78 14.82 20.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.661 -0.7 . . . . 73.12 110.632 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.543 -0.741 . . . . 72.44 109.318 179.024 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.768 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 33.4 ttm . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.91 -0.774 . . . . 63.35 108.91 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.768 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.5 m -98.15 -21.03 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.366 0.603 . . . . 75.5 109.851 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.23 88.35 3.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.433 -0.803 . . . . 74.33 109.303 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.25 -74.6 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.014 -0.365 . . . . 64.01 110.014 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -84.15 -34.91 23.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 71.22 110.184 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -101.69 35.03 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 75.42 110.367 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 p -68.7 -31.27 70.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.098 -0.501 . . . . 71.4 111.415 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 71.9 mmtt 72.56 168.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.748 0.819 . . . . 75.43 112.013 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 m -90.17 139.49 30.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.222 -0.899 . . . . 75.53 111.427 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.571 ' HG ' ' HG ' ' A' ' 62' ' ' SER . 5.7 mp -122.63 150.96 41.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.474 -0.565 . . . . 74.11 109.474 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.6 t80 -97.11 126.75 42.49 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.196 -0.668 . . . . 74.05 109.196 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -105.46 116.74 32.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.092 -0.504 . . . . 74.42 109.868 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.9 156.09 42.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 64.14 110.63 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.64 145.93 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.179 -0.464 . . . . 63.33 110.797 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.27 -166.43 14.54 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.07 -0.586 . . . . 61.23 112.001 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.58 129.5 39.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.292 -0.262 . . . . 73.4 110.292 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.852 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.3 p -73.1 132.14 33.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.965 0.412 . . . . 75.35 111.259 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 m -97.53 -49.04 5.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 64.55 111.267 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.2 169.05 9.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.2 -0.454 . . . . 74.23 110.564 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.7 pt? -134.65 154.25 51.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 75.14 110.863 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.8 mp -102.91 152.23 38.47 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.596 -0.729 . . . . 75.11 109.197 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.46 -10.93 17.67 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.964 2.443 . . . . 74.13 112.986 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.48 17.76 9.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 74.23 111.154 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 70.19 19.31 6.69 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.985 -0.552 . . . . 63.52 111.493 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -92.54 136.77 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.774 -0.824 . . . . 75.34 108.774 175.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.481 ' HE1' HG11 ' A' ' 40' ' ' VAL . 97.3 m-85 -122.01 157.8 30.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 75.55 110.561 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.12 125.08 28.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.098 -0.501 . . . . 72.01 109.764 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.852 HG12 ' HA ' ' A' ' 17' ' ' VAL . 8.6 m -133.16 154.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.452 -0.573 . . . . 73.44 109.452 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 1.03 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.49 140.99 44.22 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.038 -0.665 . . . . 74.43 111.316 177.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 tp -66.25 153.6 42.1 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.987 -1.116 . . . . 74.14 107.987 169.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.03 -11.36 28.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.438 . . . . 73.32 111.406 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -95.48 27.7 3.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 74.14 111.513 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 71.86 21.67 4.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.938 0.718 . . . . 74.25 112.938 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -120.5 119.25 32.43 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.17 -0.612 . . . . 74.45 110.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 1.03 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 36.6 mt-10 -86.63 144.1 27.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.223 0.535 . . . . 74.04 111.124 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.2 pt -130.22 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.597 -0.729 . . . . 74.13 109.731 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.591 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 4.0 mp -89.83 139.97 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.158 -0.682 . . . . 71.51 109.158 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.4 m -143.36 167.43 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.43 -0.211 . . . . 72.4 110.43 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.474 ' HA ' ' HD1' ' A' ' 26' ' ' PHE . 29.9 p80 -157.0 170.19 23.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.896 -0.409 . . . . 70.14 109.896 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG11 ' HE1' ' A' ' 26' ' ' PHE . 25.9 m -72.07 146.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.787 0.327 . . . . 74.41 110.312 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.8 t -121.72 -164.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.247 -0.433 . . . . 73.23 110.154 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.47 -91.5 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 O-C-N 124.254 0.971 . . . . 72.11 114.676 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -44.4 -44.78 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.877 0.471 . . . . 75.13 112.244 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.5 -44.34 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.696 0.284 . . . . 64.44 111.617 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -65.41 -49.82 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 74.24 110.923 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -87.23 -1.78 58.15 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.667 -0.413 . . . . 74.25 111.632 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 t -95.27 -12.77 25.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.722 -0.474 . . . . 61.43 109.722 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 57.82 77.54 0.28 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.346 -0.843 . . . . 74.11 111.629 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 HG23 HG13 ' A' ' 74' ' ' ILE . 41.9 mm -107.14 118.37 54.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.033 -0.531 . . . . 74.31 109.682 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -79.15 106.33 11.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.302 -0.408 . . . . 75.41 111.02 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 74' ' ' ILE . 35.6 mt -86.77 130.41 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.703 -0.48 . . . . 74.02 109.703 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.583 HD12 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -123.44 149.82 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 74.34 110.776 -177.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.6 mt -78.25 140.62 16.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.274 -0.421 . . . . 64.12 110.448 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 26.48 20.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 64.34 112.16 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -139.68 164.32 30.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.637 -0.505 . . . . 72.32 109.637 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 76' ' ' ARG . 32.6 mmt180 -75.87 151.08 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.499 -0.556 . . . . 73.41 109.499 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG11 HD11 ' A' ' 73' ' ' ILE . 25.9 m -136.24 151.0 28.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 72.14 110.918 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -107.4 122.4 46.54 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.763 -0.829 . . . . 74.35 108.763 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 p -112.12 131.61 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 60.42 110.501 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.653 ' OE2' ' HD2' ' A' ' 72' ' ' ARG . 42.4 tt0 -112.84 111.7 22.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.226 -0.897 . . . . 74.05 109.667 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.595 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -143.66 145.99 32.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.191 0.52 . . . . 71.32 111.147 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.571 ' HG ' ' HG ' ' A' ' 10' ' ' LEU . 4.7 m -84.65 143.21 29.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.354 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.741 HD13 ' H ' ' A' ' 63' ' ' ILE . 1.8 mp -78.06 4.04 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.298 0.571 . . . . 75.35 111.057 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -75.62 -88.52 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.325 0.491 . . . . 75.4 112.325 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -148.89 -64.42 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.84 0.681 . . . . 73.43 112.84 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.36 -33.31 67.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.77 0.319 . . . . 72.53 111.858 -175.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 61' ' ' MET . 94.6 m-20 -102.01 14.29 32.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.624 -0.262 . . . . 71.41 111.466 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.66 -32.39 22.01 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.151 -0.343 . . . . 61.3 111.921 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -100.18 -37.51 8.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.724 0.297 . . . . 74.34 110.288 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -119.73 131.12 55.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.62 . . . . 61.24 110.571 174.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.4 174.82 15.41 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.293 -0.723 . . . . 74.22 111.293 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.653 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 5.5 ptp180 -94.11 124.75 38.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.24 0.543 . . . . 75.35 109.837 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 HG11 ' A' ' 57' ' ' VAL . 5.5 tt -106.96 136.8 40.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.598 -0.728 . . . . 72.14 110.0 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.704 HG22 ' H ' ' A' ' 75' ' ' ARG . 5.6 tt -120.57 -67.94 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.821 -0.352 . . . . 75.04 111.221 177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.704 ' H ' HG22 ' A' ' 74' ' ' ILE . 8.7 ttt180 173.88 176.14 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.336 -0.616 . . . . 72.32 109.336 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.695 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -69.31 150.64 47.15 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.28 0.362 . . . . 74.42 110.174 172.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.685 ' HG ' ' H ' ' A' ' 78' ' ' LYS . 11.8 tp -137.04 176.17 8.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.529 -0.915 . . . . 73.23 108.529 166.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.685 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.02 109.2 3.38 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.345 -0.613 . . . . 74.41 109.345 176.066 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.1 66.23 3.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.56 -0.745 . . . . 65.44 113.746 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -84.32 95.27 8.67 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.584 0.707 . . . . 72.52 109.326 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.679 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 25.6 m -131.19 166.93 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.963 -0.562 . . . . 70.3 111.267 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.544 ' HA ' HG12 ' A' ' 85' ' ' ILE . 9.7 p-10 -69.11 1.66 3.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.871 0.693 . . . . 63.42 112.871 -172.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.679 ' HD3' ' HB2' ' A' ' 81' ' ' SER . 7.2 ptt180 -64.68 -32.78 74.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.382 0.512 . . . . 71.31 112.382 -174.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.415 ' HG1' ' C ' ' A' ' 83' ' ' ARG . 2.7 m -155.9 20.56 0.38 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.651 -0.42 . . . . 62.03 111.912 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.544 HG12 ' HA ' ' A' ' 82' ' ' ASP . 31.2 pt -86.61 23.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.666 -0.646 . . . . 75.34 111.166 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.3 m -125.36 16.02 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 53.53 110.097 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.557 -0.735 . . . . 74.35 109.915 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 88.2 mtp . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 110.086 -0.338 . . . . 72.41 110.086 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.466 HG21 ' HG2' ' A' ' 3' ' ' LYS . 12.9 m -69.36 -45.96 77.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.873 0.368 . . . . 75.13 110.432 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.466 ' HG2' HG21 ' A' ' 2' ' ' VAL . 71.5 mmtt -93.86 85.81 4.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.967 -1.123 . . . . 75.21 107.967 173.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.5 t70 -130.98 -42.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.083 -0.508 . . . . 74.44 110.974 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 21.8 mm-40 -61.58 -33.13 73.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.606 . . . . 75.44 110.765 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -96.7 12.16 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.995 -0.548 . . . . 75.21 110.72 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -106.65 7.97 30.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.981 -0.554 . . . . 61.1 109.624 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HE3' ' HA ' ' A' ' 5' ' ' GLU . 99.5 mttt -67.1 -31.51 72.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.602 -0.726 . . . . 73.24 110.584 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 m -87.68 81.13 7.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 73.15 109.416 172.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 10' ' ' LEU . 1.9 pt? -132.95 167.87 19.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.575 -0.739 . . . . 73.43 109.789 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 50.8 t80 -110.38 124.56 51.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.398 -0.593 . . . . 75.14 109.398 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.12 111.19 23.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.162 -0.681 . . . . 72.03 109.162 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 11' ' ' PHE . 9.9 p -129.54 162.75 36.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.801 0.334 . . . . 74.53 111.218 -173.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.18 130.02 39.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.021 -0.536 . . . . 72.54 110.115 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.15 158.68 21.62 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.205 -0.758 . . . . 34.13 111.205 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.36 123.45 47.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.212 0.506 . . . . 73.24 110.666 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.581 ' HA ' HG11 ' A' ' 28' ' ' VAL . 7.7 p -76.98 130.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.999 0.428 . . . . 72.35 110.435 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -126.55 -19.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.285 -0.416 . . . . 74.4 111.797 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -166.31 168.14 15.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.049 0.452 . . . . 75.45 111.899 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.01 150.25 37.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.416 -0.811 . . . . 74.13 109.267 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 157.12 34.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.436 -0.347 . . . . 74.12 110.752 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.85 -19.61 47.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.153 2.568 . . . . 75.41 113.022 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.09 14.08 1.26 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.545 0.202 . . . . 71.34 111.545 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.41 19.02 10.95 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.172 0.511 . . . . 74.11 111.555 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' HG2' ' HD1' ' A' ' 39' ' ' HIS . 42.5 mt-10 -105.59 135.78 46.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.586 -0.524 . . . . 63.42 109.586 174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -97.31 158.12 15.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.88 -0.6 . . . . 73.44 109.613 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -126.37 119.48 27.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.321 0.582 . . . . 74.52 110.784 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 17' ' ' VAL . 24.6 m -118.49 152.31 20.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.075 -0.966 . . . . 75.11 108.648 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -128.75 140.54 51.68 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.094 -0.643 . . . . 74.24 110.822 -177.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 59.3 tp -76.31 131.97 39.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.043 -1.466 . . . . 65.43 107.043 168.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -62.1 -7.17 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.216 0.323 . . . . 75.22 111.601 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 86' ' ' SER . 25.6 t-20 -91.46 38.97 0.99 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.705 -0.48 . . . . 71.23 109.705 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 61.82 40.24 13.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.284 0.846 . . . . 72.42 113.284 172.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -129.61 118.2 21.6 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.147 -0.346 . . . . 74.14 110.717 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -97.28 140.03 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.6 -0.273 . . . . 72.41 110.355 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 pt -134.71 145.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.0 0.428 . . . . 73.21 110.452 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 4.3 mp -89.11 148.82 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.009 -0.738 . . . . 74.43 109.009 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 85.5 m -139.93 144.89 37.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.998 0.428 . . . . 73.2 111.293 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.53 ' HD1' ' HG2' ' A' ' 25' ' ' GLU . 73.3 t60 -132.47 137.69 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.668 -0.493 . . . . 71.12 109.668 178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.67 117.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.209 0.528 . . . . 72.5 110.861 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -168.79 55.74 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.913 -0.773 . . . . 73.32 108.913 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.53 -145.96 4.55 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.434 -0.803 . . . . 63.21 111.362 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -62.63 -23.45 67.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 75.3 110.937 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 6.5 p -56.56 -39.86 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.191 -0.458 . . . . 75.13 111.483 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -33.43 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 75.42 110.296 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -66.89 -44.31 81.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.013 -0.54 . . . . 72.41 110.924 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -93.24 -1.74 55.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.961 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.9 63.91 1.8 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.587 0.554 . . . . 74.43 111.212 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.486 HG13 HD12 ' A' ' 74' ' ' ILE . 49.3 mm -95.58 139.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 65.3 110.931 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -97.3 117.27 31.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 75.52 111.179 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 51' ' ' ILE . 4.5 mp -86.9 124.18 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.707 -0.679 . . . . 74.11 109.794 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.64 HD12 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -114.32 147.91 17.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.759 0.314 . . . . 75.23 110.415 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.28 142.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.306 -0.406 . . . . 75.43 110.483 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 41.39 6.37 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.59 -0.814 . . . . 72.14 111.638 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.89 177.42 9.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.987 -0.746 . . . . 75.31 108.987 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -101.59 150.12 23.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.335 -0.617 . . . . 75.3 109.335 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 75' ' ' ARG . 34.4 m -134.99 160.61 41.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.596 0.236 . . . . 75.52 110.457 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.2 tp -106.58 116.34 31.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.713 -0.847 . . . . 73.24 108.713 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.1 p -105.9 127.57 60.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.419 0.628 . . . . 72.24 110.715 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.512 ' OE2' ' HD2' ' A' ' 72' ' ' ARG . 23.4 mt-10 -103.25 108.83 20.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.193 -0.912 . . . . 74.33 109.327 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.438 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -142.38 142.14 32.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.213 0.53 . . . . 72.34 111.531 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 p -99.48 142.2 31.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 75.05 109.958 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.683 HD13 ' H ' ' A' ' 63' ' ' ILE . 2.8 mp -78.16 3.53 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 74.45 111.244 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -61.93 -81.49 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.652 0.612 . . . . 73.41 112.652 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.32 -70.13 0.2 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.898 0.703 . . . . 75.4 112.898 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -68.02 -31.04 70.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.846 0.355 . . . . 74.21 111.546 -174.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.0 m120 -99.07 10.3 41.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.867 0.365 . . . . 73.3 110.594 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -19.62 44.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 71.11 111.007 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.469 ' HE3' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -113.12 -21.28 11.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.733 -0.387 . . . . 73.32 110.59 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.681 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -142.22 136.78 30.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 75.14 111.281 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 61' ' ' MET . . . -117.97 -175.56 16.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.682 -0.69 . . . . 70.32 111.953 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.512 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 52.6 mtt180 -89.97 116.89 28.36 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.971 -0.751 . . . . 73.45 108.971 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.628 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -108.45 130.0 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.942 -0.392 . . . . 72.11 109.942 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.74 HG21 ' H ' ' A' ' 75' ' ' ARG . 4.6 tt -132.74 -67.65 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.629 -0.26 . . . . 74.05 111.267 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.74 ' H ' HG21 ' A' ' 74' ' ' ILE . 12.0 ttt180 175.01 173.28 0.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.094 -0.706 . . . . 75.24 109.094 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -86.08 149.36 25.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.747 0.308 . . . . 74.12 110.642 175.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -93.0 145.09 24.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.433 -0.951 . . . . 73.43 108.433 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.35 126.3 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.145 -0.687 . . . . 75.44 109.145 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.05 61.87 0.58 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 109.452 -1.459 . . . . 62.52 109.452 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.8 t -146.2 -162.14 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.169 -0.515 . . . . 63.42 109.833 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 83' ' ' ARG . 20.9 m 78.8 89.97 0.06 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.947 0.899 . . . . 73.03 111.658 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 83' ' ' ARG . 34.1 t70 -69.98 13.94 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.177 -0.92 . . . . 74.41 110.787 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 76.6 169.85 0.25 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.854 0.862 . . . . 73.45 109.881 -176.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -72.75 -35.4 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.993 -0.283 . . . . 74.12 110.916 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.5 pt 45.19 22.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.627 1.171 . . . . 74.35 113.865 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 32' ' ' ASN . 33.2 p -126.79 3.54 6.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.071 0.463 . . . . 73.21 110.844 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.114 -0.946 . . . . 75.44 109.022 179.235 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.255 -0.276 . . . . 71.11 110.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG21 ' HG2' ' A' ' 3' ' ' LYS . 34.6 m -95.72 -25.0 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.827 0.346 . . . . 75.25 111.005 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' HG2' HG21 ' A' ' 2' ' ' VAL . 73.7 mmtt -119.5 92.26 3.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 74.22 110.225 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -119.95 -36.52 3.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.887 -0.597 . . . . 65.12 110.236 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 22.8 mp0 -58.47 -55.79 30.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.681 -0.859 . . . . 74.42 108.681 175.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.81 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 7.2 mmpt? -110.25 83.17 1.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.865 -1.062 . . . . 74.03 108.206 167.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -55.14 -69.92 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.378 -0.828 . . . . 72.22 111.53 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -142.93 105.18 4.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.849 -0.614 . . . . 74.41 109.885 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.7 m -87.47 97.55 10.89 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.322 -0.621 . . . . 75.04 109.322 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.9 pt? -139.2 169.02 18.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.776 -0.647 . . . . 72.54 110.715 -173.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -124.22 129.87 51.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.533 -0.543 . . . . 75.22 109.533 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -101.71 115.08 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.951 -0.568 . . . . 73.4 110.297 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.46 153.26 30.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.503 -0.317 . . . . 73.23 110.191 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -102.32 155.64 18.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 65.41 111.05 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.44 -168.81 20.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.826 -0.624 . . . . 71.43 111.756 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.14 124.27 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.901 0.351 . . . . 75.34 111.07 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.649 ' HA ' HG11 ' A' ' 28' ' ' VAL . 5.4 p -74.9 122.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.998 0.428 . . . . 73.42 109.892 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -113.57 -21.04 11.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.253 -0.43 . . . . 74.51 111.688 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.03 163.25 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.774 0.321 . . . . 73.21 110.819 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.65 HD23 HD11 ' A' ' 53' ' ' ILE . 2.7 pt? -128.92 143.5 50.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 72.3 109.705 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 23' ' ' ALA . 6.5 mp -96.34 146.75 31.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 109.289 -0.634 . . . . 74.53 109.289 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.0 20.75 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.806 2.338 . . . . 54.51 112.119 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -109.69 18.41 20.27 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.567 -0.742 . . . . 75.21 109.764 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.51 29.07 9.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.471 -0.786 . . . . 75.1 111.17 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 10.3 pt-20 -136.8 151.01 48.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.581 . . . . 74.25 110.333 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.29 163.54 13.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.315 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -126.58 130.19 50.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.525 -0.47 . . . . 74.43 110.337 174.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.649 HG11 ' HA ' ' A' ' 17' ' ' VAL . 17.7 m -125.88 146.86 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 71.54 110.838 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.65 142.39 49.07 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.882 -0.414 . . . . 74.23 109.882 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -82.68 158.33 22.99 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.865 -0.791 . . . . 74.32 108.865 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.02 -3.84 6.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.328 0.585 . . . . 72.34 110.782 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -81.72 9.95 6.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 72.24 110.204 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 64.19 33.82 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.783 -0.644 . . . . 73.31 111.919 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -124.85 120.78 32.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.804 -0.634 . . . . 71.33 109.867 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.58 144.26 42.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.429 -0.805 . . . . 65.14 111.872 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 28.3 pt -137.39 168.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.554 -0.748 . . . . 73.41 109.603 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.672 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 34.3 mt -102.21 147.89 8.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 65.6 m -137.99 163.19 32.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.894 0.378 . . . . 64.14 110.831 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 46.5 p-80 -151.31 166.56 30.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.783 -0.451 . . . . 74.21 109.783 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.38 152.0 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.597 0.237 . . . . 61.44 110.538 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -139.36 -167.9 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.525 -0.307 . . . . 74.34 110.481 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -32.39 -94.15 0.01 OUTLIER Glycine 0 C--N 1.338 0.641 0 N-CA-C 115.923 1.129 . . . . 70.43 115.923 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -52.86 -35.9 58.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.125 0.416 . . . . 74.32 112.125 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.3 t -56.47 -48.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.52 111.335 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.31 -33.29 74.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.383 -0.371 . . . . 61.41 111.133 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -85.76 -17.06 36.89 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.795 0.294 . . . . 72.4 111.795 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.7 p -74.3 -22.62 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.801 0.297 . . . . 74.34 111.801 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.74 36.74 22.3 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.11 0.481 . . . . 73.43 111.386 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.792 HG12 HG13 ' A' ' 74' ' ' ILE . 2.2 pp -76.43 163.0 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.222 -0.445 . . . . 71.5 110.677 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -102.14 109.18 20.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 73.24 110.855 -178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 74' ' ' ILE . 48.3 mt -93.03 111.56 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 72.41 109.741 175.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.595 HD12 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.34 147.88 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.832 0.348 . . . . 74.45 110.718 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.65 HD11 HD23 ' A' ' 20' ' ' LEU . 52.7 mt -75.78 140.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.074 -0.512 . . . . 72.11 110.566 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.05 57.05 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.858 -0.687 . . . . 30.12 112.329 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.58 158.22 16.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.834 -0.432 . . . . 74.32 109.834 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.413 ' HD3' ' HA ' ' A' ' 56' ' ' ARG . 62.3 mmt-85 -75.93 140.52 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.215 0.531 . . . . 73.54 110.671 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 75' ' ' ARG . 24.6 m -133.6 160.64 42.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 72.21 110.952 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.24 126.79 52.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.841 -0.618 . . . . 72.12 109.477 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.54 129.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.68 0.752 . . . . 74.05 109.952 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -117.54 109.31 16.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.037 -0.983 . . . . 73.43 109.108 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.538 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -147.77 156.07 42.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 74.45 112.252 -175.02 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 10' ' ' LEU . 16.3 m -93.53 142.89 26.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.468 -0.787 . . . . 73.35 110.439 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 63' ' ' ILE . 22.8 mm -78.86 3.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.167 -0.47 . . . . 73.04 111.941 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.41 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 89.8 m-85 -57.2 -85.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.548 0.573 . . . . 74.43 112.548 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -149.02 -69.26 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.012 0.375 . . . . 74.2 112.012 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -34.11 75.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.903 0.383 . . . . 74.34 111.29 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.589 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 13.8 m120 -83.32 -9.53 59.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.839 -0.344 . . . . 72.43 110.814 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.92 -8.14 59.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.358 0.599 . . . . 74.2 109.599 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -108.29 -49.05 3.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.3 -0.864 . . . . 74.4 109.544 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -124.34 130.04 51.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.643 -0.708 . . . . 75.31 111.058 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 61' ' ' MET . . . -118.58 -177.85 16.87 Favored Glycine 0 N--CA 1.454 -0.164 0 N-CA-C 111.449 -0.66 . . . . 71.21 111.449 176.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 5.5 ptp180 -93.31 124.97 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.514 0.657 . . . . 71.22 109.719 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.63 137.28 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 74.33 109.701 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.792 HG13 HG12 ' A' ' 49' ' ' ILE . 4.2 tt -125.58 -71.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.323 -0.551 . . . . 55.31 111.634 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.736 ' H ' HG21 ' A' ' 74' ' ' ILE . 38.1 ttt180 171.95 172.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.38 -0.6 . . . . 74.33 109.38 174.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.556 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 14.4 tpt180 -73.49 147.55 43.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.617 -0.883 . . . . 73.14 108.617 165.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.37 173.89 2.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.104 0.478 . . . . 73.44 111.115 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 112.15 10.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 75.55 110.635 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.424 ' C ' ' HG1' ' A' ' 80' ' ' THR . . . 90.56 -168.65 33.46 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.768 -0.73 . . . . 74.13 111.879 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.424 ' HG1' ' C ' ' A' ' 79' ' ' GLY . 68.2 p 51.97 26.65 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 73.22 112.182 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 p -69.01 -29.2 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 73.12 111.284 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.89 -52.96 6.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.445 0.641 . . . . 72.42 109.737 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -176.93 -62.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.673 -1.149 . . . . 73.42 108.97 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.723 HG23 ' H ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -121.04 -84.37 0.66 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.923 . . . . 62.41 110.404 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.723 ' H ' HG23 ' A' ' 84' ' ' THR . 20.8 pt 44.31 27.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.33 1.052 . . . . 74.2 112.793 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.1 p -93.05 5.75 50.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.234 0.54 . . . . 70.53 110.6 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.367 -0.825 . . . . 74.43 109.439 177.299 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.344 -0.243 . . . . 73.33 110.344 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.2 106.69 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.525 . . . . 74.23 111.232 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.0 mmtm -139.71 80.87 1.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.857 -0.61 . . . . 75.15 110.24 175.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.567 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 8.3 p-10 -170.85 -19.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.021 -0.99 . . . . 73.13 110.345 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -53.52 -40.26 65.31 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.938 -0.574 . . . . 71.33 111.568 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -107.03 25.12 11.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.256 0.551 . . . . 72.14 111.152 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' A' ' 4' ' ' ASP . 46.9 p -144.85 43.89 1.35 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.74 -0.664 . . . . 71.4 109.762 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.77 1.88 21.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.807 -0.633 . . . . 74.24 111.07 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.426 ' HG1' ' HE2' ' A' ' 64' ' ' TYR . 7.8 p -88.16 86.56 7.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.841 -0.8 . . . . 51.12 108.841 168.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.708 HD13 ' HG2' ' A' ' 60' ' ' GLU . 1.7 pt? -146.52 -177.28 5.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.548 . . . . 74.21 110.739 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -126.03 146.16 50.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.019 -0.363 . . . . 73.12 110.019 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.41 115.09 29.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 75.55 110.088 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.512 HG21 ' HE1' ' A' ' 61' ' ' MET . 42.9 t -111.13 142.9 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.159 0.504 . . . . 72.51 111.274 -172.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -93.85 121.89 35.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 74.4 109.781 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.72 140.0 6.34 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.555 -0.831 . . . . 73.35 112.292 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 56' ' ' ARG . . . -85.74 152.57 22.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.291 . . . . 75.22 110.536 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -67.75 142.5 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 75.55 110.363 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 1.044 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 12.6 t -111.97 -33.59 6.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.668 0.27 . . . . 75.54 110.551 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.72 168.6 22.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 75.54 110.256 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.6 156.0 42.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.032 0.444 . . . . 73.42 110.851 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 37.1 tp -119.09 129.86 25.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.204 -1.036 . . . . 73.33 108.204 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.44 22.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.485 0 C-N-CA 123.363 2.708 . . . . 74.54 113.333 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -105.19 25.82 10.12 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.35 -0.611 . . . . 75.14 109.35 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 71.42 27.89 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 63.3 111.069 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.734 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 tt0 -111.28 136.06 50.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.728 -0.669 . . . . 74.12 110.274 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.497 ' HB2' HG22 ' A' ' 73' ' ' ILE . 92.0 m-85 -131.29 125.76 33.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.616 -0.513 . . . . 75.24 109.616 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -110.33 114.96 28.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.101 0.477 . . . . 75.42 110.897 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.3 m -105.54 156.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.818 -0.628 . . . . 72.33 109.602 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 1.044 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.98 131.38 53.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.471 0.653 . . . . 73.33 110.921 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 64.4 tp -74.85 144.76 43.27 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.074 -1.084 . . . . 73.54 108.074 170.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.79 -20.09 54.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.906 0.384 . . . . 53.43 111.048 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 8.7 t30 -86.91 30.85 0.72 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.189 -0.46 . . . . 75.02 110.963 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 33' ' ' GLU . 28.7 tt0 67.43 38.87 3.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.405 0.622 . . . . 65.23 111.293 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -129.63 118.53 22.09 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.634 -0.666 . . . . 74.31 110.33 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.19 132.11 52.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.957 -0.386 . . . . 70.33 109.957 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.03 136.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 72.42 111.205 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 73.8 mt -79.75 109.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.352 0.596 . . . . 73.15 110.214 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 55.7 m -114.11 168.03 10.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 70.42 110.488 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -155.93 172.81 17.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.122 -0.49 . . . . 65.45 109.957 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.97 118.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.184 0.516 . . . . 73.12 110.583 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.1 p -165.98 60.47 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.899 -0.591 . . . . 74.41 110.064 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.15 -140.35 2.85 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.806 -0.711 . . . . 64.22 111.669 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.03 -30.49 71.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.797 0.332 . . . . 61.44 110.453 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.742 HG23 ' HB ' ' A' ' 49' ' ' ILE . 7.7 p -57.56 -29.61 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.985 -0.552 . . . . 63.22 111.468 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.436 ' C ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.57 -48.75 59.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 75.11 110.866 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -88.91 -21.38 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.509 0.559 . . . . 71.05 112.509 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.6 t -93.17 -14.29 27.34 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.848 -0.341 . . . . 72.12 110.879 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.69 83.81 0.12 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.663 0.602 . . . . 72.23 111.24 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.742 ' HB ' HG23 ' A' ' 44' ' ' VAL . 50.9 mm -114.26 141.97 28.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.197 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -91.84 118.14 30.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.562 -0.29 . . . . 74.5 110.642 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 74' ' ' ILE . 4.0 mp -81.73 122.29 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.097 -0.502 . . . . 75.42 109.674 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.677 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -112.39 146.28 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.942 0.401 . . . . 73.21 110.821 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 17' ' ' VAL . 45.6 mm -79.9 129.51 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.011 -0.541 . . . . 74.25 110.677 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.76 10.83 26.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.709 -0.757 . . . . 75.21 112.212 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.92 139.94 46.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.071 -0.344 . . . . 65.34 110.071 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.0 mtt180 -86.33 116.86 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 74.25 109.222 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.02 -178.04 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.186 0.517 . . . . 71.25 111.354 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 tp -112.77 122.49 47.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.789 . . . . 74.42 109.518 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.37 128.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 74.22 110.16 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HG2' HD13 ' A' ' 10' ' ' LEU . 37.0 tt0 -113.56 109.38 18.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.717 -0.674 . . . . 74.02 110.376 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.512 ' HE1' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -152.19 165.06 36.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 71.31 110.124 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 31.2 t -99.94 161.76 13.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.833 0.349 . . . . 73.35 110.534 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.8 mm -80.43 -7.89 10.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 74.41 111.325 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.426 ' HE2' ' HG1' ' A' ' 9' ' ' THR . 23.3 m-85 -69.8 -93.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.678 0.992 . . . . 64.23 113.678 -168.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 17.8 p-10 -146.18 -71.04 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.064 0.764 . . . . 64.42 113.064 -172.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.496 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -79.72 -27.28 40.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.248 0.547 . . . . 75.31 110.429 -174.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.639 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 65.4 t30 -98.43 17.13 19.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.625 -0.716 . . . . 71.15 109.08 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 62' ' ' SER . . . -101.55 -49.91 3.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 71.14 111.716 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -94.11 21.5 6.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.255 0.55 . . . . 75.42 111.378 -177.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.639 ' HE3' ' HA ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -147.57 142.15 26.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.721 -0.844 . . . . 65.31 108.721 172.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.42 163.86 25.41 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.116 -1.04 . . . . 55.44 112.559 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 2.1 ptp180 -96.72 120.42 37.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.906 0.384 . . . . 74.15 110.131 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.497 HG22 ' HB2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -114.25 137.27 48.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.047 -0.524 . . . . 75.53 109.617 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 75' ' ' ARG . 3.3 tt -129.0 -66.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.358 -0.383 . . . . 65.11 110.809 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.689 ' H ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER 175.19 172.98 0.26 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.127 -1.064 . . . . 73.35 108.127 177.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 74.2 ttt-85 -70.52 131.15 43.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.93 -0.396 . . . . 75.02 109.93 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.638 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.1 pt? -66.35 140.48 58.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 74.1 109.82 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 78' ' ' LYS . 3.6 mppt? -88.06 110.21 20.45 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.497 -0.557 . . . . 75.14 109.497 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.1 103.42 1.97 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.749 -0.659 . . . . 63.13 111.754 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 t -112.71 125.59 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.29 0.567 . . . . 71.43 110.256 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.2 m -146.71 47.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.613 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -50.53 -60.3 3.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.767 -0.651 . . . . 73.51 110.283 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -150.06 -74.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 65.22 109.172 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -165.68 95.22 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.825 0.822 . . . . 72.03 109.948 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.39 128.79 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.398 -0.819 . . . . 64.25 110.712 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -108.12 0.13 21.42 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.776 -0.647 . . . . 61.32 109.994 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.1 ttpt . . . . . 0 C--O 1.244 0.787 0 CA-C-N 115.325 -0.852 . . . . 72.14 109.256 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.703 0.287 . . . . 65.4 110.428 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.9 m -98.82 -43.93 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.682 0.277 . . . . 73.24 111.233 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -131.21 94.3 3.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.935 0.397 . . . . 75.13 109.939 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.2 -40.94 9.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.674 -0.693 . . . . 75.11 109.594 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 11.9 mt-10 -59.93 -58.3 9.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.017 -0.992 . . . . 74.11 109.722 177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 5' ' ' GLU . 11.9 mptt -84.82 94.38 8.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.032 -0.986 . . . . 74.54 108.545 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -70.27 96.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.479 -0.782 . . . . 72.24 112.522 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.35 -22.53 20.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 73.13 109.247 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -84.7 69.27 10.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.348 -0.842 . . . . 74.13 111.003 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 61' ' ' MET . 2.7 pt? -127.23 161.17 29.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 70.2 109.167 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.679 ' HB2' HD13 ' A' ' 63' ' ' ILE . 9.1 t80 -92.68 123.97 36.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.484 -0.561 . . . . 74.3 109.484 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.07 104.82 7.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.818 -0.628 . . . . 73.4 109.502 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.439 ' O ' HD11 ' A' ' 58' ' ' LEU . 14.3 m -143.16 170.47 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.844 0.354 . . . . 73.14 111.829 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -93.05 138.54 31.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.535 -0.757 . . . . 63.34 109.963 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.2 -175.93 15.19 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.058 -0.591 . . . . 62.21 112.045 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -121.84 123.78 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.697 0.285 . . . . 72.15 110.588 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.551 ' HA ' HG13 ' A' ' 28' ' ' VAL . 3.0 p -73.17 123.35 27.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.109 0.48 . . . . 74.04 109.799 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 14.6 t -100.57 -32.49 10.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.1 -0.5 . . . . 74.23 111.081 -175.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -165.26 168.17 17.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.996 0.427 . . . . 74.11 111.311 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 ' HG ' HD12 ' A' ' 53' ' ' ILE . 4.1 pp -133.84 155.61 49.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.58 -0.736 . . . . 71.43 109.757 174.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.35 143.87 36.88 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.386 -0.37 . . . . 73.4 110.108 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.67 59.91 2.12 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.176 2.584 . . . . 74.14 112.639 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.24 25.67 0.47 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.732 -0.667 . . . . 54.22 109.614 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.46 19.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.515 -0.766 . . . . 64.22 109.988 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -118.19 136.33 53.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 75.32 110.197 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 91.1 m-85 -122.78 158.75 29.52 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.628 -0.508 . . . . 75.05 109.628 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 27' ' ' ARG . 24.2 mtt85 -133.64 116.12 15.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.466 0.651 . . . . 73.23 110.521 173.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.555 HG23 HD11 ' A' ' 73' ' ' ILE . 31.0 m -116.61 156.12 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.136 -0.938 . . . . 74.11 109.543 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.803 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.049 0.452 . . . . 74.41 110.988 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.31 148.43 51.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.945 -1.131 . . . . 73.24 107.945 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.36 -17.48 54.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 74.33 111.087 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -84.44 19.26 1.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.051 -0.522 . . . . 74.34 110.379 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 68.83 50.98 0.6 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.714 0.806 . . . . 73.15 112.725 172.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -129.75 118.12 21.34 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.922 -0.399 . . . . 72.5 109.922 171.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.803 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 45.5 mt-10 -97.74 134.58 40.72 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.123 0.264 . . . . 71.33 110.778 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.553 HD13 HG23 ' A' ' 59' ' ' VAL . 31.2 pt -129.3 170.1 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 74.34 111.315 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 66.9 mt -89.35 140.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 74.43 110.432 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 17.1 t -126.44 142.0 51.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.018 0.437 . . . . 73.31 111.144 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -143.8 160.78 40.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.661 -0.7 . . . . 75.53 109.58 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.31 130.56 35.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.12 0.486 . . . . 72.43 110.406 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -112.9 -175.85 2.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.122 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -30.15 -92.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.622 0 O-C-N 124.588 1.18 . . . . 72.01 115.108 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 38.9 ttpt -48.75 -45.22 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.373 0.508 . . . . 73.24 112.373 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.66 -40.76 77.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.302 . . . . 74.31 111.48 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -62.17 -45.84 91.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 72.44 111.043 -176.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.08 -17.71 32.23 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.493 -0.483 . . . . 73.23 111.495 -175.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.7 t -84.15 -23.38 30.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.898 -0.137 . . . . 70.11 111.062 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt 60.59 87.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.528 0.518 . . . . 74.05 110.931 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.504 HG21 HG13 ' A' ' 74' ' ' ILE . 44.2 mm -107.83 141.38 23.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.342 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -89.74 106.33 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.367 -0.379 . . . . 72.33 110.667 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.55 113.85 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.258 -0.428 . . . . 73.13 109.87 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.501 ' O ' HG12 ' A' ' 17' ' ' VAL . 36.1 pt -110.82 150.38 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.398 -0.364 . . . . 73.13 110.827 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 20' ' ' LEU . 54.5 mt -77.56 137.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.501 -0.318 . . . . 63.21 110.725 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' H ' HG13 ' A' ' 17' ' ' VAL . . . 89.06 17.41 56.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.884 -0.674 . . . . 72.35 112.807 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.2 158.14 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.902 -0.407 . . . . 73.42 109.902 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.468 ' NH1' ' HB2' ' A' ' 16' ' ' ALA . 34.9 mmt180 -75.38 130.87 39.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 74.31 109.987 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.632 ' HB ' HG23 ' A' ' 73' ' ' ILE . 15.9 m -132.12 154.71 40.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.475 . . . . 74.52 111.255 -175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 13' ' ' VAL . 35.6 tp -105.86 122.53 46.29 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.424 -0.584 . . . . 72.32 109.424 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.553 HG23 HD13 ' A' ' 36' ' ' ILE . 7.5 p -104.25 131.36 53.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.308 0.575 . . . . 75.53 111.113 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -120.15 110.05 16.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 75.3 109.123 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 4.1 ppp? -131.29 159.35 38.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.823 0.344 . . . . 73.05 111.226 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.736 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 10.0 m -99.0 136.62 38.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.179 -0.464 . . . . 52.23 111.341 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.679 HD13 ' HB2' ' A' ' 11' ' ' PHE . 18.9 mm -76.97 3.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.181 0.515 . . . . 72.13 111.139 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -74.54 -92.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.794 0.664 . . . . 75.44 112.794 -173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -140.02 -69.94 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.083 0.401 . . . . 75.53 112.083 -171.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.734 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.65 -41.13 72.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 72.3 111.523 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.736 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 83.3 m-20 -90.57 15.47 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.877 0.37 . . . . 74.14 110.449 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.59 47.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.103 0.478 . . . . 74.13 110.455 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 17.83 5.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.522 0.677 . . . . 73.45 110.29 177.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -147.1 134.11 20.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 75.32 108.805 177.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.67 -178.9 16.4 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.299 -0.953 . . . . 41.53 112.354 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -111.87 139.58 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.57 -0.53 . . . . 74.41 109.57 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.632 HG23 ' HB ' ' A' ' 57' ' ' VAL . 18.6 mm -114.07 134.1 58.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.976 -0.556 . . . . 73.3 110.438 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.768 HG21 ' H ' ' A' ' 75' ' ' ARG . 4.8 tt -112.81 -69.58 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.409 -0.516 . . . . 74.22 109.97 170.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.768 ' H ' HG21 ' A' ' 74' ' ' ILE . 60.8 ttt180 172.57 172.48 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.34 -0.985 . . . . 74.01 108.34 172.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HD3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -70.02 124.55 24.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.263 -1.014 . . . . 74.11 108.263 174.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.6 pt? -63.49 145.85 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.972 0.415 . . . . 75.23 110.722 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 78' ' ' LYS . 3.9 mppt? -82.06 113.01 19.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 70.2 109.823 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.79 100.37 2.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.624 -0.798 . . . . 42.23 111.199 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -76.81 73.1 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.768 0.794 . . . . 73.22 111.38 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -104.16 83.07 2.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.594 -0.73 . . . . 74.3 110.351 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' OD2' ' HD3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -92.7 -73.82 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 73.31 110.35 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.615 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 164.93 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 124.3 1.0 . . . . 75.25 109.742 174.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 83' ' ' ARG . 33.4 m -146.73 -32.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.577 0.954 . . . . 75.51 113.577 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 82' ' ' ASP . 36.0 pt -47.04 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.77 1.026 . . . . 75.45 113.77 -167.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 m -158.63 7.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.042 -0.981 . . . . 70.44 109.843 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.844 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.876 0 CA-C-N 115.493 -0.776 . . . . 65.32 109.5 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HE2' ' HA2' ' A' ' 42' ' ' GLY . 69.8 mtm . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.814 -0.439 . . . . 73.21 109.814 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.77 -41.4 85.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.6 -0.519 . . . . 74.33 109.6 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -82.46 64.01 6.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.805 -0.813 . . . . 74.15 108.805 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' HA ' HH12 ' A' ' 72' ' ' ARG . 34.7 m-20 -169.79 -60.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.217 -1.401 . . . . 65.33 107.217 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.689 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 25.7 mm-40 -58.16 -57.83 11.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.079 -1.419 . . . . 74.51 111.575 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 6' ' ' LYS . 10.9 mptt -87.5 29.2 0.89 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.349 0.595 . . . . 72.41 110.63 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.5 m -141.16 22.89 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 72.41 110.055 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.689 ' HE3' ' HA ' ' A' ' 5' ' ' GLU . 96.3 mttt -72.01 -37.12 69.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.251 -0.431 . . . . 73.55 110.731 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 m -96.99 102.05 13.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.747 -0.464 . . . . 75.54 109.747 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.76 -178.84 6.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.059 -0.518 . . . . 73.35 109.971 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.42 124.64 43.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.011 0.434 . . . . 75.33 109.855 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 15.9 mt-10 -112.13 113.66 26.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.827 -0.624 . . . . 73.55 110.412 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.538 ' HB ' HD11 ' A' ' 30' ' ' LEU . 17.3 m -119.63 157.72 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.108 0.48 . . . . 74.53 111.089 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -112.71 117.49 32.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.956 -0.565 . . . . 53.24 109.629 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.82 -170.29 11.89 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.68 -0.772 . . . . 61.2 111.905 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.619 ' HB2' ' HD3' ' A' ' 56' ' ' ARG . . . -123.96 143.83 50.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.884 0.342 . . . . 72.41 110.722 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.687 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.3 p -71.25 139.93 19.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.233 -0.439 . . . . 73.4 110.364 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -102.35 -46.84 4.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.227 0.537 . . . . 75.2 110.548 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.6 168.45 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.298 -0.864 . . . . 63.4 109.789 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.532 HD23 HD13 ' A' ' 53' ' ' ILE . 2.6 pt? -127.29 155.54 43.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 74.22 110.707 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 23' ' ' ALA . 5.5 mp -108.04 149.32 38.97 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.478 -0.783 . . . . 73.4 109.516 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.93 12.98 0.32 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.301 2.667 . . . . 74.23 113.362 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -105.47 23.96 12.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.47 -0.332 . . . . 74.52 110.345 178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.98 32.98 19.92 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.813 0.816 . . . . 73.24 109.473 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.29 144.0 48.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.564 -1.198 . . . . 65.25 109.344 -173.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.811 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 97.0 m-85 -119.43 162.93 18.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.921 0.391 . . . . 74.14 111.073 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -134.83 115.84 14.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.853 -0.612 . . . . 73.32 109.987 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 17' ' ' VAL . 15.2 m -122.79 156.25 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.887 -0.597 . . . . 74.35 110.571 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.834 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -125.66 141.28 52.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.924 0.393 . . . . 73.44 110.541 177.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 13' ' ' VAL . 56.3 tp -62.48 159.78 14.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.425 -0.954 . . . . 74.41 108.425 169.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -9.68 41.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.101 0.41 . . . . 63.32 112.071 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -91.21 4.58 51.9 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.857 0.837 . . . . 74.2 109.623 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 68.41 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.81 -1.086 . . . . 62.34 112.772 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -130.1 119.07 22.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.843 -1.169 . . . . 70.55 107.843 164.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.834 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 32.5 mt-10 -97.58 137.4 36.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.132 0.491 . . . . 75.32 111.967 -172.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.64 167.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.466 -0.788 . . . . 73.43 109.951 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 56.3 mt -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.225 -0.443 . . . . 63.15 109.936 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.811 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 34.9 t -126.78 140.45 52.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.786 0.327 . . . . 73.23 110.677 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.68 155.58 31.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 71.43 109.407 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.6 m -71.66 130.86 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.212 0.53 . . . . 74.01 110.751 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 m -118.72 -165.19 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 53.13 109.969 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' A' ' 1' ' ' MET . . . -38.68 -92.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 O-C-N 124.191 0.932 . . . . 52.52 114.814 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -44.51 -39.71 5.06 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.786 0.661 . . . . 75.42 112.786 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.11 -39.61 86.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.624 0.231 . . . . 74.41 111.624 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' C ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.37 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.386 -0.37 . . . . 74.43 111.62 -172.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -5.94 58.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.35 -0.54 . . . . 74.25 111.305 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.1 t -86.42 -20.65 27.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.527 -0.306 . . . . 70.23 110.614 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 58.77 79.67 0.21 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 75.52 110.235 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.495 HG22 ' HA ' ' A' ' 74' ' ' ILE . 35.8 mm -105.74 138.38 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.343 -0.844 . . . . 65.34 111.173 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -108.78 107.55 18.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 74.11 110.11 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.89 111.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.465 -0.568 . . . . 72.02 109.465 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.76 HD11 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -100.58 151.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 72.53 111.988 -172.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.545 ' HA ' HG11 ' A' ' 17' ' ' VAL . 60.0 mt -78.5 128.02 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.697 -0.683 . . . . 63.23 111.407 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.0 -31.22 7.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.973 -0.632 . . . . 52.32 112.783 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -85.5 150.83 24.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.6 0.238 . . . . 75.12 110.834 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.619 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 70.9 mmt-85 -75.23 137.51 41.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.718 -0.475 . . . . 75.32 109.718 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.34 165.13 21.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.041 0.448 . . . . 65.25 111.05 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 tp -107.14 113.89 27.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.616 . . . . 64.3 109.496 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 73' ' ' ILE . 2.8 p -116.35 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.366 0.603 . . . . 65.3 110.582 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.576 ' HB3' ' HG2' ' A' ' 12' ' ' GLU . 10.7 pt-20 -108.73 117.8 35.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.711 . . . . 74.34 109.546 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.62 156.28 48.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 75.5 110.382 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 7.8 m -99.91 118.79 37.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.577 -0.527 . . . . 64.1 109.577 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.6 mt -73.61 3.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.455 0.645 . . . . 73.31 110.897 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -69.98 -74.53 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 72.45 111.95 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -148.48 -70.79 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.555 0.946 . . . . 72.42 113.555 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.776 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -80.18 -50.54 10.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.186 0.439 . . . . 61.01 112.186 -171.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.2 t30 -81.33 26.2 0.47 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 65.14 110.068 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 66' ' ' ARG . . . -98.13 -41.58 7.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.868 -0.606 . . . . 70.31 111.401 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HD2' ' H ' ' A' ' 69' ' ' LYS . 9.5 mptt -65.46 -43.16 91.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.237 0.541 . . . . 74.34 110.152 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -124.55 152.33 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.428 -0.806 . . . . 74.1 110.312 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.0 159.1 14.37 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.798 -0.715 . . . . 63.11 111.331 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.444 HH12 ' HA ' ' A' ' 4' ' ' ASP . 30.8 ptt180 -93.99 107.89 19.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.412 0.625 . . . . 75.21 109.69 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 59' ' ' VAL . 57.5 mt -105.36 134.68 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 75.44 111.192 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.739 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.5 tt -108.58 -67.54 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.029 -0.532 . . . . 63.2 109.695 171.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.739 ' H ' HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 174.73 164.53 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.521 -0.918 . . . . 75.42 108.521 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.483 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 6.3 tpt180 -71.29 129.52 39.07 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.585 -0.524 . . . . 75.31 109.585 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.69 140.31 54.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.599 -0.519 . . . . 63.32 109.599 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HD3' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -47.23 135.52 10.11 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.741 0.651 . . . . 71.43 112.183 -169.505 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.7 133.83 52.61 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.914 -1.039 . . . . 72.12 114.221 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -85.6 -37.53 19.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.143 -0.528 . . . . 73.31 109.88 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -150.15 143.85 25.31 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.498 -0.556 . . . . 72.2 109.498 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.66 -24.88 18.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.456 0.169 . . . . 72.1 111.01 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 69.43 -67.6 0.22 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.67 0.606 . . . . 72.32 111.018 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 t -174.61 -41.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.387 -0.37 . . . . 71.21 110.073 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 pt 35.83 44.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.381 1.072 . . . . 62.21 113.387 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.5 m -110.69 18.53 19.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.233 0.54 . . . . 63.15 109.966 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.594 -0.73 . . . . 74.22 110.318 -176.574 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.739 -0.467 . . . . 72.11 109.739 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.512 HG13 ' HG2' ' A' ' 3' ' ' LYS . 11.2 p -74.5 -36.26 41.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.308 0.575 . . . . 63.41 109.683 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' HG2' HG13 ' A' ' 2' ' ' VAL . 73.1 mmtt -97.06 70.69 2.41 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.871 -0.789 . . . . 60.1 108.871 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.06 -70.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 52.11 110.101 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.39 -41.13 41.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.633 . . . . 62.14 110.413 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -105.4 169.44 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.807 -0.633 . . . . 70.24 110.475 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.4 m 70.03 18.68 7.08 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.013 0.821 . . . . 75.15 111.308 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -69.86 -28.08 65.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.181 0.515 . . . . 61.24 109.771 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -68.1 94.25 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.397 -0.819 . . . . 71.53 109.145 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 60' ' ' GLU . 8.2 tt -137.93 141.4 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.774 -0.648 . . . . 63.04 110.903 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -107.43 143.75 35.33 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.126 -0.694 . . . . 73.31 109.126 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.02 123.24 46.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.973 0.416 . . . . 64.11 110.826 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 83.6 t -110.89 135.85 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.9 -0.591 . . . . 63.43 110.732 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.52 113.69 26.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.697 -0.483 . . . . 52.44 109.697 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.88 -154.12 6.16 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.771 -0.728 . . . . 51.23 111.816 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.683 ' HB2' ' HD3' ' A' ' 56' ' ' ARG . . . -149.02 143.49 26.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.876 0.338 . . . . 54.33 110.422 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.594 ' HA ' HG12 ' A' ' 28' ' ' VAL . 8.4 p -68.0 143.03 15.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.56 -0.291 . . . . 64.31 110.402 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.63 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 11.9 t -107.24 -33.9 7.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.886 -0.325 . . . . 73.25 110.939 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -165.35 158.46 16.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.618 -0.265 . . . . 73.55 110.292 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.655 HD22 HD11 ' A' ' 53' ' ' ILE . 2.5 pt? -118.54 154.29 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 73.11 110.133 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 25' ' ' GLU . 9.4 mp -116.93 157.24 46.93 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 63.14 110.293 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.26 6.85 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.517 2.811 . . . . 74.42 113.0 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.16 24.73 10.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.097 -0.501 . . . . 75.55 109.941 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.06 27.78 15.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.562 -0.745 . . . . 73.33 110.036 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 35.1 tt0 -99.12 136.52 38.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.142 -0.935 . . . . 75.13 110.521 -174.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.05 111.57 17.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.287 -0.634 . . . . 74.14 109.287 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.488 ' O ' HG22 ' A' ' 18' ' ' THR . 17.0 mtp180 -101.14 123.86 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.434 -0.58 . . . . 74.03 109.434 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.71 HG11 HG21 ' A' ' 57' ' ' VAL . 13.3 m -110.04 155.8 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.97 -0.559 . . . . 74.24 110.694 -173.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -112.72 127.3 56.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.321 0.582 . . . . 64.34 110.307 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 53.7 tp -76.53 148.74 36.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.545 -0.752 . . . . 74.23 109.105 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.08 -11.06 17.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.857 0.36 . . . . 41.14 111.504 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.616 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 11.4 t30 -93.79 24.44 4.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.292 0.567 . . . . 64.42 109.724 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 63.14 46.46 4.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.501 -0.772 . . . . 73.25 111.293 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.38 119.39 22.67 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.732 -0.605 . . . . 74.34 111.001 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -91.71 126.48 36.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.67 -0.492 . . . . 72.31 109.67 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.7 158.21 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.965 0.412 . . . . 74.31 110.973 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 72.5 mt -89.71 141.68 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 73.54 110.429 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 68.8 m -139.72 146.77 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.191 0.519 . . . . 44.05 110.531 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -139.93 167.83 21.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.781 -0.645 . . . . 72.21 109.401 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 m -84.75 118.07 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.343 0.592 . . . . 72.14 110.367 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.1 m -155.37 59.27 0.64 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 43.11 110.167 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.63 -154.4 8.1 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.443 -0.884 . . . . 55.24 112.562 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.73 -17.02 12.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.45 0.7 . . . . 74.42 111.45 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.573 HG13 ' HB ' ' A' ' 49' ' ' ILE . 18.7 t -49.78 -32.25 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 122.952 0.501 . . . . 73.03 111.477 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.449 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 2.5 tmt_? -71.28 -41.59 69.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 62.14 110.146 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 46' ' ' ARG . 11.9 mmt180 -80.21 -44.61 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 71.35 111.434 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.4 t -78.16 -23.83 47.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 72.41 110.33 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 59.21 87.55 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.618 0.723 . . . . 74.11 111.237 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' HB ' HG13 ' A' ' 44' ' ' VAL . 43.1 mm -104.31 145.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.324 -0.853 . . . . 71.04 110.28 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -99.77 113.78 26.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 73.41 110.675 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -91.62 122.47 43.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.9 -0.407 . . . . 71.2 109.9 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -125.04 148.54 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.662 0.268 . . . . 63.43 110.676 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.655 HD11 HD22 ' A' ' 20' ' ' LEU . 60.0 mt -77.91 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.865 -0.42 . . . . 74.11 109.865 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.08 -14.84 40.29 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.612 -0.804 . . . . 75.13 111.904 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -102.63 157.33 17.01 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 42.14 109.204 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.683 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 26.2 mmt180 -75.3 158.78 32.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.766 -0.457 . . . . 74.51 109.766 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.71 HG21 HG11 ' A' ' 28' ' ' VAL . 34.3 m -135.17 153.87 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.812 0.339 . . . . 70.44 110.969 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -107.39 115.84 30.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.907 -0.775 . . . . 62.11 108.907 173.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 47.4 t -97.85 109.1 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.161 -0.472 . . . . 75.54 110.115 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HB3' HD21 ' A' ' 10' ' ' LEU . 32.5 mt-10 -101.7 108.58 20.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.088 -0.505 . . . . 74.52 109.643 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -145.05 160.44 41.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 74.34 111.075 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.716 ' H ' ' HB2' ' A' ' 67' ' ' ASN . 47.7 t -100.0 144.24 29.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 61.44 109.309 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.0 mm -78.55 -17.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 111.793 0.294 . . . . 72.45 111.793 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -65.89 -84.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.865 0.691 . . . . 75.23 112.865 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -148.45 -55.34 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.158 0.429 . . . . 74.11 112.158 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -48.77 -58.56 4.6 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.676 0.61 . . . . 71.03 112.093 -176.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.716 ' HB2' ' H ' ' A' ' 62' ' ' SER . 2.3 m-20 -100.68 25.83 7.43 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.405 -0.184 . . . . 71.32 110.888 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.28 -43.88 20.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.981 0.363 . . . . 63.44 111.981 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.651 ' H ' ' HD2' ' A' ' 69' ' ' LYS . 7.3 mptt -77.52 -33.7 54.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.992 0.425 . . . . 54.4 110.418 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -134.78 149.7 50.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 72.51 110.612 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.96 175.36 15.66 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.281 -0.962 . . . . 71.11 112.106 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -93.16 109.34 20.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.484 -0.561 . . . . 64.4 109.484 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 11.9 tt -99.32 126.95 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.161 -0.472 . . . . 61.53 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.73 HG23 ' H ' ' A' ' 75' ' ' ARG . 5.2 tt -118.2 -66.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.101 -0.5 . . . . 73.05 110.684 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.73 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER 174.91 175.51 0.19 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.646 -0.872 . . . . 75.23 108.646 176.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.537 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 31.8 tpt180 -69.41 120.9 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.964 0.411 . . . . 75.34 109.956 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.6 pt? -73.72 177.57 5.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.903 -0.59 . . . . 62.32 109.962 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 122.38 20.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.214 -0.662 . . . . 63.24 109.214 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.49 44.65 3.11 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.943 -0.572 . . . . 75.22 113.505 -169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.5 p 46.33 51.19 11.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.384 0.612 . . . . 71.11 112.038 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 p -89.54 15.52 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 74.25 111.38 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.82 5.79 46.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.209 -0.451 . . . . 75.13 111.002 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -65.92 -53.06 44.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 72.45 110.721 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -155.69 -80.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.396 -0.335 . . . . 60.42 111.781 176.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.681 ' H ' HG23 ' A' ' 84' ' ' THR . 41.1 pt 40.24 39.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.716 0.806 . . . . 62.23 111.961 -173.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 m 64.69 79.91 0.24 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.396 -0.82 . . . . 71.33 110.672 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.377 -0.821 . . . . 73.12 109.946 -179.534 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' HG23 ' A' ' 2' ' ' VAL . 26.9 ttt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.59 0.233 . . . . 54.43 110.749 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.428 HG23 ' HG2' ' A' ' 1' ' ' MET . 55.5 t -133.0 99.78 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.669 0.271 . . . . 74.14 110.945 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -143.15 111.28 6.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 73.1 110.306 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' HA ' HH21 ' A' ' 66' ' ' ARG . 31.9 t70 -149.86 -61.06 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.096 -0.642 . . . . 72.44 112.376 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -68.56 -31.39 70.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.803 0.335 . . . . 73.11 110.708 -173.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -92.59 14.26 17.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 72.14 111.164 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.578 ' HB3' ' HE2' ' A' ' 64' ' ' TYR . 14.5 m -76.58 95.73 3.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.226 -0.657 . . . . 53.04 109.226 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.84 1.27 57.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 64.03 111.286 -173.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -92.57 79.13 4.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.0 -0.741 . . . . 44.33 109.0 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.621 ' HA ' HG12 ' A' ' 63' ' ' ILE . 2.0 pt? -150.14 -177.04 5.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.713 -0.676 . . . . 72.15 110.019 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -142.74 124.04 14.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 74.43 110.572 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.28 139.19 30.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.17 -0.678 . . . . 72.52 109.17 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.6 161.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 74.43 111.147 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -91.86 128.78 37.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.465 -0.568 . . . . 53.44 109.465 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.73 176.96 19.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.715 -0.755 . . . . 62.25 112.125 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.55 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.249 -0.278 . . . . 61.44 110.249 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.636 ' HA ' HG12 ' A' ' 28' ' ' VAL . 5.6 p -70.06 112.58 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.433 0.635 . . . . 74.34 110.231 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -98.23 -24.78 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.751 -0.659 . . . . 52.41 110.308 -176.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -166.95 163.2 16.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.031 -0.531 . . . . 55.43 110.287 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -136.35 155.24 50.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.545 -0.539 . . . . 52.4 109.545 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.1 mp -103.53 151.16 38.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.473 -0.566 . . . . 72.5 109.473 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.02 38.24 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.875 2.383 . . . . 65.03 112.406 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.83 28.06 2.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.728 -0.669 . . . . 71.13 110.13 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.67 20.58 12.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.577 -0.738 . . . . 71.12 111.581 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.46 135.18 45.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -118.58 139.89 50.76 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -124.45 107.2 10.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.864 0.84 . . . . 71.14 110.968 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 17' ' ' VAL . 13.7 m -96.56 148.24 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.458 -1.246 . . . . 74.02 109.114 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -116.28 140.35 49.42 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.88 -0.728 . . . . 64.43 110.388 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 48.8 tp -80.9 145.67 31.19 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.471 -0.937 . . . . 73.14 108.471 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.91 -8.75 51.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.798 0.332 . . . . 74.13 111.03 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.571 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 61.7 t30 -89.11 14.83 9.86 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.633 0.73 . . . . 72.03 109.536 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 68.15 52.19 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.159 -0.928 . . . . 73.23 112.764 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -129.8 141.25 50.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 71.43 109.434 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.54 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.116 0.484 . . . . 75.15 110.737 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 pt -132.26 154.85 40.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.803 -0.635 . . . . 70.13 110.513 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 2.5 mp -88.92 134.41 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.799 -0.637 . . . . 74.11 109.589 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 62.0 m -122.95 140.74 52.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.468 . . . . 73.24 110.036 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -151.57 149.49 29.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.413 -0.958 . . . . 70.24 108.413 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -70.76 118.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.403 0.621 . . . . 74.33 110.663 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 m -153.22 53.53 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 63.05 109.864 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.96 -159.59 12.12 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 51.04 112.577 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -59.17 -22.09 60.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.784 0.434 . . . . 75.21 111.277 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.824 HG23 ' HB ' ' A' ' 49' ' ' ILE . 5.6 p -53.25 -35.01 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.171 -0.468 . . . . 63.45 111.335 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -68.94 -38.62 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.475 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -81.97 -28.79 32.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 64.33 111.409 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -86.59 -5.57 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.699 -0.228 . . . . 75.14 111.252 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.8 mttt 60.61 37.91 19.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.971 0.415 . . . . 54.25 110.86 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.824 ' HB ' HG23 ' A' ' 44' ' ' VAL . 47.5 mm -66.0 133.68 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.291 0.567 . . . . 73.12 111.535 -175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 ttt85 -88.99 105.45 17.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.477 -0.783 . . . . 72.33 110.888 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 74' ' ' ILE . 51.9 mt -85.89 123.63 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.047 -0.524 . . . . 61.42 109.98 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -118.63 151.84 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.851 0.358 . . . . 72.14 111.062 -175.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -78.48 141.88 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 73.32 110.974 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.446 ' H ' HG13 ' A' ' 17' ' ' VAL . . . 89.68 9.2 66.7 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.028 -0.606 . . . . 71.13 112.637 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.93 151.53 27.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.698 0.285 . . . . 72.45 110.36 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.716 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 17.5 mmm180 -77.63 145.48 36.72 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.98 -0.748 . . . . 74.41 108.98 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG21 HG11 ' A' ' 28' ' ' VAL . 30.2 m -132.68 154.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.855 0.36 . . . . 71.35 111.2 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 tp -106.64 106.65 17.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.673 -0.862 . . . . 70.41 108.673 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.39 127.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.453 0.644 . . . . 72.41 111.195 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -102.9 111.22 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.177 -0.92 . . . . 72.4 109.669 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.562 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -133.87 158.6 43.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.001 0.429 . . . . 75.21 111.004 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 18.7 m -100.26 143.35 30.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.971 -0.559 . . . . 72.41 110.759 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 10' ' ' LEU . 18.9 mm -77.97 3.37 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.282 0.563 . . . . 74.42 111.267 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.578 ' HE2' ' HB3' ' A' ' 7' ' ' SER . 87.8 m-85 -78.72 -91.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.322 0.49 . . . . 75.15 112.322 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.07 -69.25 0.23 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.812 0.671 . . . . 73.42 112.812 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.718 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -55.88 -44.81 78.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.674 0.273 . . . . 74.21 111.129 -175.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 61' ' ' MET . 84.2 m-20 -99.24 21.94 11.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.537 -0.301 . . . . 62.54 111.197 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.35 -18.32 22.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.468 0.651 . . . . 53.23 109.55 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -102.08 -45.34 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.198 -0.91 . . . . 74.22 109.873 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 12.5 ptmm? -106.83 137.65 44.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.434 -0.803 . . . . 63.23 110.841 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.79 169.81 13.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.666 -0.778 . . . . 73.03 111.963 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.476 ' NH2' ' HA ' ' A' ' 5' ' ' GLU . 60.1 mtt180 -92.87 109.35 20.79 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.523 -0.547 . . . . 54.44 109.523 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 14.5 tt -102.39 143.74 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 73.4 110.793 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.4 tt -140.8 -65.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.626 . . . . 70.52 110.261 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.692 ' H ' HG23 ' A' ' 74' ' ' ILE . 9.5 mtp180 176.13 173.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.615 1.166 . . . . 53.13 108.118 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.716 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -87.05 132.6 33.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.215 -0.661 . . . . 65.23 109.215 173.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.584 ' N ' ' HD3' ' A' ' 76' ' ' ARG . 52.1 tp -62.56 145.69 53.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.751 -0.463 . . . . 60.55 109.751 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.704 ' H ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -47.86 124.88 7.97 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.689 0.618 . . . . 63.32 111.075 -176.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.48 161.36 51.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.4 -0.818 . . . . 72.14 113.125 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.8 t -105.35 150.25 25.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.924 -0.398 . . . . 75.1 109.924 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -100.81 6.2 43.72 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.398 0.518 . . . . 74.15 112.398 -171.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 16.7 p-10 -78.62 -45.56 21.3 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.923 -0.399 . . . . 75.51 109.923 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 63.33 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 61.24 112.518 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -96.09 -34.68 11.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.99 -0.55 . . . . 75.51 111.402 -171.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 35.2 pt -113.46 160.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.277 -0.419 . . . . 71.02 111.165 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.5 m -74.25 -55.68 5.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 41.11 109.592 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? . . . . . 0 C--O 1.245 0.862 0 N-CA-C 108.685 -0.857 . . . . 74.4 108.685 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 110.123 -0.325 . . . . 73.34 110.123 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 t 50.36 80.03 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.818 -0.628 . . . . 61.21 111.989 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 3' ' ' LYS . 39.2 mmtm -138.27 101.76 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.59 . . . . 74.14 109.579 176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -119.57 -57.1 2.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 72.52 111.042 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.27 -42.77 73.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.415 0.626 . . . . 75.24 109.957 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.92 100.91 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.577 -0.897 . . . . 71.23 108.577 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.3 m -85.96 -7.91 58.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.656 -0.702 . . . . 71.24 112.694 -169.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.73 -162.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.317 0.386 . . . . 72.34 110.495 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -84.43 106.29 15.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 63.21 110.005 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.4 pt? -137.81 151.33 48.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.038 -0.528 . . . . 53.24 110.184 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -105.57 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.164 0.507 . . . . 73.2 110.029 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' HB3' HD11 ' A' ' 58' ' ' LEU . 9.3 mt-10 -92.46 104.08 16.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.679 -0.691 . . . . 65.42 109.603 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.5 149.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.955 -0.566 . . . . 75.42 111.148 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.66 133.98 53.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.925 -0.58 . . . . 71.21 110.614 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.72 163.55 32.7 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 74.2 111.475 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 56' ' ' ARG . . . -86.51 128.46 34.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.862 0.363 . . . . 70.23 110.998 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 4.6 p -75.06 124.85 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 75.25 110.245 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.1 t -104.0 -30.52 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.289 -0.414 . . . . 55.43 111.656 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.03 168.42 26.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.557 -0.292 . . . . 72.53 110.741 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.781 HD22 HD11 ' A' ' 53' ' ' ILE . 2.4 pt? -143.28 155.46 44.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.921 -0.581 . . . . 73.14 109.751 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 19.4 tp -107.65 142.81 25.98 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.442 -0.947 . . . . 63.11 108.442 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.53 ' HD2' HD12 ' A' ' 21' ' ' LEU . 42.1 Cg_endo -67.51 36.22 0.16 Allowed 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 123.219 2.613 . . . . 74.42 113.377 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -133.84 28.0 3.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 62.3 109.428 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.33 24.02 10.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.264 -0.88 . . . . 71.1 111.261 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 40.5 tt0 -100.66 136.52 40.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.867 -0.606 . . . . 44.52 110.132 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 38' ' ' CYS . 72.1 m-85 -121.83 147.52 45.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.83 -0.804 . . . . 74.42 108.83 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -128.7 112.18 13.95 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.375 -0.53 . . . . 73.13 111.123 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.7 m -101.71 151.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.281 -0.872 . . . . 72.53 109.073 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.21 131.48 56.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.969 -0.692 . . . . 71.14 109.711 175.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.3 tp -85.91 156.99 20.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.481 -0.781 . . . . 71.02 109.221 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.7 -1.13 8.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.354 0.597 . . . . 70.44 110.889 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -88.12 12.45 13.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 72.51 109.49 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 69.0 31.74 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.477 -0.783 . . . . 50.23 111.281 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.35 140.01 50.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.441 -0.345 . . . . 64.15 110.826 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -93.65 143.35 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.52 -0.309 . . . . 75.41 110.206 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.0 mt -118.82 133.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.409 -0.36 . . . . 70.44 110.335 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 64.5 mt -77.21 113.48 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.239 0.542 . . . . 51.52 110.304 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 26' ' ' PHE . 28.3 m -108.67 143.5 37.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.108 -0.496 . . . . 65.3 110.204 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -148.95 156.23 41.98 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.96 -0.755 . . . . 74.54 108.96 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.81 132.21 33.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.722 -0.473 . . . . 74.35 109.722 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -117.99 -166.07 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.892 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -93.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.237 -0.892 . . . . 52.14 114.933 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -49.16 -39.58 29.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.578 0.584 . . . . 71.04 112.578 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.679 HG13 ' HB ' ' A' ' 49' ' ' ILE . 57.1 t -58.21 -40.66 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.899 0.381 . . . . 54.11 110.883 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -67.35 -39.73 85.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 63.21 110.644 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 1.8 mpt_? -76.4 -32.92 58.81 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.146 -0.221 . . . . 73.31 111.396 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -80.97 -9.99 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 72.52 110.847 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 66.55 37.51 4.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.679 -0.691 . . . . 74.34 111.239 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.774 HG21 HG13 ' A' ' 74' ' ' ILE . 50.0 mm -74.4 143.28 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.77 -0.65 . . . . 75.02 109.721 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 50' ' ' ARG . 22.5 ttt180 -116.3 119.91 37.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.371 -0.377 . . . . 72.11 111.222 -175.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 51' ' ' ILE . 4.0 mp -86.84 116.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.941 -0.572 . . . . 62.13 109.48 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -105.91 147.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.917 0.389 . . . . 72.44 110.968 -177.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.781 HD11 HD22 ' A' ' 20' ' ' LEU . 60.7 mt -78.73 130.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.496 . . . . 61.54 110.354 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.73 -18.53 11.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.55 -0.833 . . . . 53.32 112.521 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.02 155.52 17.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 63.52 109.755 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.9 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -96.92 109.98 22.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.32 -0.993 . . . . 73.0 108.32 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 73' ' ' ILE . 26.7 m -116.61 174.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 73.45 112.233 -163.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 12' ' ' GLU . 44.4 tp -106.3 124.62 49.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.258 -0.883 . . . . 73.11 110.344 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 5.2 p -119.27 120.6 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.704 -0.68 . . . . 50.44 109.408 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 28.5 mt-10 -98.54 109.47 22.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.807 -0.633 . . . . 75.41 110.222 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -125.35 153.06 43.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.174 -0.466 . . . . 74.01 111.105 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.672 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 47.2 t -100.02 143.96 29.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 73.33 110.711 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 63' ' ' ILE . 27.0 mm -79.54 3.2 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.271 -0.422 . . . . 73.11 111.581 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -73.81 -93.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.012 -0.43 . . . . 73.5 111.855 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -149.95 -67.51 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.337 0.495 . . . . 54.33 112.337 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' CD ' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.93 -39.45 89.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.896 0.332 . . . . 74.31 111.896 -174.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.672 ' HB2' ' HB3' ' A' ' 62' ' ' SER . 74.1 m-20 -98.75 20.11 13.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.569 -0.287 . . . . 72.43 110.345 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.96 -38.83 11.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.245 -0.434 . . . . 62.45 111.145 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 12.2 mptt -77.55 -44.75 27.52 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.209 0.528 . . . . 71.31 109.891 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -126.88 139.91 52.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 64.42 110.799 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.39 14.4 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.617 -0.72 . . . . 74.33 111.665 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HG3' ' HB2' ' A' ' 60' ' ' GLU . 13.3 ptt180 -91.5 109.17 20.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.391 0.615 . . . . 73.12 110.342 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 57' ' ' VAL . 13.4 tt -96.42 131.49 43.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.35 -0.841 . . . . 70.52 109.494 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.774 HG13 HG21 ' A' ' 49' ' ' ILE . 5.4 tt -116.38 -68.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.559 -0.457 . . . . 75.24 111.832 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.693 ' H ' HG23 ' A' ' 74' ' ' ILE . 19.4 ttt180 174.42 172.99 0.2 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.166 -0.679 . . . . 54.0 109.166 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 27.5 tpt180 -78.85 127.54 32.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.8 -0.444 . . . . 70.21 109.8 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.5 pt? -61.85 123.56 18.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.315 -0.624 . . . . 73.45 109.315 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.635 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -78.41 161.05 27.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.905 -0.405 . . . . 73.21 109.905 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -65.69 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.797 -0.716 . . . . 75.05 111.735 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m 62.75 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.375 0.67 . . . . 75.3 111.84 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 p -91.33 75.72 6.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 55.13 111.299 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -76.98 -48.46 17.94 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.97 -0.559 . . . . 62.13 110.059 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 61.23 -94.25 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.266 -0.879 . . . . 62.33 110.137 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.2 m -163.56 -45.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.561 -0.904 . . . . 74.22 108.561 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.8 pt 50.54 20.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.973 1.309 . . . . 72.31 113.524 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -134.96 153.03 52.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.007 -0.368 . . . . 75.24 110.007 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.861 -0.59 . . . . 71.11 110.313 -179.428 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 25.1 ttt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.408 -0.59 . . . . 64.11 109.408 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.42 -46.65 96.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.014 0.435 . . . . 61.54 110.386 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.25 74.93 7.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.928 -0.767 . . . . 61.42 108.928 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 1' ' ' MET . 12.4 t70 -105.22 -54.37 2.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 65.32 110.361 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.95 -25.92 67.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.162 -0.926 . . . . 71.23 111.701 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 9.7 tptm -97.49 -0.65 45.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.001 0.371 . . . . 72.11 112.001 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.3 p -104.64 94.74 5.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.831 0.348 . . . . 72.22 110.762 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -135.98 -29.31 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 70.15 110.865 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -95.79 92.89 6.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.988 0.423 . . . . 74.01 110.102 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 60' ' ' GLU . 2.2 pt? -150.81 168.92 22.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.273 -0.421 . . . . 62.24 110.948 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 63' ' ' ILE . 32.7 t80 -106.2 130.53 54.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.474 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.15 127.23 53.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.845 -0.616 . . . . 62.32 110.87 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 59' ' ' VAL . 3.6 m -141.79 177.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.968 0.413 . . . . 72.34 111.432 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.95 173.41 7.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 64.31 111.331 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.69 174.3 46.92 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.763 -0.935 . . . . 43.41 110.763 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.88 123.62 29.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.187 0.494 . . . . 62.44 110.554 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.832 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.5 p -72.01 134.09 30.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 72.2 110.963 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -103.8 -47.56 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.025 -0.534 . . . . 75.23 110.981 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.18 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 63.24 110.608 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.586 HD22 HD11 ' A' ' 53' ' ' ILE . 2.5 pt? -135.15 155.74 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 64.25 110.847 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 19.0 tp -118.78 139.57 27.34 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.39 -0.967 . . . . 73.01 108.39 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.66 4.67 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.308 2.672 . . . . 75.04 113.889 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.5 1.94 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.341 -0.244 . . . . 64.25 110.341 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.56 27.39 17.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.501 0.667 . . . . 61.32 110.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 33.1 tt0 -112.88 136.6 52.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.121 -0.945 . . . . 72.3 110.134 -172.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.839 ' HB2' ' HB2' ' A' ' 38' ' ' CYS . 99.0 m-85 -125.91 162.56 24.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.438 -0.346 . . . . 73.41 110.169 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -137.09 112.96 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.266 0.555 . . . . 72.24 110.844 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.832 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.7 m -118.28 155.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 61.25 109.25 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.741 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -117.71 130.26 56.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.294 0.568 . . . . 61.03 110.722 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.74 144.92 50.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.089 -1.078 . . . . 62.32 108.089 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.65 1.09 3.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.819 0.342 . . . . 73.31 111.542 -175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -108.45 34.69 3.51 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.392 0.615 . . . . 74.51 109.869 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 66.9 38.5 3.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.184 0.809 . . . . 74.13 113.184 171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -128.99 118.71 23.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.366 -0.533 . . . . 55.1 111.253 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 44.4 mt-10 -104.22 127.44 51.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.528 -0.545 . . . . 70.32 109.528 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.39 147.99 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.974 0.416 . . . . 65.25 111.335 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.63 112.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.862 -0.608 . . . . 64.25 109.368 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.839 ' HB2' ' HB2' ' A' ' 26' ' ' PHE . 15.7 m -98.4 141.56 31.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.264 -0.425 . . . . 45.42 110.778 -174.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -151.26 127.76 10.74 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.341 -0.615 . . . . 72.21 109.341 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 m -72.15 117.53 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.17 0.509 . . . . 70.11 110.912 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 m -160.67 55.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 44.34 110.146 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.646 ' HA3' ' HD3' ' A' ' 72' ' ' ARG . . . -164.74 -135.74 1.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.767 -1.206 . . . . 62.14 113.389 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.09 -18.22 60.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.427 0.691 . . . . 74.02 111.626 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 74' ' ' ILE . 12.1 t -54.3 -38.85 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 43.34 110.461 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 4.3 tmt_? -70.7 -28.55 64.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.57 -0.741 . . . . 74.22 110.647 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.41 -53.35 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.188 0.518 . . . . 72.41 110.856 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 t -90.89 -9.16 47.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.747 -0.66 . . . . 53.32 111.866 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 55.44 46.52 23.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.273 0.358 . . . . 75.43 111.346 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.809 HD12 HD11 ' A' ' 74' ' ' ILE . 44.2 mt -83.04 139.54 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.998 0.428 . . . . 74.04 110.593 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.62 125.64 34.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.899 -0.592 . . . . 75.12 111.122 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.25 125.72 44.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.095 -0.502 . . . . 73.41 109.653 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -128.57 148.52 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.684 0.278 . . . . 60.55 110.825 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.586 HD11 HD22 ' A' ' 20' ' ' LEU . 61.3 mt -74.39 139.39 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 64.25 110.744 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.62 -15.67 52.73 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.832 -0.699 . . . . 71.44 111.794 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.87 175.31 6.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.584 -0.524 . . . . 70.25 109.584 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 13.9 mmm180 -92.38 154.02 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.67 ' HB ' HG23 ' A' ' 73' ' ' ILE . 35.1 m -127.0 152.89 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.048 0.451 . . . . 74.34 110.92 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.9 tp -107.65 122.34 46.51 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 51.54 108.517 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.653 ' HB ' HG13 ' A' ' 73' ' ' ILE . 2.2 p -116.78 121.6 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.252 0.549 . . . . 63.31 111.317 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 8.3 pt-20 -109.25 114.2 27.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.226 -0.897 . . . . 71.52 109.864 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 3.7 ppp? -123.44 159.2 29.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.831 0.348 . . . . 71.24 110.766 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 16.0 m -99.11 130.39 45.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.735 0.302 . . . . 74.44 110.952 -174.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 11' ' ' PHE . 46.7 mm -69.35 -19.08 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.923 -0.58 . . . . 74.13 111.156 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -60.38 -88.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.54 0.57 . . . . 71.25 112.54 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -150.26 -68.75 0.19 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.799 0.666 . . . . 75.35 112.799 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.883 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.23 -48.13 68.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.994 -0.548 . . . . 74.44 112.382 -172.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 6.3 m-20 -99.46 26.94 5.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.712 0.264 . . . . 61.42 111.712 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.79 -44.07 43.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.639 0.257 . . . . 73.25 111.065 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -89.94 -14.55 33.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.83 0.348 . . . . 64.23 111.262 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HD2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.73 134.54 25.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.203 0.525 . . . . 71.14 111.267 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.47 -175.92 14.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.652 -0.704 . . . . 72.31 111.952 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.646 ' HD3' ' HA3' ' A' ' 42' ' ' GLY . 76.5 mtt180 -92.44 108.54 20.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.657 -0.498 . . . . 70.42 109.657 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.67 HG23 ' HB ' ' A' ' 57' ' ' VAL . 2.8 mp -99.19 124.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.388 -0.597 . . . . 41.52 109.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.809 HD11 HD12 ' A' ' 49' ' ' ILE . 9.0 tt -118.46 -70.28 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.032 -0.667 . . . . 62.23 112.504 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.715 ' H ' HG23 ' A' ' 74' ' ' ILE . 4.4 tmt_? 173.3 148.11 0.06 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.865 -0.42 . . . . 71.15 109.865 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.549 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -149.67 147.84 28.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.134 -0.321 . . . . 72.34 110.134 171.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 78' ' ' LYS . 20.5 tp -52.18 149.48 5.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.934 -0.576 . . . . 72.41 111.119 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 10.7 mptt -63.53 179.45 0.46 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.218 0.532 . . . . 65.15 110.998 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.07 -176.92 35.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.618 -0.801 . . . . 64.15 111.542 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -128.56 152.67 48.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.888 0.344 . . . . 74.33 110.374 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m 66.15 179.8 0.2 Allowed 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.736 0.648 . . . . 64.52 111.541 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' HG12 ' A' ' 85' ' ' ILE . 1.4 m-20 -92.48 -2.19 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 74.41 110.497 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 64.72 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 71.1 111.636 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -136.73 -8.05 1.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.897 0.332 . . . . 71.53 111.897 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 82' ' ' ASP . 29.1 pt -77.44 82.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.683 0.754 . . . . 51.41 111.53 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.3 m -94.78 14.82 20.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.661 -0.7 . . . . 70.21 110.632 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.543 -0.741 . . . . 71.14 109.318 179.024 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.748 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 33.4 ttm . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.91 -0.774 . . . . 63.35 108.91 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.748 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.5 m -98.15 -21.03 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.366 0.603 . . . . 75.5 109.851 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.23 88.35 3.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.433 -0.803 . . . . 74.33 109.303 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.25 -74.6 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.014 -0.365 . . . . 63.03 110.014 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -84.15 -34.91 23.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 71.22 110.184 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -101.69 35.03 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 72.25 110.367 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 p -68.7 -31.27 70.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.098 -0.501 . . . . 64.51 111.415 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 71.9 mmtt 72.56 168.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.748 0.819 . . . . 75.43 112.013 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 m -90.17 139.49 30.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.222 -0.899 . . . . 75.53 111.427 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HG ' ' OG ' ' A' ' 62' ' ' SER . 5.7 mp -122.63 150.96 41.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.474 -0.565 . . . . 62.24 109.474 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.6 t80 -97.11 126.75 42.49 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.196 -0.668 . . . . 74.05 109.196 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -105.46 116.74 32.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.092 -0.504 . . . . 72.21 109.868 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.9 156.09 42.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 61.22 110.63 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.64 145.93 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.179 -0.464 . . . . 63.33 110.797 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.27 -166.43 14.54 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.07 -0.586 . . . . 42.3 112.001 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.58 129.5 39.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.292 -0.262 . . . . 73.22 110.292 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.865 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.3 p -73.1 132.14 33.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.965 0.412 . . . . 72.41 111.259 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 m -97.53 -49.04 5.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 64.55 111.267 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.2 169.05 9.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.2 -0.454 . . . . 33.41 110.564 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.7 pt? -134.65 154.25 51.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 65.41 110.863 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 25' ' ' GLU . 6.8 mp -102.91 152.23 38.47 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.596 -0.729 . . . . 75.11 109.197 175.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.46 -10.93 17.67 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.964 2.443 . . . . 74.13 112.986 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.48 17.76 9.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 63.14 111.154 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 70.19 19.31 6.69 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.985 -0.552 . . . . 60.34 111.493 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 10.6 tp10 -92.54 136.77 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.774 -0.824 . . . . 75.34 108.774 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' HE1' HG13 ' A' ' 40' ' ' VAL . 97.3 m-85 -122.01 157.8 30.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 75.55 110.561 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.12 125.08 28.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.098 -0.501 . . . . 72.01 109.764 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 17' ' ' VAL . 8.6 m -133.16 154.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.452 -0.573 . . . . 73.44 109.452 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 1.043 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.49 140.99 44.22 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.038 -0.665 . . . . 51.53 111.316 177.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 tp -66.25 153.6 42.1 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.987 -1.116 . . . . 74.14 107.987 169.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.03 -11.36 28.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.438 . . . . 63.53 111.406 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -95.48 27.7 3.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 51.11 111.513 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 71.86 21.67 4.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.938 0.718 . . . . 64.13 112.938 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -120.5 119.25 32.43 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.17 -0.612 . . . . 74.45 110.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 1.043 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 36.6 mt-10 -86.63 144.1 27.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.223 0.535 . . . . 60.41 111.124 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.2 pt -130.22 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.597 -0.729 . . . . 63.44 109.731 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 4.0 mp -89.83 139.97 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.158 -0.682 . . . . 65.23 109.158 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.4 m -143.36 167.43 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.43 -0.211 . . . . 71.34 110.43 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.476 ' HA ' ' HD1' ' A' ' 26' ' ' PHE . 29.9 p80 -157.0 170.19 23.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.896 -0.409 . . . . 70.14 109.896 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.499 HG13 ' HE1' ' A' ' 26' ' ' PHE . 25.9 m -72.07 146.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.787 0.327 . . . . 62.11 110.312 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.8 t -121.72 -164.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.247 -0.433 . . . . 61.01 110.154 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.47 -91.5 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 O-C-N 124.254 0.971 . . . . 60.13 114.676 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -44.4 -44.78 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.877 0.471 . . . . 75.13 112.244 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.5 -44.34 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.696 0.284 . . . . 64.42 111.617 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -65.41 -49.82 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 63.32 110.923 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -87.23 -1.78 58.15 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.667 -0.413 . . . . 74.25 111.632 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 t -95.27 -12.77 25.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.722 -0.474 . . . . 61.43 109.722 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 57.82 77.54 0.28 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.346 -0.843 . . . . 65.23 111.629 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.455 HG21 HG13 ' A' ' 74' ' ' ILE . 41.9 mm -107.14 118.37 54.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.033 -0.531 . . . . 63.41 109.682 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -79.15 106.33 11.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.302 -0.408 . . . . 75.04 111.02 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 74' ' ' ILE . 35.6 mt -86.77 130.41 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.703 -0.48 . . . . 74.02 109.703 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -123.44 149.82 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 74.13 110.776 -177.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.6 mt -78.25 140.62 16.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.274 -0.421 . . . . 63.15 110.448 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 26.48 20.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 64.34 112.16 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -139.68 164.32 30.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.637 -0.505 . . . . 72.32 109.637 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 76' ' ' ARG . 32.6 mmt180 -75.87 151.08 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.499 -0.556 . . . . 73.41 109.499 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 73' ' ' ILE . 25.9 m -136.24 151.0 28.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 72.14 110.918 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -107.4 122.4 46.54 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.763 -0.829 . . . . 64.4 108.763 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 p -112.12 131.61 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 44.25 110.501 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.663 ' OE2' ' HD2' ' A' ' 72' ' ' ARG . 42.4 tt0 -112.84 111.7 22.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.226 -0.897 . . . . 60.34 109.667 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.599 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -143.66 145.99 32.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.191 0.52 . . . . 62.44 111.147 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.533 ' H ' ' CB ' ' A' ' 67' ' ' ASN . 4.7 m -84.65 143.21 29.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 54.24 110.354 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.778 ' H ' HD12 ' A' ' 63' ' ' ILE . 1.8 mp -78.06 4.04 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.298 0.571 . . . . 75.35 111.057 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -75.62 -88.52 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.325 0.491 . . . . 75.4 112.325 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -148.89 -64.42 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.84 0.681 . . . . 73.43 112.84 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.36 -33.31 67.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.77 0.319 . . . . 72.53 111.858 -175.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.599 ' O ' ' HB2' ' A' ' 61' ' ' MET . 94.6 m-20 -102.01 14.29 32.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.624 -0.262 . . . . 71.41 111.466 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.66 -32.39 22.01 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.151 -0.343 . . . . 43.13 111.921 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -100.18 -37.51 8.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.724 0.297 . . . . 74.34 110.288 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -119.73 131.12 55.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.62 . . . . 53.4 110.571 174.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.4 174.82 15.41 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.293 -0.723 . . . . 74.22 111.293 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.663 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 5.5 ptp180 -94.11 124.75 38.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.24 0.543 . . . . 74.11 109.837 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.558 HD11 HG11 ' A' ' 57' ' ' VAL . 5.5 tt -106.96 136.8 40.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.598 -0.728 . . . . 72.14 110.0 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.724 HG23 ' H ' ' A' ' 75' ' ' ARG . 5.6 tt -120.57 -67.94 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.821 -0.352 . . . . 75.04 111.221 177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.724 ' H ' HG23 ' A' ' 74' ' ' ILE . 8.7 ttt180 173.88 176.14 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.336 -0.616 . . . . 72.11 109.336 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.687 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -69.31 150.64 47.15 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.28 0.362 . . . . 71.24 110.174 172.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.653 ' HG ' ' H ' ' A' ' 78' ' ' LYS . 11.8 tp -137.04 176.17 8.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.529 -0.915 . . . . 73.23 108.529 166.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.653 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.02 109.2 3.38 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.345 -0.613 . . . . 52.02 109.345 176.066 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.1 66.23 3.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.56 -0.745 . . . . 65.44 113.746 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -84.32 95.27 8.67 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.584 0.707 . . . . 72.13 109.326 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.699 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 25.6 m -131.19 166.93 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.963 -0.562 . . . . 70.3 111.267 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.577 ' HA ' HG12 ' A' ' 85' ' ' ILE . 9.7 p-10 -69.11 1.66 3.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.871 0.693 . . . . 63.32 112.871 -172.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.699 ' HD3' ' HB2' ' A' ' 81' ' ' SER . 7.2 ptt180 -64.68 -32.78 74.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.382 0.512 . . . . 71.31 112.382 -174.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -155.9 20.56 0.38 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.651 -0.42 . . . . 60.03 111.912 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 82' ' ' ASP . 31.2 pt -86.61 23.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.666 -0.646 . . . . 65.2 111.166 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.3 m -125.36 16.02 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 53.53 110.097 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.557 -0.735 . . . . 74.35 109.915 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 88.2 mtp . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 110.086 -0.338 . . . . 72.41 110.086 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG23 ' HG2' ' A' ' 3' ' ' LYS . 12.9 m -69.36 -45.96 77.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.873 0.368 . . . . 70.43 110.432 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 2' ' ' VAL . 71.5 mmtt -93.86 85.81 4.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.967 -1.123 . . . . 75.21 107.967 173.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.5 t70 -130.98 -42.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.083 -0.508 . . . . 74.44 110.974 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 21.8 mm-40 -61.58 -33.13 73.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.606 . . . . 75.44 110.765 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -96.7 12.16 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.995 -0.548 . . . . 75.21 110.72 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -106.65 7.97 30.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.981 -0.554 . . . . 61.1 109.624 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 5' ' ' GLU . 99.5 mttt -67.1 -31.51 72.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.602 -0.726 . . . . 73.24 110.584 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 m -87.68 81.13 7.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 61.04 109.416 172.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.9 pt? -132.95 167.87 19.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.575 -0.739 . . . . 62.02 109.789 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.408 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 50.8 t80 -110.38 124.56 51.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.398 -0.593 . . . . 61.21 109.398 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.12 111.19 23.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.162 -0.681 . . . . 72.03 109.162 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' HB ' ' CE2' ' A' ' 11' ' ' PHE . 9.9 p -129.54 162.75 36.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.801 0.334 . . . . 74.53 111.218 -173.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.18 130.02 39.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.021 -0.536 . . . . 72.54 110.115 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.15 158.68 21.62 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.205 -0.758 . . . . 32.21 111.205 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.36 123.45 47.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.212 0.506 . . . . 70.44 110.666 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.599 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.7 p -76.98 130.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.999 0.428 . . . . 72.35 110.435 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -126.55 -19.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.285 -0.416 . . . . 74.12 111.797 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -166.31 168.14 15.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.049 0.452 . . . . 71.04 111.899 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.01 150.25 37.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.416 -0.811 . . . . 72.23 109.267 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 157.12 34.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.436 -0.347 . . . . 71.31 110.752 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.85 -19.61 47.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.153 2.568 . . . . 73.33 113.022 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.09 14.08 1.26 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.545 0.202 . . . . 71.34 111.545 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.41 19.02 10.95 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.172 0.511 . . . . 74.11 111.555 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 135.78 46.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.586 -0.524 . . . . 63.42 109.586 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -97.31 158.12 15.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.88 -0.6 . . . . 73.44 109.613 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -126.37 119.48 27.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.321 0.582 . . . . 74.52 110.784 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 17' ' ' VAL . 24.6 m -118.49 152.31 20.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.075 -0.966 . . . . 75.11 108.648 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -128.75 140.54 51.68 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.094 -0.643 . . . . 74.24 110.822 -177.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 59.3 tp -76.31 131.97 39.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.043 -1.466 . . . . 64.25 107.043 168.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -62.1 -7.17 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.216 0.323 . . . . 71.15 111.601 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' SER . 25.6 t-20 -91.46 38.97 0.99 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.705 -0.48 . . . . 71.23 109.705 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 61.82 40.24 13.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.284 0.846 . . . . 72.42 113.284 172.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -129.61 118.2 21.6 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.147 -0.346 . . . . 71.25 110.717 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -97.28 140.03 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.6 -0.273 . . . . 72.32 110.355 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 pt -134.71 145.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.0 0.428 . . . . 73.21 110.452 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 4.3 mp -89.11 148.82 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.009 -0.738 . . . . 74.43 109.009 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 85.5 m -139.93 144.89 37.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.998 0.428 . . . . 73.0 111.293 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -132.47 137.69 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.668 -0.493 . . . . 71.12 109.668 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.67 117.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.209 0.528 . . . . 54.33 110.861 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -168.79 55.74 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.913 -0.773 . . . . 70.02 108.913 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.53 -145.96 4.55 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.434 -0.803 . . . . 63.21 111.362 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -62.63 -23.45 67.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 75.3 110.937 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 6.5 p -56.56 -39.86 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.191 -0.458 . . . . 60.4 111.483 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -33.43 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 65.11 110.296 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -66.89 -44.31 81.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.013 -0.54 . . . . 72.33 110.924 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -93.24 -1.74 55.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 73.3 110.961 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.9 63.91 1.8 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.587 0.554 . . . . 61.32 111.212 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG13 HD11 ' A' ' 74' ' ' ILE . 49.3 mm -95.58 139.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 55.21 110.931 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -97.3 117.27 31.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 71.13 111.179 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 51' ' ' ILE . 4.5 mp -86.9 124.18 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.707 -0.679 . . . . 72.35 109.794 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.722 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -114.32 147.91 17.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.759 0.314 . . . . 75.23 110.415 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.28 142.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.306 -0.406 . . . . 75.43 110.483 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 41.39 6.37 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.59 -0.814 . . . . 70.54 111.638 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.89 177.42 9.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.987 -0.746 . . . . 74.44 108.987 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -101.59 150.12 23.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.335 -0.617 . . . . 65.43 109.335 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 28' ' ' VAL . 34.4 m -134.99 160.61 41.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.596 0.236 . . . . 72.14 110.457 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.2 tp -106.58 116.34 31.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.713 -0.847 . . . . 73.24 108.713 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.1 p -105.9 127.57 60.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.419 0.628 . . . . 72.24 110.715 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' OE2' ' HD2' ' A' ' 72' ' ' ARG . 23.4 mt-10 -103.25 108.83 20.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.193 -0.912 . . . . 74.1 109.327 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.473 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -142.38 142.14 32.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.213 0.53 . . . . 70.1 111.531 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 p -99.48 142.2 31.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 75.05 109.958 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.727 ' H ' HD12 ' A' ' 63' ' ' ILE . 2.8 mp -78.16 3.53 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 71.12 111.244 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -61.93 -81.49 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.652 0.612 . . . . 73.41 112.652 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.32 -70.13 0.2 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.898 0.703 . . . . 75.4 112.898 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.902 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -68.02 -31.04 70.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.846 0.355 . . . . 73.51 111.546 -174.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.0 m120 -99.07 10.3 41.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.867 0.365 . . . . 73.14 110.594 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -19.62 44.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 33.12 111.007 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HE3' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -113.12 -21.28 11.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.733 -0.387 . . . . 73.32 110.59 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -142.22 136.78 30.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 74.52 111.281 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 61' ' ' MET . . . -117.97 -175.56 16.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.682 -0.69 . . . . 63.44 111.953 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 52.6 mtt180 -89.97 116.89 28.36 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.971 -0.751 . . . . 73.45 108.971 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -108.45 130.0 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.942 -0.392 . . . . 70.53 109.942 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.749 HG23 ' H ' ' A' ' 75' ' ' ARG . 4.6 tt -132.74 -67.65 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.629 -0.26 . . . . 64.35 111.267 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.749 ' H ' HG23 ' A' ' 74' ' ' ILE . 12.0 ttt180 175.01 173.28 0.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.094 -0.706 . . . . 74.01 109.094 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -86.08 149.36 25.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.747 0.308 . . . . 74.12 110.642 175.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -93.0 145.09 24.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.433 -0.951 . . . . 72.53 108.433 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.35 126.3 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.145 -0.687 . . . . 73.32 109.145 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.05 61.87 0.58 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 109.452 -1.459 . . . . 42.22 109.452 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.406 HG21 ' HD3' ' A' ' 76' ' ' ARG . 8.8 t -146.2 -162.14 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.169 -0.515 . . . . 62.23 109.833 -168.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 83' ' ' ARG . 20.9 m 78.8 89.97 0.06 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.947 0.899 . . . . 73.03 111.658 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 83' ' ' ARG . 34.1 t70 -69.98 13.94 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.177 -0.92 . . . . 54.54 110.787 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 76.6 169.85 0.25 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.854 0.862 . . . . 70.31 109.881 -176.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -72.75 -35.4 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.993 -0.283 . . . . 53.43 110.916 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.5 pt 45.19 22.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.627 1.171 . . . . 74.35 113.865 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 32' ' ' ASN . 33.2 p -126.79 3.54 6.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.071 0.463 . . . . 73.12 110.844 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.114 -0.946 . . . . 75.44 109.022 179.235 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.255 -0.276 . . . . 64.43 110.255 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 3' ' ' LYS . 34.6 m -95.72 -25.0 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.827 0.346 . . . . 73.43 111.005 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 2' ' ' VAL . 73.7 mmtt -119.5 92.26 3.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 73.5 110.225 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -119.95 -36.52 3.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.887 -0.597 . . . . 65.12 110.236 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 22.8 mp0 -58.47 -55.79 30.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.681 -0.859 . . . . 74.42 108.681 175.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.861 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 7.2 mmpt? -110.25 83.17 1.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.865 -1.062 . . . . 74.03 108.206 167.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -55.14 -69.92 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.378 -0.828 . . . . 61.11 111.53 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -142.93 105.18 4.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.849 -0.614 . . . . 70.32 109.885 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.7 m -87.47 97.55 10.89 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.322 -0.621 . . . . 75.04 109.322 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.9 pt? -139.2 169.02 18.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.776 -0.647 . . . . 71.44 110.715 -173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 63' ' ' ILE . 66.5 t80 -124.22 129.87 51.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.533 -0.543 . . . . 75.22 109.533 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -101.71 115.08 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.951 -0.568 . . . . 73.4 110.297 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.46 153.26 30.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.503 -0.317 . . . . 73.23 110.191 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -102.32 155.64 18.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 65.41 111.05 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.44 -168.81 20.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.826 -0.624 . . . . 61.41 111.756 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.14 124.27 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.901 0.351 . . . . 75.34 111.07 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.67 ' HA ' HG12 ' A' ' 28' ' ' VAL . 5.4 p -74.9 122.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.998 0.428 . . . . 65.0 109.892 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -113.57 -21.04 11.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.253 -0.43 . . . . 73.1 111.688 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.03 163.25 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.774 0.321 . . . . 43.13 110.819 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.665 HD22 HD11 ' A' ' 53' ' ' ILE . 2.7 pt? -128.92 143.5 50.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 72.3 109.705 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 23' ' ' ALA . 6.5 mp -96.34 146.75 31.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 109.289 -0.634 . . . . 61.44 109.289 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.0 20.75 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.806 2.338 . . . . 54.51 112.119 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -109.69 18.41 20.27 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.567 -0.742 . . . . 75.21 109.764 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.51 29.07 9.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.471 -0.786 . . . . 75.1 111.17 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 10.3 pt-20 -136.8 151.01 48.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.581 . . . . 73.5 110.333 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.29 163.54 13.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 73.34 110.315 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -126.58 130.19 50.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.525 -0.47 . . . . 74.43 110.337 174.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 17' ' ' VAL . 17.7 m -125.88 146.86 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 71.54 110.838 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.65 142.39 49.07 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.882 -0.414 . . . . 52.35 109.882 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -82.68 158.33 22.99 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.865 -0.791 . . . . 53.31 108.865 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.02 -3.84 6.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.328 0.585 . . . . 72.34 110.782 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -81.72 9.95 6.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 71.14 110.204 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 64.19 33.82 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.783 -0.644 . . . . 73.31 111.919 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -124.85 120.78 32.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.804 -0.634 . . . . 71.33 109.867 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.58 144.26 42.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.429 -0.805 . . . . 65.14 111.872 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 28.3 pt -137.39 168.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.554 -0.748 . . . . 73.41 109.603 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 34.3 mt -102.21 147.89 8.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.313 -0.625 . . . . 71.43 109.313 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 65.6 m -137.99 163.19 32.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.894 0.378 . . . . 62.13 110.831 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 46.5 p-80 -151.31 166.56 30.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.783 -0.451 . . . . 74.21 109.783 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.38 152.0 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.597 0.237 . . . . 50.41 110.538 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -139.36 -167.9 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.525 -0.307 . . . . 73.32 110.481 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -32.39 -94.15 0.01 OUTLIER Glycine 0 C--N 1.338 0.641 0 N-CA-C 115.923 1.129 . . . . 70.43 115.923 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -52.86 -35.9 58.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.125 0.416 . . . . 74.32 112.125 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.3 t -56.47 -48.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.52 111.335 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.31 -33.29 74.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.383 -0.371 . . . . 55.44 111.133 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -85.76 -17.06 36.89 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.795 0.294 . . . . 62.4 111.795 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.7 p -74.3 -22.62 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.801 0.297 . . . . 74.34 111.801 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.74 36.74 22.3 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.11 0.481 . . . . 62.22 111.386 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.777 HG12 HG13 ' A' ' 74' ' ' ILE . 2.2 pp -76.43 163.0 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.222 -0.445 . . . . 55.33 110.677 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.412 ' HG2' HG23 ' A' ' 52' ' ' ILE . 71.1 ttt180 -102.14 109.18 20.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 73.24 110.855 -178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 74' ' ' ILE . 48.3 mt -93.03 111.56 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 53.1 109.741 175.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.646 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.34 147.88 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.832 0.348 . . . . 74.45 110.718 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.665 HD11 HD22 ' A' ' 20' ' ' LEU . 52.7 mt -75.78 140.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.074 -0.512 . . . . 72.11 110.566 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.05 57.05 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.858 -0.687 . . . . 30.12 112.329 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.58 158.22 16.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.834 -0.432 . . . . 63.43 109.834 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 56' ' ' ARG . 62.3 mmt-85 -75.93 140.52 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.215 0.531 . . . . 73.54 110.671 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 75' ' ' ARG . 24.6 m -133.6 160.64 42.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 72.21 110.952 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.24 126.79 52.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.841 -0.618 . . . . 60.43 109.477 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.54 129.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.68 0.752 . . . . 74.05 109.952 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -117.54 109.31 16.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.037 -0.983 . . . . 73.43 109.108 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.578 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -147.77 156.07 42.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 71.55 112.252 -175.02 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' LEU . 16.3 m -93.53 142.89 26.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.468 -0.787 . . . . 61.31 110.439 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 63' ' ' ILE . 22.8 mm -78.86 3.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.167 -0.47 . . . . 73.04 111.941 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 89.8 m-85 -57.2 -85.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.548 0.573 . . . . 74.43 112.548 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -149.02 -69.26 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.012 0.375 . . . . 74.2 112.012 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -34.11 75.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.903 0.383 . . . . 74.21 111.29 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 13.8 m120 -83.32 -9.53 59.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.839 -0.344 . . . . 72.43 110.814 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.92 -8.14 59.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.358 0.599 . . . . 74.2 109.599 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -108.29 -49.05 3.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.3 -0.864 . . . . 64.41 109.544 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -124.34 130.04 51.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.643 -0.708 . . . . 63.24 111.058 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 61' ' ' MET . . . -118.58 -177.85 16.87 Favored Glycine 0 N--CA 1.454 -0.164 0 N-CA-C 111.449 -0.66 . . . . 71.21 111.449 176.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 5.5 ptp180 -93.31 124.97 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.514 0.657 . . . . 71.22 109.719 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.41 HD11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -113.63 137.28 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 64.43 109.701 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.777 HG13 HG12 ' A' ' 49' ' ' ILE . 4.2 tt -125.58 -71.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.323 -0.551 . . . . 55.31 111.634 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.746 ' H ' HG23 ' A' ' 74' ' ' ILE . 38.1 ttt180 171.95 172.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.38 -0.6 . . . . 72.24 109.38 174.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 14.4 tpt180 -73.49 147.55 43.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.617 -0.883 . . . . 71.2 108.617 165.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.37 173.89 2.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.104 0.478 . . . . 73.44 111.115 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.411 ' H ' ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -74.45 112.15 10.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 62.45 110.635 -176.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.56 -168.65 33.46 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.768 -0.73 . . . . 74.13 111.879 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p 51.97 26.65 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 73.22 112.182 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 p -69.01 -29.2 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 73.12 111.284 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.89 -52.96 6.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.445 0.641 . . . . 71.21 109.737 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -176.93 -62.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.673 -1.149 . . . . 72.32 108.97 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.72 HG23 ' H ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -121.04 -84.37 0.66 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.923 . . . . 55.01 110.404 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.72 ' H ' HG23 ' A' ' 84' ' ' THR . 20.8 pt 44.31 27.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.33 1.052 . . . . 72.14 112.793 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.1 p -93.05 5.75 50.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.234 0.54 . . . . 63.1 110.6 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.367 -0.825 . . . . 74.43 109.439 177.299 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.344 -0.243 . . . . 73.33 110.344 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.2 106.69 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.525 . . . . 63.55 111.232 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 30.0 mmtm -139.71 80.87 1.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.857 -0.61 . . . . 54.42 110.24 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.568 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 8.3 p-10 -170.85 -19.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.021 -0.99 . . . . 73.13 110.345 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -53.52 -40.26 65.31 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.938 -0.574 . . . . 71.33 111.568 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -107.03 25.12 11.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.256 0.551 . . . . 63.41 111.152 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 4' ' ' ASP . 46.9 p -144.85 43.89 1.35 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.74 -0.664 . . . . 71.4 109.762 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.77 1.88 21.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.807 -0.633 . . . . 74.24 111.07 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 p -88.16 86.56 7.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.841 -0.8 . . . . 51.1 108.841 168.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 60' ' ' GLU . 1.7 pt? -146.52 -177.28 5.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.548 . . . . 74.21 110.739 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -126.03 146.16 50.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.019 -0.363 . . . . 73.12 110.019 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.41 115.09 29.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 75.24 110.088 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -111.13 142.9 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.159 0.504 . . . . 72.51 111.274 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -93.85 121.89 35.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 74.4 109.781 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.72 140.0 6.34 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.555 -0.831 . . . . 73.35 112.292 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 56' ' ' ARG . . . -85.74 152.57 22.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.291 . . . . 64.3 110.536 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -67.75 142.5 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 75.41 110.363 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 1.067 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 12.6 t -111.97 -33.59 6.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.668 0.27 . . . . 75.54 110.551 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.72 168.6 22.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 75.54 110.256 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.6 156.0 42.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.032 0.444 . . . . 73.42 110.851 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 37.1 tp -119.09 129.86 25.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.204 -1.036 . . . . 73.33 108.204 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.44 22.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.485 0 C-N-CA 123.363 2.708 . . . . 74.54 113.333 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -105.19 25.82 10.12 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.35 -0.611 . . . . 75.14 109.35 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 71.42 27.89 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 63.03 111.069 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 tt0 -111.28 136.06 50.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.728 -0.669 . . . . 74.12 110.274 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB2' HG21 ' A' ' 73' ' ' ILE . 92.0 m-85 -131.29 125.76 33.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.616 -0.513 . . . . 75.24 109.616 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -110.33 114.96 28.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.101 0.477 . . . . 61.32 110.897 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.3 m -105.54 156.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.818 -0.628 . . . . 72.33 109.602 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 1.067 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.98 131.38 53.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.471 0.653 . . . . 73.33 110.921 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.62 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 64.4 tp -74.85 144.76 43.27 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.074 -1.084 . . . . 64.3 108.074 170.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.79 -20.09 54.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.906 0.384 . . . . 53.43 111.048 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.62 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 8.7 t30 -86.91 30.85 0.72 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.189 -0.46 . . . . 73.13 110.963 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 28.7 tt0 67.43 38.87 3.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.405 0.622 . . . . 52.21 111.293 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -129.63 118.53 22.09 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.634 -0.666 . . . . 65.45 110.33 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.19 132.11 52.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.957 -0.386 . . . . 70.33 109.957 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.03 136.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 72.42 111.205 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 73.8 mt -79.75 109.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.352 0.596 . . . . 64.51 110.214 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 55.7 m -114.11 168.03 10.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 70.42 110.488 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -155.93 172.81 17.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.122 -0.49 . . . . 65.45 109.957 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.97 118.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.184 0.516 . . . . 73.11 110.583 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.1 p -165.98 60.47 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.899 -0.591 . . . . 74.41 110.064 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.15 -140.35 2.85 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.806 -0.711 . . . . 24.34 111.669 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.03 -30.49 71.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.797 0.332 . . . . 54.11 110.453 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.759 HG23 ' HB ' ' A' ' 49' ' ' ILE . 7.7 p -57.56 -29.61 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.985 -0.552 . . . . 63.22 111.468 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.57 -48.75 59.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 70.2 110.866 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 46' ' ' ARG . 3.6 ptt180 -88.91 -21.38 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.509 0.559 . . . . 71.05 112.509 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.6 t -93.17 -14.29 27.34 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.848 -0.341 . . . . 72.12 110.879 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.69 83.81 0.12 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.663 0.602 . . . . 52.33 111.24 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 44' ' ' VAL . 50.9 mm -114.26 141.97 28.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.112 -0.494 . . . . 75.22 110.197 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -91.84 118.14 30.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.562 -0.29 . . . . 74.5 110.642 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 74' ' ' ILE . 4.0 mp -81.73 122.29 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.097 -0.502 . . . . 62.0 109.674 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.752 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -112.39 146.28 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.942 0.401 . . . . 73.21 110.821 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.446 ' HA ' HG11 ' A' ' 17' ' ' VAL . 45.6 mm -79.9 129.51 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.011 -0.541 . . . . 74.25 110.677 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.76 10.83 26.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.709 -0.757 . . . . 75.21 112.212 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.92 139.94 46.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.071 -0.344 . . . . 65.34 110.071 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.0 mtt180 -86.33 116.86 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 72.41 109.222 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.02 -178.04 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.186 0.517 . . . . 65.53 111.354 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 tp -112.77 122.49 47.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.789 . . . . 74.15 109.518 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.37 128.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 51.13 110.16 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.726 ' HG2' HD11 ' A' ' 10' ' ' LEU . 37.0 tt0 -113.56 109.38 18.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.717 -0.674 . . . . 73.23 110.376 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -152.19 165.06 36.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 71.31 110.124 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 31.2 t -99.94 161.76 13.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.833 0.349 . . . . 73.35 110.534 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.8 mm -80.43 -7.89 10.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 74.41 111.325 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.8 -93.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.678 0.992 . . . . 64.21 113.678 -168.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 17.8 p-10 -146.18 -71.04 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.064 0.764 . . . . 64.42 113.064 -172.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.589 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -79.72 -27.28 40.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.248 0.547 . . . . 65.12 110.429 -174.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.672 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 65.4 t30 -98.43 17.13 19.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.625 -0.716 . . . . 71.15 109.08 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 62' ' ' SER . . . -101.55 -49.91 3.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 71.14 111.716 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -94.11 21.5 6.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.255 0.55 . . . . 75.42 111.378 -177.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -147.57 142.15 26.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.721 -0.844 . . . . 65.31 108.721 172.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.42 163.86 25.41 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.116 -1.04 . . . . 53.1 112.559 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 2.1 ptp180 -96.72 120.42 37.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.906 0.384 . . . . 74.15 110.131 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -114.25 137.27 48.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.047 -0.524 . . . . 75.53 109.617 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.663 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.3 tt -129.0 -66.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.358 -0.383 . . . . 65.11 110.809 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.663 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER 175.19 172.98 0.26 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.127 -1.064 . . . . 73.3 108.127 177.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 74.2 ttt-85 -70.52 131.15 43.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.93 -0.396 . . . . 75.02 109.93 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.679 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.1 pt? -66.35 140.48 58.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 71.04 109.82 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 78' ' ' LYS . 3.6 mppt? -88.06 110.21 20.45 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.497 -0.557 . . . . 65.24 109.497 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.1 103.42 1.97 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.749 -0.659 . . . . 33.52 111.754 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 t -112.71 125.59 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.29 0.567 . . . . 71.43 110.256 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.2 m -146.71 47.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 62.41 110.613 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -50.53 -60.3 3.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.767 -0.651 . . . . 73.51 110.283 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -150.06 -74.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 55.31 109.172 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -165.68 95.22 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.825 0.822 . . . . 53.54 109.948 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.39 128.79 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.398 -0.819 . . . . 53.1 110.712 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -108.12 0.13 21.42 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.776 -0.647 . . . . 52.41 109.994 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 87' ' ' LYS . 34.1 ttpt . . . . . 0 C--O 1.244 0.787 0 CA-C-N 115.325 -0.852 . . . . 72.14 109.256 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.703 0.287 . . . . 60.23 110.428 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.9 m -98.82 -43.93 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.682 0.277 . . . . 63.52 111.233 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -131.21 94.3 3.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.935 0.397 . . . . 74.45 109.939 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.2 -40.94 9.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.674 -0.693 . . . . 71.25 109.594 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 11.9 mt-10 -59.93 -58.3 9.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.017 -0.992 . . . . 74.11 109.722 177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' HD2' ' HB2' ' A' ' 5' ' ' GLU . 11.9 mptt -84.82 94.38 8.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.032 -0.986 . . . . 73.42 108.545 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -70.27 96.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.479 -0.782 . . . . 72.24 112.522 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.35 -22.53 20.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 42.22 109.247 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -84.7 69.27 10.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.348 -0.842 . . . . 74.13 111.003 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.7 pt? -127.23 161.17 29.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 70.2 109.167 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.696 ' HB2' HD11 ' A' ' 63' ' ' ILE . 9.1 t80 -92.68 123.97 36.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.484 -0.561 . . . . 74.3 109.484 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.07 104.82 7.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.818 -0.628 . . . . 73.4 109.502 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HD12 ' A' ' 58' ' ' LEU . 14.3 m -143.16 170.47 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.844 0.354 . . . . 73.11 111.829 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -93.05 138.54 31.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.535 -0.757 . . . . 63.34 109.963 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.2 -175.93 15.19 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.058 -0.591 . . . . 41.34 112.045 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -121.84 123.78 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.697 0.285 . . . . 71.2 110.588 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 28' ' ' VAL . 3.0 p -73.17 123.35 27.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.109 0.48 . . . . 74.04 109.799 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 14.6 t -100.57 -32.49 10.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.1 -0.5 . . . . 73.4 111.081 -175.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -165.26 168.17 17.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.996 0.427 . . . . 63.52 111.311 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.499 ' HG ' HD11 ' A' ' 53' ' ' ILE . 4.1 pp -133.84 155.61 49.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.58 -0.736 . . . . 71.35 109.757 174.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.35 143.87 36.88 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.386 -0.37 . . . . 72.12 110.108 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.67 59.91 2.12 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.176 2.584 . . . . 74.14 112.639 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.24 25.67 0.47 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.732 -0.667 . . . . 25.32 109.614 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.46 19.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.515 -0.766 . . . . 64.22 109.988 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -118.19 136.33 53.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 75.32 110.197 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 91.1 m-85 -122.78 158.75 29.52 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.628 -0.508 . . . . 73.14 109.628 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 27' ' ' ARG . 24.2 mtt85 -133.64 116.12 15.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.466 0.651 . . . . 73.23 110.521 173.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 17' ' ' VAL . 31.0 m -116.61 156.12 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.136 -0.938 . . . . 54.22 109.543 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.832 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.049 0.452 . . . . 72.32 110.988 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.31 148.43 51.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.945 -1.131 . . . . 73.11 107.945 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.36 -17.48 54.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 74.33 111.087 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -84.44 19.26 1.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.051 -0.522 . . . . 74.34 110.379 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 68.83 50.98 0.6 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.714 0.806 . . . . 73.15 112.725 172.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -129.75 118.12 21.34 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.922 -0.399 . . . . 72.5 109.922 171.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.832 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 45.5 mt-10 -97.74 134.58 40.72 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.123 0.264 . . . . 71.33 110.778 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 59' ' ' VAL . 31.2 pt -129.3 170.1 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 70.21 111.315 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 66.9 mt -89.35 140.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 70.42 110.432 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 17.1 t -126.44 142.0 51.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.018 0.437 . . . . 73.31 111.144 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -143.8 160.78 40.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.661 -0.7 . . . . 75.53 109.58 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.31 130.56 35.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.12 0.486 . . . . 55.45 110.406 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -112.9 -175.85 2.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.122 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -30.15 -92.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.622 0 O-C-N 124.588 1.18 . . . . 54.3 115.108 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.63 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 38.9 ttpt -48.75 -45.22 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.373 0.508 . . . . 73.24 112.373 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.66 -40.76 77.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.302 . . . . 74.31 111.48 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -62.17 -45.84 91.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 61.42 111.043 -176.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.08 -17.71 32.23 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.493 -0.483 . . . . 73.23 111.495 -175.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.7 t -84.15 -23.38 30.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.898 -0.137 . . . . 70.11 111.062 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt 60.59 87.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.528 0.518 . . . . 62.13 110.931 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.536 HG21 HG13 ' A' ' 74' ' ' ILE . 44.2 mm -107.83 141.38 23.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 71.13 110.342 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -89.74 106.33 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.367 -0.379 . . . . 62.54 110.667 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.55 113.85 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.258 -0.428 . . . . 70.15 109.87 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.506 ' O ' HG11 ' A' ' 17' ' ' VAL . 36.1 pt -110.82 150.38 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.398 -0.364 . . . . 73.13 110.827 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 20' ' ' LEU . 54.5 mt -77.56 137.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.501 -0.318 . . . . 63.21 110.725 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' H ' HG13 ' A' ' 17' ' ' VAL . . . 89.06 17.41 56.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.884 -0.674 . . . . 72.35 112.807 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.2 158.14 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.902 -0.407 . . . . 73.42 109.902 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' NH1' ' HB2' ' A' ' 16' ' ' ALA . 34.9 mmt180 -75.38 130.87 39.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 72.24 109.987 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.642 ' HB ' HG23 ' A' ' 73' ' ' ILE . 15.9 m -132.12 154.71 40.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.475 . . . . 74.52 111.255 -175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 13' ' ' VAL . 35.6 tp -105.86 122.53 46.29 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.424 -0.584 . . . . 64.22 109.424 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.546 HG21 HD11 ' A' ' 36' ' ' ILE . 7.5 p -104.25 131.36 53.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.308 0.575 . . . . 72.21 111.113 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -120.15 110.05 16.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 64.3 109.123 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 4.1 ppp? -131.29 159.35 38.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.823 0.344 . . . . 72.35 111.226 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.748 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 10.0 m -99.0 136.62 38.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.179 -0.464 . . . . 44.02 111.341 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 11' ' ' PHE . 18.9 mm -76.97 3.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.181 0.515 . . . . 70.52 111.139 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -74.54 -92.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.794 0.664 . . . . 74.32 112.794 -173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -140.02 -69.94 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.083 0.401 . . . . 75.53 112.083 -171.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.765 ' H ' ' HD2' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.65 -41.13 72.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 70.1 111.523 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.748 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 83.3 m-20 -90.57 15.47 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.877 0.37 . . . . 70.11 110.449 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.59 47.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.103 0.478 . . . . 72.33 110.455 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 17.83 5.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.522 0.677 . . . . 71.13 110.29 177.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -147.1 134.11 20.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 75.02 108.805 177.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.67 -178.9 16.4 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.299 -0.953 . . . . 40.23 112.354 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -111.87 139.58 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.57 -0.53 . . . . 73.33 109.57 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 57' ' ' VAL . 18.6 mm -114.07 134.1 58.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.976 -0.556 . . . . 64.31 110.438 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.756 HG23 ' H ' ' A' ' 75' ' ' ARG . 4.8 tt -112.81 -69.58 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.409 -0.516 . . . . 74.22 109.97 170.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.756 ' H ' HG23 ' A' ' 74' ' ' ILE . 60.8 ttt180 172.57 172.48 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.34 -0.985 . . . . 74.01 108.34 172.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' HD3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -70.02 124.55 24.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.263 -1.014 . . . . 71.35 108.263 174.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.6 pt? -63.49 145.85 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.972 0.415 . . . . 73.04 110.722 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 78' ' ' LYS . 3.9 mppt? -82.06 113.01 19.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 70.2 109.823 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.79 100.37 2.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.624 -0.798 . . . . 42.23 111.199 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -76.81 73.1 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.768 0.794 . . . . 71.11 111.38 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -104.16 83.07 2.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.594 -0.73 . . . . 73.23 110.351 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD2' ' HD3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -92.7 -73.82 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 73.31 110.35 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.629 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 164.93 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 124.3 1.0 . . . . 72.23 109.742 174.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 83' ' ' ARG . 33.4 m -146.73 -32.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.577 0.954 . . . . 72.31 113.577 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 82' ' ' ASP . 36.0 pt -47.04 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.77 1.026 . . . . 75.45 113.77 -167.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 m -158.63 7.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.042 -0.981 . . . . 70.44 109.843 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.859 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.876 0 CA-C-N 115.493 -0.776 . . . . 63.34 109.5 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.814 -0.439 . . . . 73.21 109.814 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.77 -41.4 85.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.6 -0.519 . . . . 74.33 109.6 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -82.46 64.01 6.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.805 -0.813 . . . . 74.15 108.805 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.426 ' HA ' HH12 ' A' ' 72' ' ' ARG . 34.7 m-20 -169.79 -60.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.217 -1.401 . . . . 64.14 107.217 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 25.7 mm-40 -58.16 -57.83 11.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.079 -1.419 . . . . 64.5 111.575 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 6' ' ' LYS . 10.9 mptt -87.5 29.2 0.89 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.349 0.595 . . . . 72.41 110.63 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.5 m -141.16 22.89 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 72.41 110.055 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.704 ' HE3' ' HA ' ' A' ' 5' ' ' GLU . 96.3 mttt -72.01 -37.12 69.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.251 -0.431 . . . . 73.55 110.731 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 m -96.99 102.05 13.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.747 -0.464 . . . . 75.54 109.747 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.76 -178.84 6.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.059 -0.518 . . . . 40.4 109.971 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.42 124.64 43.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.011 0.434 . . . . 75.33 109.855 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 15.9 mt-10 -112.13 113.66 26.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.827 -0.624 . . . . 71.15 110.412 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.543 ' HB ' HD13 ' A' ' 30' ' ' LEU . 17.3 m -119.63 157.72 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.108 0.48 . . . . 74.53 111.089 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -112.71 117.49 32.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.956 -0.565 . . . . 51.05 109.629 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.82 -170.29 11.89 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.68 -0.772 . . . . 45.21 111.905 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.643 ' HB2' ' HD3' ' A' ' 56' ' ' ARG . . . -123.96 143.83 50.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.884 0.342 . . . . 72.41 110.722 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.695 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.3 p -71.25 139.93 19.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.233 -0.439 . . . . 73.4 110.364 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -102.35 -46.84 4.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.227 0.537 . . . . 62.53 110.548 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.6 168.45 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.298 -0.864 . . . . 63.4 109.789 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 53' ' ' ILE . 2.6 pt? -127.29 155.54 43.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 70.34 110.707 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 21' ' ' LEU . 5.5 mp -108.04 149.32 38.97 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.478 -0.783 . . . . 73.4 109.516 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.93 12.98 0.32 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.301 2.667 . . . . 71.42 113.362 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.47 23.96 12.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.47 -0.332 . . . . 74.52 110.345 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.98 32.98 19.92 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.813 0.816 . . . . 65.54 109.473 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.29 144.0 48.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.564 -1.198 . . . . 65.25 109.344 -173.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 97.0 m-85 -119.43 162.93 18.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.921 0.391 . . . . 72.44 111.073 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -134.83 115.84 14.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.853 -0.612 . . . . 50.35 109.987 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 17' ' ' VAL . 15.2 m -122.79 156.25 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.887 -0.597 . . . . 74.35 110.571 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.862 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -125.66 141.28 52.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.924 0.393 . . . . 73.44 110.541 177.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 13' ' ' VAL . 56.3 tp -62.48 159.78 14.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.425 -0.954 . . . . 25.11 108.425 169.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -9.68 41.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.101 0.41 . . . . 63.32 112.071 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -91.21 4.58 51.9 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.857 0.837 . . . . 63.2 109.623 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 68.41 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.81 -1.086 . . . . 62.34 112.772 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -130.1 119.07 22.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.843 -1.169 . . . . 70.55 107.843 164.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.862 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 32.5 mt-10 -97.58 137.4 36.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.132 0.491 . . . . 74.31 111.967 -172.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.64 167.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.466 -0.788 . . . . 73.43 109.951 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 56.3 mt -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.225 -0.443 . . . . 60.11 109.936 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.83 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 34.9 t -126.78 140.45 52.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.786 0.327 . . . . 73.23 110.677 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.68 155.58 31.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 71.24 109.407 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.6 m -71.66 130.86 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.212 0.53 . . . . 61.24 110.751 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 m -118.72 -165.19 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 53.13 109.969 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -38.68 -92.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 O-C-N 124.191 0.932 . . . . 52.52 114.814 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -44.51 -39.71 5.06 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.786 0.661 . . . . 63.14 112.786 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.11 -39.61 86.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.624 0.231 . . . . 54.23 111.624 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.492 ' HD3' ' C ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.37 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.386 -0.37 . . . . 74.43 111.62 -172.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -5.94 58.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.35 -0.54 . . . . 74.25 111.305 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.1 t -86.42 -20.65 27.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.527 -0.306 . . . . 70.23 110.614 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 58.77 79.67 0.21 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 75.52 110.235 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 74' ' ' ILE . 35.8 mm -105.74 138.38 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.343 -0.844 . . . . 62.01 111.173 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -108.78 107.55 18.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 74.11 110.11 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.89 111.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.465 -0.568 . . . . 72.02 109.465 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.847 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -100.58 151.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 65.3 111.988 -172.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.585 ' HA ' HG11 ' A' ' 17' ' ' VAL . 60.0 mt -78.5 128.02 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.697 -0.683 . . . . 34.45 111.407 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.0 -31.22 7.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.973 -0.632 . . . . 52.32 112.783 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -85.5 150.83 24.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.6 0.238 . . . . 75.12 110.834 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.643 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 70.9 mmt-85 -75.23 137.51 41.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.718 -0.475 . . . . 54.04 109.718 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.34 165.13 21.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.041 0.448 . . . . 52.12 111.05 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 tp -107.14 113.89 27.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.616 . . . . 64.3 109.496 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 73' ' ' ILE . 2.8 p -116.35 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.366 0.603 . . . . 52.44 110.582 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.599 ' HB3' ' HG2' ' A' ' 12' ' ' GLU . 10.7 pt-20 -108.73 117.8 35.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.711 . . . . 74.34 109.546 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.62 156.28 48.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 63.21 110.382 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 7.8 m -99.91 118.79 37.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.577 -0.527 . . . . 64.1 109.577 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.6 mt -73.61 3.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.455 0.645 . . . . 73.31 110.897 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -69.98 -74.53 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 72.45 111.95 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -148.48 -70.79 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.555 0.946 . . . . 33.54 113.555 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -80.18 -50.54 10.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.186 0.439 . . . . 54.41 112.186 -171.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.2 t30 -81.33 26.2 0.47 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 64.01 110.068 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.13 -41.58 7.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.868 -0.606 . . . . 51.43 111.401 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' H ' ' HD2' ' A' ' 69' ' ' LYS . 9.5 mptt -65.46 -43.16 91.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.237 0.541 . . . . 72.43 110.152 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -124.55 152.33 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.428 -0.806 . . . . 72.41 110.312 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.0 159.1 14.37 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.798 -0.715 . . . . 63.11 111.331 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.426 HH12 ' HA ' ' A' ' 4' ' ' ASP . 30.8 ptt180 -93.99 107.89 19.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.412 0.625 . . . . 74.44 109.69 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.561 HG12 ' HB ' ' A' ' 59' ' ' VAL . 57.5 mt -105.36 134.68 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 70.33 111.192 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.709 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.5 tt -108.58 -67.54 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.029 -0.532 . . . . 63.2 109.695 171.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.709 ' H ' HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 174.73 164.53 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.521 -0.918 . . . . 75.42 108.521 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 6.3 tpt180 -71.29 129.52 39.07 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.585 -0.524 . . . . 70.31 109.585 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.69 140.31 54.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.599 -0.519 . . . . 44.42 109.599 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -47.23 135.52 10.11 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.741 0.651 . . . . 71.43 112.183 -169.505 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.7 133.83 52.61 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.914 -1.039 . . . . 72.12 114.221 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -85.6 -37.53 19.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.143 -0.528 . . . . 70.05 109.88 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -150.15 143.85 25.31 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.498 -0.556 . . . . 72.2 109.498 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.66 -24.88 18.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.456 0.169 . . . . 72.1 111.01 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 69.43 -67.6 0.22 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.67 0.606 . . . . 72.04 111.018 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 t -174.61 -41.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.387 -0.37 . . . . 71.21 110.073 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 pt 35.83 44.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.381 1.072 . . . . 44.33 113.387 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.5 m -110.69 18.53 19.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.233 0.54 . . . . 52.25 109.966 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.594 -0.73 . . . . 62.43 110.318 -176.574 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 109.739 -0.467 . . . . 72.109999999999999 109.739 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.512 HG13 ' HG2' ' A' ' 3' ' ' LYS . 11.2 p -74.5 -36.26 41.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.308 0.575 . . . . 63.409999999999997 109.683 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' HG2' HG13 ' A' ' 2' ' ' VAL . 73.1 mmtt -97.06 70.69 2.41 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.871 -0.789 . . . . 60.100000000000001 108.871 174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -152.06 -70.48 0.16 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.866 -0.606 . . . . 52.109999999999999 110.101 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -77.39 -41.13 41.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.806 -0.633 . . . . 62.140000000000001 110.413 -178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -105.4 169.44 8.46 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.807 -0.633 . . . . 70.239999999999995 110.475 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.4 m 70.03 18.68 7.08 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 124.013 0.821 . . . . 75.150000000000006 111.308 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -69.86 -28.08 65.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.181 0.515 . . . . 61.240000000000002 109.771 173.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.1 p -68.1 94.25 0.49 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.397 -0.819 . . . . 71.530000000000001 109.145 173.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.592 HD21 ' HB3' ' A' ' 60' ' ' GLU . 8.2 tt -137.93 141.4 40.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.774 -0.648 . . . . 63.039999999999999 110.903 -168.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -107.43 143.75 35.33 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.126 -0.694 . . . . 73.310000000000002 109.126 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -117.02 123.24 46.4 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.973 0.416 . . . . 64.109999999999999 110.826 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 59' ' ' VAL . 83.6 t -110.89 135.85 48.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.9 -0.591 . . . . 63.43 110.732 -178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -100.52 113.69 26.7 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.697 -0.483 . . . . 52.439999999999998 109.697 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -147.88 -154.12 6.16 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.771 -0.728 . . . . 51.229999999999997 111.816 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.683 ' HB2' ' HD3' ' A' ' 56' ' ' ARG . . . -149.02 143.49 26.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.876 0.338 . . . . 54.329999999999998 110.422 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.594 ' HA ' HG12 ' A' ' 28' ' ' VAL . 8.4 p -68.0 143.03 15.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.56 -0.291 . . . . 64.310000000000002 110.402 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.63 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 11.9 t -107.24 -33.9 7.28 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.886 -0.325 . . . . 73.25 110.939 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -165.35 158.46 16.17 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.618 -0.265 . . . . 73.549999999999997 110.292 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.655 HD22 HD11 ' A' ' 53' ' ' ILE . 2.5 pt? -118.54 154.29 32.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.875 0.369 . . . . 73.109999999999999 110.133 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 25' ' ' GLU . 9.4 mp -116.93 157.24 46.93 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 63.140000000000001 110.293 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -66.26 6.85 0.44 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.517 2.811 . . . . 74.420000000000002 113.0 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -103.16 24.73 10.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.097 -0.501 . . . . 75.549999999999997 109.941 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.06 27.78 15.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.562 -0.745 . . . . 73.329999999999998 110.036 -177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 35.1 tt0 -99.12 136.52 38.97 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.142 -0.935 . . . . 75.129999999999995 110.521 -174.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -121.05 111.57 17.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.287 -0.634 . . . . 74.140000000000001 109.287 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.488 ' O ' HG22 ' A' ' 18' ' ' THR . 17.0 mtp180 -101.14 123.86 45.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.434 -0.58 . . . . 74.030000000000001 109.434 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.71 HG11 HG21 ' A' ' 57' ' ' VAL . 13.3 m -110.04 155.8 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.97 -0.559 . . . . 74.239999999999995 110.694 -173.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.63 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -112.72 127.3 56.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.321 0.582 . . . . 64.340000000000003 110.307 178.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.616 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 53.7 tp -76.53 148.74 36.92 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.545 -0.752 . . . . 74.230000000000004 109.105 174.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -63.08 -11.06 17.09 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.857 0.36 . . . . 41.140000000000001 111.504 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.616 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 11.4 t30 -93.79 24.44 4.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.292 0.567 . . . . 64.420000000000002 109.724 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 63.14 46.46 4.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.501 -0.772 . . . . 73.25 111.293 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.38 119.39 22.67 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.732 -0.605 . . . . 74.340000000000003 111.001 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -91.71 126.48 36.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.67 -0.492 . . . . 72.310000000000002 109.67 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.2 pt -126.7 158.21 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.965 0.412 . . . . 74.310000000000002 110.973 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 72.5 mt -89.71 141.68 13.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.032 -0.531 . . . . 73.540000000000006 110.429 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 68.8 m -139.72 146.77 40.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.191 0.519 . . . . 44.049999999999997 110.531 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -139.93 167.83 21.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.781 -0.645 . . . . 72.209999999999994 109.401 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.1 m -84.75 118.07 31.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.343 0.592 . . . . 72.140000000000001 110.367 177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 65.1 m -155.37 59.27 0.64 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.731 -0.668 . . . . 43.109999999999999 110.167 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.63 -154.4 8.1 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.443 -0.884 . . . . 55.240000000000002 112.562 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.73 -17.02 12.9 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.45 0.7 . . . . 74.420000000000002 111.45 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.573 HG13 ' HB ' ' A' ' 49' ' ' ILE . 18.7 t -49.78 -32.25 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 122.952 0.501 . . . . 73.030000000000001 111.477 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.449 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 2.5 tmt_? -71.28 -41.59 69.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 62.140000000000001 110.146 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 46' ' ' ARG . 11.9 mmt180 -80.21 -44.61 19.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.907 0.384 . . . . 71.349999999999994 111.434 -176.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.4 t -78.16 -23.83 47.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.43 . . . . 72.409999999999997 110.33 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 59.21 87.55 0.08 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.618 0.723 . . . . 74.109999999999999 111.237 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' HB ' HG13 ' A' ' 44' ' ' VAL . 43.1 mm -104.31 145.16 13.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.324 -0.853 . . . . 71.040000000000006 110.28 -177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -99.77 113.78 26.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 73.409999999999997 110.675 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 51' ' ' ILE . 3.9 mp -91.62 122.47 43.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.9 -0.407 . . . . 71.200000000000003 109.9 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.635 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -125.04 148.54 29.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.662 0.268 . . . . 63.43 110.676 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.655 HD11 HD22 ' A' ' 20' ' ' LEU . 60.0 mt -77.91 138.82 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.865 -0.42 . . . . 74.109999999999999 109.865 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.08 -14.84 40.29 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.612 -0.804 . . . . 75.129999999999995 111.904 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -102.63 157.33 17.01 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.204 -0.665 . . . . 42.140000000000001 109.204 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.683 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 26.2 mmt180 -75.3 158.78 32.33 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.766 -0.457 . . . . 74.510000000000005 109.766 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.71 HG21 HG11 ' A' ' 28' ' ' VAL . 34.3 m -135.17 153.87 34.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.812 0.339 . . . . 70.439999999999998 110.969 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.6 tp -107.39 115.84 30.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.907 -0.775 . . . . 62.109999999999999 108.907 173.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.498 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 47.4 t -97.85 109.1 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.161 -0.472 . . . . 75.540000000000006 110.115 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HB3' HD21 ' A' ' 10' ' ' LEU . 32.5 mt-10 -101.7 108.58 20.15 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.088 -0.505 . . . . 74.519999999999996 109.643 177.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -145.05 160.44 41.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.051 0.453 . . . . 74.340000000000003 111.075 -179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.716 ' H ' ' HB2' ' A' ' 67' ' ' ASN . 47.7 t -100.0 144.24 29.28 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.309 -0.626 . . . . 61.439999999999998 109.309 177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.0 mm -78.55 -17.09 13.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 111.793 0.294 . . . . 72.450000000000003 111.793 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -65.89 -84.22 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.865 0.691 . . . . 75.230000000000004 112.865 -170.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -148.45 -55.34 0.2 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.158 0.429 . . . . 74.109999999999999 112.158 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -48.77 -58.56 4.6 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.676 0.61 . . . . 71.030000000000001 112.093 -176.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.716 ' HB2' ' H ' ' A' ' 62' ' ' SER . 2.3 m-20 -100.68 25.83 7.43 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 122.405 -0.184 . . . . 71.319999999999993 110.888 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.28 -43.88 20.56 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.981 0.363 . . . . 63.439999999999998 111.981 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.651 ' HD2' ' H ' ' A' ' 69' ' ' LYS . 7.3 mptt -77.52 -33.7 54.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.992 0.425 . . . . 54.399999999999999 110.418 -176.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.8 OUTLIER -134.78 149.7 50.44 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.801 -0.636 . . . . 72.510000000000005 110.612 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.96 175.36 15.66 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.281 -0.962 . . . . 71.109999999999999 112.106 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -93.16 109.34 20.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.484 -0.561 . . . . 64.400000000000006 109.484 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 11.9 tt -99.32 126.95 52.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.161 -0.472 . . . . 61.530000000000001 110.617 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.73 HG23 ' H ' ' A' ' 75' ' ' ARG . 5.2 tt -118.2 -66.32 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.101 -0.5 . . . . 73.049999999999997 110.684 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.73 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER 174.91 175.51 0.19 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.646 -0.872 . . . . 75.230000000000004 108.646 176.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.537 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 31.8 tpt180 -69.41 120.9 15.93 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.964 0.411 . . . . 75.340000000000003 109.956 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 77' ' ' LEU . 2.6 pt? -73.72 177.57 5.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.903 -0.59 . . . . 62.32 109.962 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.95 122.38 20.72 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.214 -0.662 . . . . 63.240000000000002 109.214 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.49 44.65 3.11 Favored Glycine 0 N--CA 1.452 -0.29 0 CA-C-N 115.943 -0.572 . . . . 75.219999999999999 113.505 -169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.5 p 46.33 51.19 11.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.384 0.612 . . . . 71.109999999999999 112.038 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 p -89.54 15.52 9.26 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.883 -0.599 . . . . 74.25 111.38 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -90.82 5.79 46.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.209 -0.451 . . . . 75.129999999999995 111.002 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -65.92 -53.06 44.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 72.450000000000003 110.721 -177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.681 HG23 ' H ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -155.69 -80.49 0.08 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 119.396 -0.335 . . . . 60.420000000000002 111.781 176.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.681 ' H ' HG23 ' A' ' 84' ' ' THR . 41.1 pt 40.24 39.78 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.716 0.806 . . . . 62.229999999999997 111.961 -173.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 59.9 m 64.69 79.91 0.24 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.396 -0.82 . . . . 71.329999999999998 110.672 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.377 -0.821 . . . . 73.120000000000005 109.946 -179.534 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' HG23 ' A' ' 2' ' ' VAL . 26.9 ttt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.59 0.233 . . . . 54.43 110.749 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.428 HG23 ' HG2' ' A' ' 1' ' ' MET . 55.5 t -133.0 99.78 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-O 120.669 0.271 . . . . 74.140000000000001 110.945 -177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -143.15 111.28 6.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.166 -0.47 . . . . 73.099999999999994 110.306 178.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' HA ' HH21 ' A' ' 66' ' ' ARG . 31.9 t70 -149.86 -61.06 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.096 -0.642 . . . . 72.439999999999998 112.376 173.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.476 ' HA ' ' NH2' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -68.56 -31.39 70.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.803 0.335 . . . . 73.109999999999999 110.708 -173.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -92.59 14.26 17.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.033 -0.53 . . . . 72.140000000000001 111.164 -178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.578 ' HB3' ' HE2' ' A' ' 64' ' ' TYR . 14.5 m -76.58 95.73 3.98 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.226 -0.657 . . . . 53.039999999999999 109.226 175.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.84 1.27 57.09 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.008 -0.542 . . . . 64.030000000000001 111.286 -173.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.2 m -92.57 79.13 4.88 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.0 -0.741 . . . . 44.329999999999998 109.0 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.621 ' HA ' HG12 ' A' ' 63' ' ' ILE . 2.0 pt? -150.14 -177.04 5.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.713 -0.676 . . . . 72.150000000000006 110.019 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -142.74 124.04 14.67 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 110.572 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.28 139.19 30.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.17 -0.678 . . . . 72.519999999999996 109.17 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.6 161.61 27.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.698 0.285 . . . . 74.430000000000007 111.147 -175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -91.86 128.78 37.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.465 -0.568 . . . . 53.439999999999998 109.465 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.73 176.96 19.62 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.715 -0.755 . . . . 62.25 112.125 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -133.63 123.55 25.24 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.249 -0.278 . . . . 61.439999999999998 110.249 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.636 ' HA ' HG12 ' A' ' 28' ' ' VAL . 5.6 p -70.06 112.58 5.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.433 0.635 . . . . 74.340000000000003 110.231 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER -98.23 -24.78 15.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.751 -0.659 . . . . 52.409999999999997 110.308 -176.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -166.95 163.2 16.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.031 -0.531 . . . . 55.43 110.287 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -136.35 155.24 50.33 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.545 -0.539 . . . . 52.399999999999999 109.545 177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 7.1 mp -103.53 151.16 38.65 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 109.473 -0.566 . . . . 72.5 109.473 177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.02 38.24 0.46 Allowed 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.875 2.383 . . . . 65.030000000000001 112.406 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.83 28.06 2.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.728 -0.669 . . . . 71.129999999999995 110.13 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.67 20.58 12.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.577 -0.738 . . . . 71.120000000000005 111.581 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.46 135.18 45.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.513 -0.551 . . . . 74.219999999999999 109.513 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -118.58 139.89 50.76 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.596 -0.89 . . . . 73.239999999999995 108.596 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -124.45 107.2 10.84 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.864 0.84 . . . . 71.140000000000001 110.968 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 17' ' ' VAL . 13.7 m -96.56 148.24 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.458 -1.246 . . . . 74.019999999999996 109.114 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.546 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -116.28 140.35 49.42 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 119.88 -0.728 . . . . 64.430000000000007 110.388 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.571 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 48.8 tp -80.9 145.67 31.19 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.471 -0.937 . . . . 73.140000000000001 108.471 174.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.91 -8.75 51.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.798 0.332 . . . . 74.129999999999995 111.03 -177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.571 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 61.7 t30 -89.11 14.83 9.86 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.633 0.73 . . . . 72.030000000000001 109.536 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 68.15 52.19 0.68 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.159 -0.928 . . . . 73.230000000000004 112.764 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -129.8 141.25 50.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.823 -0.626 . . . . 71.430000000000007 109.434 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.54 139.62 49.43 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.116 0.484 . . . . 75.150000000000006 110.737 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.1 pt -132.26 154.85 40.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.803 -0.635 . . . . 70.129999999999995 110.513 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 2.5 mp -88.92 134.41 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.799 -0.637 . . . . 74.109999999999999 109.589 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 62.0 m -122.95 140.74 52.69 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.082 0.468 . . . . 73.239999999999995 110.036 176.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -151.57 149.49 29.24 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.413 -0.958 . . . . 70.239999999999995 108.413 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.7 m -70.76 118.47 15.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.403 0.621 . . . . 74.329999999999998 110.663 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.7 m -153.22 53.53 0.75 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.708 -0.678 . . . . 63.049999999999997 109.864 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -165.96 -159.59 12.12 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 51.039999999999999 112.577 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -59.17 -22.09 60.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.784 0.434 . . . . 75.209999999999994 111.277 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.824 HG23 ' HB ' ' A' ' 49' ' ' ILE . 5.6 p -53.25 -35.01 23.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.171 -0.468 . . . . 63.450000000000003 111.335 178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -68.94 -38.62 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 75.129999999999995 110.475 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -81.97 -28.79 32.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 64.329999999999998 111.409 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -86.59 -5.57 59.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.699 -0.228 . . . . 75.140000000000001 111.252 -176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.8 mttt 60.61 37.91 19.02 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.971 0.415 . . . . 54.25 110.86 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.824 ' HB ' HG23 ' A' ' 44' ' ' VAL . 47.5 mm -66.0 133.68 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.291 0.567 . . . . 73.120000000000005 111.535 -175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 29.8 ttt85 -88.99 105.45 17.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.477 -0.783 . . . . 72.329999999999998 110.888 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 74' ' ' ILE . 51.9 mt -85.89 123.63 39.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.047 -0.524 . . . . 61.420000000000002 109.98 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -118.63 151.84 20.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.851 0.358 . . . . 72.140000000000001 111.062 -175.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 54.6 mt -78.48 141.88 14.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 110.974 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.446 ' H ' HG13 ' A' ' 17' ' ' VAL . . . 89.68 9.2 66.7 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.028 -0.606 . . . . 71.129999999999995 112.637 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -110.93 151.53 27.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.698 0.285 . . . . 72.450000000000003 110.36 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.716 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 17.5 mmm180 -77.63 145.48 36.72 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.98 -0.748 . . . . 74.409999999999997 108.98 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG21 HG11 ' A' ' 28' ' ' VAL . 30.2 m -132.68 154.73 40.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.855 0.36 . . . . 71.349999999999994 111.2 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.7 tp -106.64 106.65 17.28 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.673 -0.862 . . . . 70.409999999999997 108.673 174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.7 p -97.39 127.64 49.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.453 0.644 . . . . 72.409999999999997 111.195 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -102.9 111.22 23.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.177 -0.92 . . . . 72.400000000000006 109.669 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.562 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -133.87 158.6 43.0 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.001 0.429 . . . . 75.209999999999994 111.004 179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.462 ' HA ' ' HB2' ' A' ' 10' ' ' LEU . 18.7 m -100.26 143.35 30.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.971 -0.559 . . . . 72.409999999999997 110.759 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.621 HG12 ' HA ' ' A' ' 10' ' ' LEU . 18.9 mm -77.97 3.37 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 121.282 0.563 . . . . 74.420000000000002 111.267 -176.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.578 ' HE2' ' HB3' ' A' ' 7' ' ' SER . 87.8 m-85 -78.72 -91.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.322 0.49 . . . . 75.150000000000006 112.322 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -148.07 -69.25 0.23 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.812 0.671 . . . . 73.420000000000002 112.812 -175.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.718 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -55.88 -44.81 78.5 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.674 0.273 . . . . 74.209999999999994 111.129 -175.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.562 ' O ' ' HB2' ' A' ' 61' ' ' MET . 84.2 m-20 -99.24 21.94 11.21 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.537 -0.301 . . . . 62.539999999999999 111.197 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -93.35 -18.32 22.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.468 0.651 . . . . 53.229999999999997 109.55 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -102.08 -45.34 5.19 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.198 -0.91 . . . . 74.219999999999999 109.873 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 12.5 ptmm? -106.83 137.65 44.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.434 -0.803 . . . . 63.229999999999997 110.841 177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -116.79 169.81 13.18 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.666 -0.778 . . . . 73.030000000000001 111.963 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.476 ' NH2' ' HA ' ' A' ' 5' ' ' GLU . 60.1 mtt180 -92.87 109.35 20.79 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.523 -0.547 . . . . 54.439999999999998 109.523 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 14.5 tt -102.39 143.74 14.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.926 -0.579 . . . . 73.400000000000006 110.793 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.692 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.4 tt -140.8 -65.76 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.824 -0.626 . . . . 70.519999999999996 110.261 176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.692 ' H ' HG23 ' A' ' 74' ' ' ILE . 9.5 mtp180 176.13 173.55 0.35 Allowed 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.615 1.166 . . . . 53.130000000000003 108.118 175.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.716 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -87.05 132.6 33.76 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.215 -0.661 . . . . 65.230000000000004 109.215 173.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.584 ' N ' ' HD3' ' A' ' 76' ' ' ARG . 52.1 tp -62.56 145.69 53.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.751 -0.463 . . . . 60.549999999999997 109.751 176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.704 ' HD3' ' H ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -47.86 124.88 7.97 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.689 0.618 . . . . 63.32 111.075 -176.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.48 161.36 51.51 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.4 -0.818 . . . . 72.140000000000001 113.125 -174.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.8 t -105.35 150.25 25.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.924 -0.398 . . . . 75.099999999999994 109.924 178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -100.81 6.2 43.72 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.398 0.518 . . . . 74.150000000000006 112.398 -171.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 16.7 p-10 -78.62 -45.56 21.3 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.923 -0.399 . . . . 75.510000000000005 109.923 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 63.33 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.578 -0.737 . . . . 61.240000000000002 112.518 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.7 m -96.09 -34.68 11.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.99 -0.55 . . . . 75.510000000000005 111.402 -171.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 35.2 pt -113.46 160.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.277 -0.419 . . . . 71.019999999999996 111.165 -173.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.5 m -74.25 -55.68 5.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.05 -0.523 . . . . 41.109999999999999 109.592 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? . . . . . 0 C--O 1.245 0.862 0 N-CA-C 108.685 -0.857 . . . . 74.400000000000006 108.685 174.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 110.123 -0.325 . . . . 73.340000000000003 110.123 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 t 50.36 80.03 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.818 -0.628 . . . . 61.210000000000001 111.989 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 39.2 mmtm -138.27 101.76 4.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.903 -0.59 . . . . 74.140000000000001 109.579 176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -119.57 -57.1 2.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.865 -0.607 . . . . 72.519999999999996 111.042 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.27 -42.77 73.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.415 0.626 . . . . 75.239999999999995 109.957 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -113.92 100.91 8.78 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.577 -0.897 . . . . 71.230000000000004 108.577 170.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 24.3 m -85.96 -7.91 58.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.656 -0.702 . . . . 71.239999999999995 112.694 -169.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.73 -162.74 0.28 Allowed 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.317 0.386 . . . . 72.340000000000003 110.495 -175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -84.43 106.29 15.92 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 63.210000000000001 110.005 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 2.4 pt? -137.81 151.33 48.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.038 -0.528 . . . . 53.240000000000002 110.184 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -105.57 124.61 49.84 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.164 0.507 . . . . 73.200000000000003 110.029 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' HB3' HD11 ' A' ' 58' ' ' LEU . 9.3 mt-10 -92.46 104.08 16.44 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.679 -0.691 . . . . 65.420000000000002 109.603 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.5 149.34 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.955 -0.566 . . . . 75.420000000000002 111.148 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -123.66 133.98 53.82 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.925 -0.58 . . . . 71.209999999999994 110.614 -177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.72 163.55 32.7 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.475 -0.65 . . . . 74.200000000000003 111.475 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 56' ' ' ARG . . . -86.51 128.46 34.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.862 0.363 . . . . 70.230000000000004 110.998 -179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 4.6 p -75.06 124.85 33.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 75.25 110.245 178.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.1 t -104.0 -30.52 10.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.289 -0.414 . . . . 55.43 111.656 -173.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.03 168.42 26.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.557 -0.292 . . . . 72.530000000000001 110.741 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.781 HD22 HD11 ' A' ' 53' ' ' ILE . 2.4 pt? -143.28 155.46 44.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.921 -0.581 . . . . 73.140000000000001 109.751 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 19.4 tp -107.65 142.81 25.98 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 108.442 -0.947 . . . . 63.109999999999999 108.442 177.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.53 ' HD2' HD12 ' A' ' 21' ' ' LEU . 42.1 Cg_endo -67.51 36.22 0.16 Allowed 'Trans proline' 0 N--CA 1.479 0.66 0 C-N-CA 123.219 2.613 . . . . 74.420000000000002 113.377 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -133.84 28.0 3.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.797 -0.638 . . . . 62.299999999999997 109.428 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.33 24.02 10.62 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.264 -0.88 . . . . 71.099999999999994 111.261 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.765 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 40.5 tt0 -100.66 136.52 40.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.867 -0.606 . . . . 44.520000000000003 110.132 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' HB2' ' HB2' ' A' ' 38' ' ' CYS . 72.1 m-85 -121.83 147.52 45.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.83 -0.804 . . . . 74.420000000000002 108.83 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -128.7 112.18 13.95 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.375 -0.53 . . . . 73.129999999999995 111.123 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 23.7 m -101.71 151.32 5.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.281 -0.872 . . . . 72.530000000000001 109.073 174.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.21 131.48 56.92 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 119.969 -0.692 . . . . 71.140000000000001 109.711 175.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.3 tp -85.91 156.99 20.28 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.481 -0.781 . . . . 71.019999999999996 109.221 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -69.7 -1.13 8.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.354 0.597 . . . . 70.439999999999998 110.889 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -88.12 12.45 13.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.374 -0.83 . . . . 72.510000000000005 109.49 174.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 69.0 31.74 4.03 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.477 -0.783 . . . . 50.229999999999997 111.281 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -130.35 140.01 50.64 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.441 -0.345 . . . . 64.150000000000006 110.826 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -93.65 143.35 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.52 -0.309 . . . . 75.409999999999997 110.206 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.0 mt -118.82 133.79 64.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.409 -0.36 . . . . 70.439999999999998 110.335 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 64.5 mt -77.21 113.48 16.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.239 0.542 . . . . 51.520000000000003 110.304 179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.708 ' HB2' ' HB2' ' A' ' 26' ' ' PHE . 28.3 m -108.67 143.5 37.67 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.108 -0.496 . . . . 65.299999999999997 110.204 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -148.95 156.23 41.98 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.96 -0.755 . . . . 74.540000000000006 108.96 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.81 132.21 33.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.722 -0.473 . . . . 74.349999999999994 109.722 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 t -117.99 -166.07 1.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.892 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -49.03 -93.4 0.01 OUTLIER Glycine 0 CA--C 1.519 0.285 0 CA-C-N 115.237 -0.892 . . . . 52.140000000000001 114.933 -174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -49.16 -39.58 29.53 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.578 0.584 . . . . 71.040000000000006 112.578 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.679 HG13 ' HB ' ' A' ' 49' ' ' ILE . 57.1 t -58.21 -40.66 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.899 0.381 . . . . 54.109999999999999 110.883 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -67.35 -39.73 85.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 63.210000000000001 110.644 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 1.8 mpt_? -76.4 -32.92 58.81 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 121.146 -0.221 . . . . 73.310000000000002 111.396 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.2 p -80.97 -9.99 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.761 0.315 . . . . 72.519999999999996 110.847 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 66.55 37.51 4.48 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.679 -0.691 . . . . 74.340000000000003 111.239 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.774 HG21 HG13 ' A' ' 74' ' ' ILE . 50.0 mm -74.4 143.28 13.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.77 -0.65 . . . . 75.019999999999996 109.721 177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 50' ' ' ARG . 22.5 ttt180 -116.3 119.91 37.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.371 -0.377 . . . . 72.109999999999999 111.222 -175.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 51' ' ' ILE . 4.0 mp -86.84 116.93 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.941 -0.572 . . . . 62.130000000000003 109.48 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.765 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -105.91 147.7 11.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.917 0.389 . . . . 72.439999999999998 110.968 -177.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.781 HD11 HD22 ' A' ' 20' ' ' LEU . 60.7 mt -78.73 130.5 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.11 -0.496 . . . . 61.539999999999999 110.354 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.73 -18.53 11.67 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.55 -0.833 . . . . 53.32 112.521 177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.02 155.52 17.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.755 -0.461 . . . . 63.520000000000003 109.755 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.9 ' HD3' ' H ' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -96.92 109.98 22.59 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.32 -0.993 . . . . 73.0 108.32 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 73' ' ' ILE . 26.7 m -116.61 174.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.188 0.518 . . . . 73.450000000000003 112.233 -163.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 12' ' ' GLU . 44.4 tp -106.3 124.62 49.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.258 -0.883 . . . . 73.109999999999999 110.344 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 5.2 p -119.27 120.6 64.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.704 -0.68 . . . . 50.439999999999998 109.408 174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 28.5 mt-10 -98.54 109.47 22.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.807 -0.633 . . . . 75.409999999999997 110.222 -175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -125.35 153.06 43.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.174 -0.466 . . . . 74.010000000000005 111.105 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.672 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 47.2 t -100.02 143.96 29.62 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.14 -0.482 . . . . 73.329999999999998 110.711 -176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.421 ' O ' HG22 ' A' ' 63' ' ' ILE . 27.0 mm -79.54 3.2 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 116.271 -0.422 . . . . 73.109999999999999 111.581 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -73.81 -93.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 O-C-N 122.012 -0.43 . . . . 73.5 111.855 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -149.95 -67.51 0.2 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.337 0.495 . . . . 54.329999999999998 112.337 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' H ' ' CD ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -60.93 -39.45 89.45 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.896 0.332 . . . . 74.310000000000002 111.896 -174.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.672 ' HB2' ' HB3' ' A' ' 62' ' ' SER . 74.1 m-20 -98.75 20.11 13.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.569 -0.287 . . . . 72.430000000000007 110.345 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.96 -38.83 11.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.245 -0.434 . . . . 62.450000000000003 111.145 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 12.2 mptt -77.55 -44.75 27.52 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-O 121.209 0.528 . . . . 71.310000000000002 109.891 178.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -126.88 139.91 52.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.303 -0.862 . . . . 64.420000000000002 110.799 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -130.5 -176.39 14.4 Favored Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.617 -0.72 . . . . 74.329999999999998 111.665 -178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.603 ' HG3' ' HB2' ' A' ' 60' ' ' GLU . 13.3 ptt180 -91.5 109.17 20.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.391 0.615 . . . . 73.120000000000005 110.342 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 57' ' ' VAL . 13.4 tt -96.42 131.49 43.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.35 -0.841 . . . . 70.519999999999996 109.494 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.774 HG13 HG21 ' A' ' 49' ' ' ILE . 5.4 tt -116.38 -68.25 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.559 -0.457 . . . . 75.239999999999995 111.832 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.693 ' H ' HG23 ' A' ' 74' ' ' ILE . 19.4 ttt180 174.42 172.99 0.2 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 109.166 -0.679 . . . . 54.0 109.166 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.748 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 27.5 tpt180 -78.85 127.54 32.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.8 -0.444 . . . . 70.209999999999994 109.8 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD23 ' H ' ' A' ' 77' ' ' LEU . 2.5 pt? -61.85 123.56 18.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.315 -0.624 . . . . 73.450000000000003 109.315 174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -78.41 161.05 27.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.905 -0.405 . . . . 73.209999999999994 109.905 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.25 -65.69 2.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.797 -0.716 . . . . 75.049999999999997 111.735 -174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m 62.75 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.375 0.67 . . . . 75.299999999999997 111.84 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.1 p -91.33 75.72 6.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.082 -0.508 . . . . 55.130000000000003 111.299 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -76.98 -48.46 17.94 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.97 -0.559 . . . . 62.130000000000003 110.059 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 61.23 -94.25 0.04 OUTLIER 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.266 -0.879 . . . . 62.329999999999998 110.137 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 86.2 m -163.56 -45.07 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.561 -0.904 . . . . 74.219999999999999 108.561 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.8 pt 50.54 20.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.973 1.309 . . . . 72.310000000000002 113.524 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 16.2 p -134.96 153.03 52.22 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.007 -0.368 . . . . 75.239999999999995 110.007 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.861 -0.59 . . . . 71.109999999999999 110.313 -179.428 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 25.1 ttt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.408 -0.59 . . . . 64.109999999999999 109.408 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.42 -46.65 96.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 121.014 0.435 . . . . 61.539999999999999 110.386 174.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -89.25 74.93 7.85 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.928 -0.767 . . . . 61.420000000000002 108.928 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 1' ' ' MET . 12.4 t70 -105.22 -54.37 2.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.638 -0.71 . . . . 65.319999999999993 110.361 -175.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.95 -25.92 67.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.162 -0.926 . . . . 71.230000000000004 111.701 -176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 9.7 tptm -97.49 -0.65 45.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.001 0.371 . . . . 72.109999999999999 112.001 -173.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.3 p -104.64 94.74 5.46 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.831 0.348 . . . . 72.219999999999999 110.762 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -135.98 -29.31 1.02 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.995 -0.548 . . . . 70.150000000000006 110.865 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -95.79 92.89 6.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.988 0.423 . . . . 74.010000000000005 110.102 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 60' ' ' GLU . 2.2 pt? -150.81 168.92 22.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.273 -0.421 . . . . 62.240000000000002 110.948 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 63' ' ' ILE . 32.7 t80 -106.2 130.53 54.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.474 -174.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -119.15 127.23 53.13 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.845 -0.616 . . . . 62.32 110.87 -175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 HG23 HG13 ' A' ' 59' ' ' VAL . 3.6 m -141.79 177.32 3.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 120.968 0.413 . . . . 72.340000000000003 111.432 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -94.95 173.41 7.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 64.310000000000002 111.331 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.69 174.3 46.92 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.763 -0.935 . . . . 43.409999999999997 110.763 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.88 123.62 29.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.187 0.494 . . . . 62.439999999999998 110.554 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.832 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.5 p -72.01 134.09 30.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.096 -0.502 . . . . 72.200000000000003 110.963 -177.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.6 m -103.8 -47.56 4.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.025 -0.534 . . . . 75.230000000000004 110.981 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.6 168.18 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 63.240000000000002 110.608 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.586 HD22 HD11 ' A' ' 53' ' ' ILE . 2.5 pt? -135.15 155.74 50.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 64.25 110.847 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 19.0 tp -118.78 139.57 27.34 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 108.39 -0.967 . . . . 73.010000000000005 108.39 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.66 4.67 0.25 Allowed 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.308 2.672 . . . . 75.040000000000006 113.889 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 28.5 1.94 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.341 -0.244 . . . . 64.25 110.341 177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.56 27.39 17.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.501 0.667 . . . . 61.32 110.12 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 33.1 tt0 -112.88 136.6 52.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.121 -0.945 . . . . 72.299999999999997 110.134 -172.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.839 ' HB2' ' HB2' ' A' ' 38' ' ' CYS . 99.0 m-85 -125.91 162.56 24.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.438 -0.346 . . . . 73.409999999999997 110.169 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -137.09 112.96 9.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.266 0.555 . . . . 72.239999999999995 110.844 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.832 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.7 m -118.28 155.6 20.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.107 -0.951 . . . . 61.25 109.25 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.741 ' HD3' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -117.71 130.26 56.22 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.294 0.568 . . . . 61.030000000000001 110.722 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.1 tp -70.74 144.92 50.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 108.089 -1.078 . . . . 62.32 108.089 170.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.65 1.09 3.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.819 0.342 . . . . 73.310000000000002 111.542 -175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -108.45 34.69 3.51 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.392 0.615 . . . . 74.510000000000005 109.869 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 66.9 38.5 3.64 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.184 0.809 . . . . 74.129999999999995 113.184 171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -128.99 118.71 23.04 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.366 -0.533 . . . . 55.100000000000001 111.253 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 44.4 mt-10 -104.22 127.44 51.84 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.528 -0.545 . . . . 70.319999999999993 109.528 176.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 pt -117.39 147.99 20.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.974 0.416 . . . . 65.25 111.335 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 61.2 mt -73.63 112.51 10.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.862 -0.608 . . . . 64.25 109.368 177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.839 ' HB2' ' HB2' ' A' ' 26' ' ' PHE . 15.7 m -98.4 141.56 31.12 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.264 -0.425 . . . . 45.420000000000002 110.778 -174.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -151.26 127.76 10.74 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.341 -0.615 . . . . 72.209999999999994 109.341 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 m -72.15 117.53 15.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.17 0.509 . . . . 70.109999999999999 110.912 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.3 m -160.67 55.76 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.819 -0.628 . . . . 44.340000000000003 110.146 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.646 ' HA3' ' HD3' ' A' ' 72' ' ' ARG . . . -164.74 -135.74 1.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 119.767 -1.206 . . . . 62.140000000000001 113.389 -178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -62.09 -18.22 60.05 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.427 0.691 . . . . 74.019999999999996 111.626 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.575 HG22 ' HB ' ' A' ' 74' ' ' ILE . 12.1 t -54.3 -38.85 41.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.12 0.486 . . . . 43.340000000000003 110.461 176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 4.3 tmt_? -70.7 -28.55 64.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.57 -0.741 . . . . 74.219999999999999 110.647 -176.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.41 -53.35 8.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.188 0.518 . . . . 72.409999999999997 110.856 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 13.7 t -90.89 -9.16 47.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.747 -0.66 . . . . 53.32 111.866 -170.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 55.44 46.52 23.05 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.273 0.358 . . . . 75.430000000000007 111.346 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.809 HD12 HD11 ' A' ' 74' ' ' ILE . 44.2 mt -83.04 139.54 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.998 0.428 . . . . 74.040000000000006 110.593 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.0 tpt180 -87.62 125.64 34.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.899 -0.592 . . . . 75.120000000000005 111.122 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.25 125.72 44.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.095 -0.502 . . . . 73.409999999999997 109.653 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -128.57 148.52 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.684 0.278 . . . . 60.549999999999997 110.825 179.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.586 HD11 HD22 ' A' ' 20' ' ' LEU . 61.3 mt -74.39 139.39 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 64.25 110.744 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.62 -15.67 52.73 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.832 -0.699 . . . . 71.439999999999998 111.794 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.87 175.31 6.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.584 -0.524 . . . . 70.25 109.584 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.605 ' HG3' ' HA ' ' A' ' 78' ' ' LYS . 13.9 mmm180 -92.38 154.02 18.81 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.397 -0.594 . . . . 74.25 109.397 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.67 ' HB ' HG23 ' A' ' 73' ' ' ILE . 35.1 m -127.0 152.89 35.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.92 -178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 48.9 tp -107.65 122.34 46.51 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.517 -0.92 . . . . 51.539999999999999 108.517 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.653 ' HB ' HG13 ' A' ' 73' ' ' ILE . 2.2 p -116.78 121.6 68.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 121.252 0.549 . . . . 63.310000000000002 111.317 -177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.573 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 8.3 pt-20 -109.25 114.2 27.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.226 -0.897 . . . . 71.519999999999996 109.864 174.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.451 ' O ' ' HB2' ' A' ' 10' ' ' LEU . 3.7 ppp? -123.44 159.2 29.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.831 0.348 . . . . 71.239999999999995 110.766 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 16.0 m -99.11 130.39 45.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.735 0.302 . . . . 74.439999999999998 110.952 -174.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.449 HD11 ' HB2' ' A' ' 11' ' ' PHE . 46.7 mm -69.35 -19.08 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.923 -0.58 . . . . 74.129999999999995 111.156 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -60.38 -88.71 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.54 0.57 . . . . 71.25 112.54 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -150.26 -68.75 0.19 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.799 0.666 . . . . 75.349999999999994 112.799 -172.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.883 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -53.23 -48.13 68.43 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.994 -0.548 . . . . 74.439999999999998 112.382 -172.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 6.3 m-20 -99.46 26.94 5.61 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 111.712 0.264 . . . . 61.420000000000002 111.712 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.79 -44.07 43.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.639 0.257 . . . . 73.25 111.065 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -89.94 -14.55 33.89 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.83 0.348 . . . . 64.230000000000004 111.262 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.482 ' O ' ' HD2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -143.73 134.54 25.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.203 0.525 . . . . 71.140000000000001 111.267 -179.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -125.47 -175.92 14.37 Favored Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.652 -0.704 . . . . 72.310000000000002 111.952 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.646 ' HD3' ' HA3' ' A' ' 42' ' ' GLY . 76.5 mtt180 -92.44 108.54 20.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.657 -0.498 . . . . 70.420000000000002 109.657 178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.67 HG23 ' HB ' ' A' ' 57' ' ' VAL . 2.8 mp -99.19 124.11 52.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.388 -0.597 . . . . 41.520000000000003 109.388 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.809 HD11 HD12 ' A' ' 49' ' ' ILE . 9.0 tt -118.46 -70.28 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.032 -0.667 . . . . 62.229999999999997 112.504 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.715 ' H ' HG23 ' A' ' 74' ' ' ILE . 4.4 tmt_? 173.3 148.11 0.06 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.865 -0.42 . . . . 71.150000000000006 109.865 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.549 ' N ' ' HD3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -149.67 147.84 28.56 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.134 -0.321 . . . . 72.340000000000003 110.134 171.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 78' ' ' LYS . 20.5 tp -52.18 149.48 5.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.934 -0.576 . . . . 72.409999999999997 111.119 173.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.605 ' HA ' ' HG3' ' A' ' 56' ' ' ARG . 10.7 mptt -63.53 179.45 0.46 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.218 0.532 . . . . 65.150000000000006 110.998 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.07 -176.92 35.53 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.618 -0.801 . . . . 64.150000000000006 111.542 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 10.2 t -128.56 152.67 48.04 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.888 0.344 . . . . 74.329999999999998 110.374 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.4 m 66.15 179.8 0.2 Allowed 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.736 0.648 . . . . 64.519999999999996 111.541 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' HG12 ' A' ' 85' ' ' ILE . 1.4 m-20 -92.48 -2.19 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.176 -0.465 . . . . 74.409999999999997 110.497 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 64.72 -82.76 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 71.099999999999994 111.636 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -136.73 -8.05 1.89 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.897 0.332 . . . . 71.530000000000001 111.897 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 82' ' ' ASP . 29.1 pt -77.44 82.29 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 121.683 0.754 . . . . 51.409999999999997 111.53 -176.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.3 m -94.78 14.82 20.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.661 -0.7 . . . . 70.209999999999994 110.632 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.543 -0.741 . . . . 71.140000000000001 109.318 179.024 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.748 ' HG2' ' H ' ' A' ' 2' ' ' VAL . 33.4 ttm . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 108.91 -0.774 . . . . 63.350000000000001 108.91 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.748 ' H ' ' HG2' ' A' ' 1' ' ' MET . 17.5 m -98.15 -21.03 5.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.366 0.603 . . . . 75.5 109.851 170.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.9 mmpt? -100.23 88.35 3.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.433 -0.803 . . . . 74.329999999999998 109.303 176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.25 -74.6 0.61 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.014 -0.365 . . . . 63.030000000000001 110.014 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -84.15 -34.91 23.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.136 -0.484 . . . . 71.219999999999999 110.184 177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -101.69 35.03 2.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.875 -0.602 . . . . 72.25 110.367 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 p -68.7 -31.27 70.23 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.098 -0.501 . . . . 64.510000000000005 111.415 -178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 8' ' ' LYS . 71.9 mmtt 72.56 168.94 0.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.748 0.819 . . . . 75.430000000000007 112.013 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 m -90.17 139.49 30.59 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.222 -0.899 . . . . 75.530000000000001 111.427 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 ' HG ' ' OG ' ' A' ' 62' ' ' SER . 5.7 mp -122.63 150.96 41.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.474 -0.565 . . . . 62.240000000000002 109.474 174.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.6 t80 -97.11 126.75 42.49 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.196 -0.668 . . . . 74.049999999999997 109.196 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -105.46 116.74 32.46 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.092 -0.504 . . . . 72.209999999999994 109.868 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.7 p -131.9 156.09 42.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.794 0.33 . . . . 61.219999999999999 110.63 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.64 145.93 24.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.179 -0.464 . . . . 63.329999999999998 110.797 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -153.27 -166.43 14.54 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 121.07 -0.586 . . . . 42.299999999999997 112.001 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.58 129.5 39.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.292 -0.262 . . . . 73.219999999999999 110.292 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.865 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.3 p -73.1 132.14 33.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.965 0.412 . . . . 72.409999999999997 111.259 -177.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 m -97.53 -49.04 5.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.15 -0.477 . . . . 64.549999999999997 111.267 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -169.2 169.05 9.52 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.2 -0.454 . . . . 33.409999999999997 110.564 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.7 pt? -134.65 154.25 51.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 65.409999999999997 110.863 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 25' ' ' GLU . 6.8 mp -102.91 152.23 38.47 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.596 -0.729 . . . . 75.109999999999999 109.197 175.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -61.46 -10.93 17.67 Favored 'Trans proline' 0 CA--C 1.532 0.403 0 C-N-CA 122.964 2.443 . . . . 74.129999999999995 112.986 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.48 17.76 9.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 63.140000000000001 111.154 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 70.19 19.31 6.69 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.985 -0.552 . . . . 60.340000000000003 111.493 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 21' ' ' LEU . 10.6 tp10 -92.54 136.77 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.774 -0.824 . . . . 75.340000000000003 108.774 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.499 ' HE1' HG13 ' A' ' 40' ' ' VAL . 97.3 m-85 -122.01 157.8 30.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 120.943 0.401 . . . . 75.549999999999997 110.561 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -133.12 125.08 28.74 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.098 -0.501 . . . . 72.010000000000005 109.764 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.865 HG12 ' HA ' ' A' ' 17' ' ' VAL . 8.6 m -133.16 154.48 39.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.452 -0.573 . . . . 73.439999999999998 109.452 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 1.043 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -110.49 140.99 44.22 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.038 -0.665 . . . . 51.530000000000001 111.316 177.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 tp -66.25 153.6 42.1 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.987 -1.116 . . . . 74.140000000000001 107.987 169.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -64.03 -11.36 28.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.438 . . . . 63.530000000000001 111.406 -174.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -95.48 27.7 3.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 51.109999999999999 111.513 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 71.86 21.67 4.12 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.938 0.718 . . . . 64.129999999999995 112.938 171.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -120.5 119.25 32.43 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.17 -0.612 . . . . 74.450000000000003 110.294 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 1.043 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 36.6 mt-10 -86.63 144.1 27.32 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.223 0.535 . . . . 60.409999999999997 111.124 -176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.2 pt -130.22 150.34 34.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.597 -0.729 . . . . 63.439999999999998 109.731 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 4.0 mp -89.83 139.97 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 109.158 -0.682 . . . . 65.230000000000004 109.158 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 61.4 m -143.36 167.43 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.43 -0.211 . . . . 71.340000000000003 110.43 -177.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.476 ' HA ' ' HD1' ' A' ' 26' ' ' PHE . 29.9 p80 -157.0 170.19 23.1 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.896 -0.409 . . . . 70.140000000000001 109.896 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.499 HG13 ' HE1' ' A' ' 26' ' ' PHE . 25.9 m -72.07 146.42 11.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.787 0.327 . . . . 62.109999999999999 110.312 177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 17.8 t -121.72 -164.84 1.18 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.247 -0.433 . . . . 61.009999999999998 110.154 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -42.47 -91.5 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 O-C-N 124.254 0.971 . . . . 60.130000000000003 114.676 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -44.4 -44.78 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.877 0.471 . . . . 75.129999999999995 112.244 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.5 t -55.5 -44.34 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.696 0.284 . . . . 64.420000000000002 111.617 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -65.41 -49.82 67.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.431 -0.35 . . . . 63.32 110.923 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -87.23 -1.78 58.15 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.667 -0.413 . . . . 74.25 111.632 -174.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 t -95.27 -12.77 25.64 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.722 -0.474 . . . . 61.43 109.722 173.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.7 mttt 57.82 77.54 0.28 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.346 -0.843 . . . . 65.230000000000004 111.629 177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.455 HG21 HG13 ' A' ' 74' ' ' ILE . 41.9 mm -107.14 118.37 54.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.033 -0.531 . . . . 63.409999999999997 109.682 176.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -79.15 106.33 11.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.302 -0.408 . . . . 75.040000000000006 111.02 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 74' ' ' ILE . 35.6 mt -86.77 130.41 36.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 109.703 -0.48 . . . . 74.019999999999996 109.703 176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.643 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -123.44 149.82 27.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.591 0.234 . . . . 74.129999999999995 110.776 -177.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 57.6 mt -78.25 140.62 16.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.274 -0.421 . . . . 63.149999999999999 110.448 177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.43 26.48 20.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 64.340000000000003 112.16 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -139.68 164.32 30.24 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.637 -0.505 . . . . 72.319999999999993 109.637 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 76' ' ' ARG . 32.6 mmt180 -75.87 151.08 37.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.499 -0.556 . . . . 73.409999999999997 109.499 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.558 HG11 HD11 ' A' ' 73' ' ' ILE . 25.9 m -136.24 151.0 28.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 120.919 0.39 . . . . 72.140000000000001 110.918 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.6 tp -107.4 122.4 46.54 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.763 -0.829 . . . . 64.400000000000006 108.763 174.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.7 p -112.12 131.61 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.371 0.605 . . . . 44.25 110.501 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.663 ' OE2' ' HD2' ' A' ' 72' ' ' ARG . 42.4 tt0 -112.84 111.7 22.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.226 -0.897 . . . . 60.340000000000003 109.667 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.599 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -143.66 145.99 32.88 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.191 0.52 . . . . 62.439999999999998 111.147 -178.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.533 ' H ' ' CB ' ' A' ' 67' ' ' ASN . 4.7 m -84.65 143.21 29.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.17 -0.468 . . . . 54.240000000000002 110.354 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.778 ' H ' HD12 ' A' ' 63' ' ' ILE . 1.8 mp -78.06 4.04 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.298 0.571 . . . . 75.349999999999994 111.057 -176.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -75.62 -88.52 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.325 0.491 . . . . 75.400000000000006 112.325 -176.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -148.89 -64.42 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.84 0.681 . . . . 73.430000000000007 112.84 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.634 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.36 -33.31 67.66 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.77 0.319 . . . . 72.530000000000001 111.858 -175.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.599 ' O ' ' HB2' ' A' ' 61' ' ' MET . 94.6 m-20 -102.01 14.29 32.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.624 -0.262 . . . . 71.409999999999997 111.466 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -85.66 -32.39 22.01 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.151 -0.343 . . . . 43.130000000000003 111.921 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -100.18 -37.51 8.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.724 0.297 . . . . 74.340000000000003 110.288 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -119.73 131.12 55.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.62 . . . . 53.399999999999999 110.571 174.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -117.4 174.82 15.41 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.293 -0.723 . . . . 74.219999999999999 111.293 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.663 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 5.5 ptp180 -94.11 124.75 38.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.24 0.543 . . . . 74.109999999999999 109.837 177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.558 HD11 HG11 ' A' ' 57' ' ' VAL . 5.5 tt -106.96 136.8 40.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.598 -0.728 . . . . 72.140000000000001 110.0 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.724 HG23 ' H ' ' A' ' 75' ' ' ARG . 5.6 tt -120.57 -67.94 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 120.821 -0.352 . . . . 75.040000000000006 111.221 177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.724 ' H ' HG23 ' A' ' 74' ' ' ILE . 8.7 ttt180 173.88 176.14 0.13 Allowed 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.336 -0.616 . . . . 72.109999999999999 109.336 176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.687 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 0.6 OUTLIER -69.31 150.64 47.15 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 123.28 0.362 . . . . 71.239999999999995 110.174 172.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.653 ' HG ' ' H ' ' A' ' 78' ' ' LYS . 11.8 tp -137.04 176.17 8.95 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.529 -0.915 . . . . 73.230000000000004 108.529 166.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.653 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -68.02 109.2 3.38 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.345 -0.613 . . . . 52.020000000000003 109.345 176.066 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.1 66.23 3.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.56 -0.745 . . . . 65.439999999999998 113.746 -168.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.0 t -84.32 95.27 8.67 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.584 0.707 . . . . 72.129999999999995 109.326 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.699 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 25.6 m -131.19 166.93 20.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.963 -0.562 . . . . 70.299999999999997 111.267 -174.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.577 ' HA ' HG12 ' A' ' 85' ' ' ILE . 9.7 p-10 -69.11 1.66 3.41 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.871 0.693 . . . . 63.32 112.871 -172.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.699 ' HD3' ' HB2' ' A' ' 81' ' ' SER . 7.2 ptt180 -64.68 -32.78 74.61 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.382 0.512 . . . . 71.310000000000002 112.382 -174.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 2.7 m -155.9 20.56 0.38 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 120.651 -0.42 . . . . 60.030000000000001 111.912 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 82' ' ' ASP . 31.2 pt -86.61 23.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.666 -0.646 . . . . 65.200000000000003 111.166 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.3 m -125.36 16.02 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.06 -0.518 . . . . 53.530000000000001 110.097 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.557 -0.735 . . . . 74.349999999999994 109.915 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 4' ' ' ASP . 88.2 mtp . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 110.086 -0.338 . . . . 72.409999999999997 110.086 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG23 ' HG2' ' A' ' 3' ' ' LYS . 12.9 m -69.36 -45.96 77.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.873 0.368 . . . . 70.430000000000007 110.432 176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 2' ' ' VAL . 71.5 mmtt -93.86 85.81 4.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 173.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 1' ' ' MET . 2.5 t70 -130.98 -42.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.083 -0.508 . . . . 74.439999999999998 110.974 -170.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 21.8 mm-40 -61.58 -33.13 73.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.868 -0.606 . . . . 75.439999999999998 110.765 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -96.7 12.16 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.995 -0.548 . . . . 75.209999999999994 110.72 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.3 m -106.65 7.97 30.87 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.981 -0.554 . . . . 61.100000000000001 109.624 175.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 5' ' ' GLU . 99.5 mttt -67.1 -31.51 72.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.602 -0.726 . . . . 73.239999999999995 110.584 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.1 m -87.68 81.13 7.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 61.039999999999999 109.416 172.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 10' ' ' LEU . 1.9 pt? -132.95 167.87 19.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.575 -0.739 . . . . 62.020000000000003 109.789 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.408 ' CE2' ' HB ' ' A' ' 13' ' ' VAL . 50.8 t80 -110.38 124.56 51.93 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.398 -0.593 . . . . 61.210000000000001 109.398 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -100.12 111.19 23.47 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.162 -0.681 . . . . 72.030000000000001 109.162 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' HB ' ' CE2' ' A' ' 11' ' ' PHE . 9.9 p -129.54 162.75 36.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.801 0.334 . . . . 74.530000000000001 111.218 -173.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -93.18 130.02 39.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.021 -0.536 . . . . 72.540000000000006 110.115 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.15 158.68 21.62 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.205 -0.758 . . . . 32.210000000000001 111.205 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.36 123.45 47.43 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 117.212 0.506 . . . . 70.439999999999998 110.666 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.599 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.7 p -76.98 130.39 36.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.999 0.428 . . . . 72.349999999999994 110.435 -178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.3 t -126.55 -19.52 4.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.285 -0.416 . . . . 74.120000000000005 111.797 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -166.31 168.14 15.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.049 0.452 . . . . 71.040000000000006 111.899 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.01 150.25 37.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 109.267 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 8.1 mp -104.49 157.12 34.78 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.436 -0.347 . . . . 71.310000000000002 110.752 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.85 -19.61 47.95 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.153 2.568 . . . . 73.329999999999998 113.022 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -78.09 14.08 1.26 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.545 0.202 . . . . 71.340000000000003 111.545 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.41 19.02 10.95 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.172 0.511 . . . . 74.109999999999999 111.555 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -105.59 135.78 46.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.586 -0.524 . . . . 63.420000000000002 109.586 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -97.31 158.12 15.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.88 -0.6 . . . . 73.439999999999998 109.613 -178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 41.1 mtt180 -126.37 119.48 27.41 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.321 0.582 . . . . 74.519999999999996 110.784 175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 17' ' ' VAL . 24.6 m -118.49 152.31 20.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.075 -0.966 . . . . 75.109999999999999 108.648 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -128.75 140.54 51.68 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.094 -0.643 . . . . 74.239999999999995 110.822 -177.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 59.3 tp -76.31 131.97 39.52 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 107.043 -1.466 . . . . 64.25 107.043 168.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -62.1 -7.17 3.64 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.216 0.323 . . . . 71.150000000000006 111.601 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' SER . 25.6 t-20 -91.46 38.97 0.99 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.705 -0.48 . . . . 71.230000000000004 109.705 175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 61.82 40.24 13.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.284 0.846 . . . . 72.420000000000002 113.284 172.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -129.61 118.2 21.6 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.147 -0.346 . . . . 71.25 110.717 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -97.28 140.03 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.6 -0.273 . . . . 72.319999999999993 110.355 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 pt -134.71 145.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.0 0.428 . . . . 73.209999999999994 110.452 175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 4.3 mp -89.11 148.82 4.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.009 -0.738 . . . . 74.430000000000007 109.009 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 85.5 m -139.93 144.89 37.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.998 0.428 . . . . 73.0 111.293 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -132.47 137.69 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.668 -0.493 . . . . 71.120000000000005 109.668 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.67 117.69 15.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.209 0.528 . . . . 54.329999999999998 110.861 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -168.79 55.74 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.913 -0.773 . . . . 70.019999999999996 108.913 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -163.53 -145.96 4.55 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.434 -0.803 . . . . 63.210000000000001 111.362 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -62.63 -23.45 67.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.844 0.354 . . . . 75.299999999999997 110.937 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 74' ' ' ILE . 6.5 p -56.56 -39.86 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.191 -0.458 . . . . 60.399999999999999 111.483 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -33.43 25.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.862 0.363 . . . . 65.109999999999999 110.296 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -66.89 -44.31 81.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.013 -0.54 . . . . 72.329999999999998 110.924 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.9 t -93.24 -1.74 55.83 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.257 -0.429 . . . . 73.299999999999997 110.961 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.0 mttt 56.9 63.91 1.8 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.587 0.554 . . . . 61.32 111.212 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG13 HD11 ' A' ' 74' ' ' ILE . 49.3 mm -95.58 139.68 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.679 -0.691 . . . . 55.210000000000001 110.931 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -97.3 117.27 31.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 71.129999999999995 111.179 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 51' ' ' ILE . 4.5 mp -86.9 124.18 40.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.707 -0.679 . . . . 72.349999999999994 109.794 178.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.722 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -114.32 147.91 17.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.759 0.314 . . . . 75.230000000000004 110.415 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 50.2 mt -78.28 142.45 14.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.306 -0.406 . . . . 75.430000000000007 110.483 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.82 41.39 6.37 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.59 -0.814 . . . . 70.540000000000006 111.638 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -148.89 177.42 9.56 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.987 -0.746 . . . . 74.439999999999998 108.987 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 mmt85 -101.59 150.12 23.41 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.335 -0.617 . . . . 65.430000000000007 109.335 176.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 28' ' ' VAL . 34.4 m -134.99 160.61 41.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 120.596 0.236 . . . . 72.140000000000001 110.457 178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 54.2 tp -106.58 116.34 31.75 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.713 -0.847 . . . . 73.239999999999995 108.713 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 72' ' ' ARG . 5.1 p -105.9 127.57 60.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.419 0.628 . . . . 72.239999999999995 110.715 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' OE2' ' HD2' ' A' ' 72' ' ' ARG . 23.4 mt-10 -103.25 108.83 20.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.193 -0.912 . . . . 74.099999999999994 109.327 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.473 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -142.38 142.14 32.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.213 0.53 . . . . 70.099999999999994 111.531 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 p -99.48 142.2 31.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.855 -0.611 . . . . 75.049999999999997 109.958 176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.727 ' H ' HD12 ' A' ' 63' ' ' ILE . 2.8 mp -78.16 3.53 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 71.120000000000005 111.244 -173.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -61.93 -81.49 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.652 0.612 . . . . 73.409999999999997 112.652 -176.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.32 -70.13 0.2 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.898 0.703 . . . . 75.400000000000006 112.898 -173.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.902 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -68.02 -31.04 70.43 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.846 0.355 . . . . 73.510000000000005 111.546 -174.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 20.0 m120 -99.07 10.3 41.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.867 0.365 . . . . 73.140000000000001 110.594 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.85 -19.62 44.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.185 -0.461 . . . . 33.119999999999997 111.007 -177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HE3' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -113.12 -21.28 11.12 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.733 -0.387 . . . . 73.319999999999993 110.59 177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -142.22 136.78 30.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.198 0.523 . . . . 74.519999999999996 111.281 -178.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 61' ' ' MET . . . -117.97 -175.56 16.87 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.682 -0.69 . . . . 63.439999999999998 111.953 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 52.6 mtt180 -89.97 116.89 28.36 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.971 -0.751 . . . . 73.450000000000003 108.971 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 38' ' ' CYS . 0.0 OUTLIER -108.45 130.0 61.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.942 -0.392 . . . . 70.530000000000001 109.942 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.749 HG23 ' H ' ' A' ' 75' ' ' ARG . 4.6 tt -132.74 -67.65 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.629 -0.26 . . . . 64.349999999999994 111.267 177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.749 ' H ' HG23 ' A' ' 74' ' ' ILE . 12.0 ttt180 175.01 173.28 0.23 Allowed 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.094 -0.706 . . . . 74.010000000000005 109.094 174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.467 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -86.08 149.36 25.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.747 0.308 . . . . 74.120000000000005 110.642 175.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.6 tp -93.0 145.09 24.63 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.433 -0.951 . . . . 72.530000000000001 108.433 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -65.35 126.3 27.78 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.145 -0.687 . . . . 73.319999999999993 109.145 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.05 61.87 0.58 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 109.452 -1.459 . . . . 42.219999999999999 109.452 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.406 HG21 ' HD3' ' A' ' 76' ' ' ARG . 8.8 t -146.2 -162.14 1.46 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.169 -0.515 . . . . 62.229999999999997 109.833 -168.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 83' ' ' ARG . 20.9 m 78.8 89.97 0.06 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.947 0.899 . . . . 73.030000000000001 111.658 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.518 ' O ' ' HB2' ' A' ' 83' ' ' ARG . 34.1 t70 -69.98 13.94 0.13 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.177 -0.92 . . . . 54.539999999999999 110.787 173.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 76.6 169.85 0.25 Allowed 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.854 0.862 . . . . 70.310000000000002 109.881 -176.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 11.3 t -72.75 -35.4 67.49 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.993 -0.283 . . . . 53.43 110.916 -176.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.5 pt 45.19 22.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.627 1.171 . . . . 74.349999999999994 113.865 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.494 ' HB3' ' HA ' ' A' ' 32' ' ' ASN . 33.2 p -126.79 3.54 6.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.071 0.463 . . . . 73.120000000000005 110.844 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.3 tpmt? . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.114 -0.946 . . . . 75.439999999999998 109.022 179.235 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 110.255 -0.276 . . . . 64.430000000000007 110.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 3' ' ' LYS . 34.6 m -95.72 -25.0 4.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.827 0.346 . . . . 73.430000000000007 111.005 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.509 ' HG2' HG23 ' A' ' 2' ' ' VAL . 73.7 mmtt -119.5 92.26 3.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.243 -0.435 . . . . 73.5 110.225 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -119.95 -36.52 3.26 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.887 -0.597 . . . . 65.120000000000005 110.236 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 22.8 mp0 -58.47 -55.79 30.44 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.681 -0.859 . . . . 74.420000000000002 108.681 175.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.861 ' HE2' ' HA ' ' A' ' 6' ' ' LYS . 7.2 mmpt? -110.25 83.17 1.71 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.865 -1.062 . . . . 74.030000000000001 108.206 167.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.1 m -55.14 -69.92 0.12 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.378 -0.828 . . . . 61.109999999999999 111.53 -174.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -142.93 105.18 4.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.849 -0.614 . . . . 70.319999999999993 109.885 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.7 m -87.47 97.55 10.89 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.322 -0.621 . . . . 75.040000000000006 109.322 173.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 62' ' ' SER . 1.9 pt? -139.2 169.02 18.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.776 -0.647 . . . . 71.439999999999998 110.715 -173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HB3' HD11 ' A' ' 63' ' ' ILE . 66.5 t80 -124.22 129.87 51.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.533 -0.543 . . . . 75.219999999999999 109.533 179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -101.71 115.08 29.74 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.951 -0.568 . . . . 73.400000000000006 110.297 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.2 p -136.46 153.26 30.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.503 -0.317 . . . . 73.230000000000004 110.191 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -102.32 155.64 18.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.984 0.421 . . . . 65.409999999999997 111.05 -179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.44 -168.81 20.44 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.826 -0.624 . . . . 61.409999999999997 111.756 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.14 124.27 42.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.901 0.351 . . . . 75.340000000000003 111.07 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.67 ' HA ' HG12 ' A' ' 28' ' ' VAL . 5.4 p -74.9 122.48 28.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.998 0.428 . . . . 65.0 109.892 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 t -113.57 -21.04 11.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.253 -0.43 . . . . 73.099999999999994 111.688 -174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.03 163.25 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.774 0.321 . . . . 43.130000000000003 110.819 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.665 HD22 HD11 ' A' ' 53' ' ' ILE . 2.7 pt? -128.92 143.5 50.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.072 -0.513 . . . . 72.299999999999997 109.705 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 23' ' ' ALA . 6.5 mp -96.34 146.75 31.85 Favored Pre-proline 0 C--N 1.314 -0.959 0 N-CA-C 109.289 -0.634 . . . . 61.439999999999998 109.289 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.0 20.75 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.806 2.338 . . . . 54.509999999999998 112.119 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -109.69 18.41 20.27 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.567 -0.742 . . . . 75.209999999999994 109.764 178.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 66.51 29.07 9.26 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.471 -0.786 . . . . 75.099999999999994 111.17 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' CYS . 10.3 pt-20 -136.8 151.01 48.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.581 . . . . 73.5 110.333 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -108.29 163.54 13.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.12 -0.491 . . . . 73.340000000000003 110.315 -174.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -126.58 130.19 50.04 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.525 -0.47 . . . . 74.430000000000007 110.337 174.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 17' ' ' VAL . 17.7 m -125.88 146.86 30.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.011 -0.54 . . . . 71.540000000000006 110.838 -176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.65 142.39 49.07 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.882 -0.414 . . . . 52.350000000000001 109.882 175.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -82.68 158.33 22.99 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.865 -0.791 . . . . 53.310000000000002 108.865 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -66.02 -3.84 6.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.328 0.585 . . . . 72.340000000000003 110.782 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -81.72 9.95 6.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 71.140000000000001 110.204 176.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 64.19 33.82 11.46 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.783 -0.644 . . . . 73.310000000000002 111.919 176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -124.85 120.78 32.66 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.804 -0.634 . . . . 71.329999999999998 109.867 175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.58 144.26 42.36 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.429 -0.805 . . . . 65.140000000000001 111.872 -173.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.469 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 28.3 pt -137.39 168.29 21.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.554 -0.748 . . . . 73.409999999999997 109.603 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 34.3 mt -102.21 147.89 8.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.313 -0.625 . . . . 71.430000000000007 109.313 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 65.6 m -137.99 163.19 32.16 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.894 0.378 . . . . 62.130000000000003 110.831 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.609 ' O ' ' HA ' ' A' ' 72' ' ' ARG . 46.5 p-80 -151.31 166.56 30.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.783 -0.451 . . . . 74.209999999999994 109.783 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -78.38 152.0 5.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.597 0.237 . . . . 50.409999999999997 110.538 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.1 m -139.36 -167.9 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.525 -0.307 . . . . 73.319999999999993 110.481 175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -32.39 -94.15 0.01 OUTLIER Glycine 0 C--N 1.338 0.641 0 N-CA-C 115.923 1.129 . . . . 70.430000000000007 115.923 -173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -52.86 -35.9 58.27 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.125 0.416 . . . . 74.319999999999993 112.125 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 83.3 t -56.47 -48.33 80.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.867 0.365 . . . . 73.519999999999996 111.335 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.45 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -67.31 -33.29 74.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.383 -0.371 . . . . 55.439999999999998 111.133 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -85.76 -17.06 36.89 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.795 0.294 . . . . 62.399999999999999 111.795 -176.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.7 p -74.3 -22.62 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.801 0.297 . . . . 74.340000000000003 111.801 -174.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 59.74 36.74 22.3 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.11 0.481 . . . . 62.219999999999999 111.386 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.777 HG12 HG13 ' A' ' 74' ' ' ILE . 2.2 pp -76.43 163.0 4.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.222 -0.445 . . . . 55.329999999999998 110.677 175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.412 ' HG2' HG23 ' A' ' 52' ' ' ILE . 71.1 ttt180 -102.14 109.18 20.81 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.803 0.335 . . . . 73.239999999999995 110.855 -178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 74' ' ' ILE . 48.3 mt -93.03 111.56 24.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.133 -0.485 . . . . 53.100000000000001 109.741 175.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.646 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -117.34 147.88 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.832 0.348 . . . . 74.450000000000003 110.718 179.185 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.665 HD11 HD22 ' A' ' 20' ' ' LEU . 52.7 mt -75.78 140.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.074 -0.512 . . . . 72.109999999999999 110.566 -177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 99.28 -18.05 57.05 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.858 -0.687 . . . . 30.120000000000001 112.329 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -92.58 158.22 16.1 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.834 -0.432 . . . . 63.43 109.834 -178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 56' ' ' ARG . 62.3 mmt-85 -75.93 140.52 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.215 0.531 . . . . 73.540000000000006 110.671 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 75' ' ' ARG . 24.6 m -133.6 160.64 42.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.783 -0.644 . . . . 72.209999999999994 110.952 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.24 126.79 52.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.841 -0.618 . . . . 60.43 109.477 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.54 129.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.68 0.752 . . . . 74.049999999999997 109.952 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 72' ' ' ARG . 38.7 tt0 -117.54 109.31 16.55 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.037 -0.983 . . . . 73.430000000000007 109.108 -176.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.578 ' HB3' ' HA3' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -147.77 156.07 42.35 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.422 0.629 . . . . 71.549999999999997 112.252 -175.02 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 10' ' ' LEU . 16.3 m -93.53 142.89 26.83 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.468 -0.787 . . . . 61.310000000000002 110.439 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.43 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.8 mm -78.86 3.74 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.167 -0.47 . . . . 73.040000000000006 111.941 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 62' ' ' SER . 89.8 m-85 -57.2 -85.24 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.548 0.573 . . . . 74.430000000000007 112.548 -176.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -149.02 -69.26 0.21 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.012 0.375 . . . . 74.200000000000003 112.012 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -34.11 75.75 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.903 0.383 . . . . 74.209999999999994 111.29 -174.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 70' ' ' LYS . 13.8 m120 -83.32 -9.53 59.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.839 -0.344 . . . . 72.430000000000007 110.814 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.92 -8.14 59.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.358 0.599 . . . . 74.200000000000003 109.599 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -108.29 -49.05 3.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.3 -0.864 . . . . 64.409999999999997 109.544 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER -124.34 130.04 51.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.643 -0.708 . . . . 63.240000000000002 111.058 174.204 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 61' ' ' MET . . . -118.58 -177.85 16.87 Favored Glycine 0 N--CA 1.454 -0.164 0 N-CA-C 111.449 -0.66 . . . . 71.209999999999994 111.449 176.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 39' ' ' HIS . 5.5 ptp180 -93.31 124.97 37.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.514 0.657 . . . . 71.219999999999999 109.719 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.41 HD11 HG11 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -113.63 137.28 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.827 -0.624 . . . . 64.430000000000007 109.701 -177.644 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.777 HG13 HG12 ' A' ' 49' ' ' ILE . 4.2 tt -125.58 -71.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 120.323 -0.551 . . . . 55.310000000000002 111.634 177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.746 ' H ' HG23 ' A' ' 74' ' ' ILE . 38.1 ttt180 171.95 172.22 0.1 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.38 -0.6 . . . . 72.239999999999995 109.38 174.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' H ' ' HG2' ' A' ' 75' ' ' ARG . 14.4 tpt180 -73.49 147.55 43.97 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.617 -0.883 . . . . 71.200000000000003 108.617 165.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.37 173.89 2.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.104 0.478 . . . . 73.439999999999998 111.115 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.411 ' H ' ' HE3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -74.45 112.15 10.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.982 -0.554 . . . . 62.450000000000003 110.635 -176.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.56 -168.65 33.46 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.768 -0.73 . . . . 74.129999999999995 111.879 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p 51.97 26.65 3.83 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.401 0.68 . . . . 73.219999999999999 112.182 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.0 p -69.01 -29.2 67.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 73.120000000000005 111.284 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.89 -52.96 6.9 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.445 0.641 . . . . 71.209999999999994 109.737 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -176.93 -62.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.673 -1.149 . . . . 72.319999999999993 108.97 -178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.72 HG23 ' H ' ' A' ' 85' ' ' ILE . 0.6 OUTLIER -121.04 -84.37 0.66 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.168 -0.923 . . . . 55.009999999999998 110.404 179.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.72 ' H ' HG23 ' A' ' 84' ' ' THR . 20.8 pt 44.31 27.24 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.33 1.052 . . . . 72.140000000000001 112.793 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.1 p -93.05 5.75 50.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.234 0.54 . . . . 63.100000000000001 110.6 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.367 -0.825 . . . . 74.430000000000007 109.439 177.299 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.5 mtt . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 110.344 -0.243 . . . . 73.329999999999998 110.344 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.2 106.69 9.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.044 -0.525 . . . . 63.549999999999997 111.232 -177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 3' ' ' LYS . 30.0 mmtm -139.71 80.87 1.79 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.857 -0.61 . . . . 54.420000000000002 110.24 175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.568 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 8.3 p-10 -170.85 -19.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.021 -0.99 . . . . 73.129999999999995 110.345 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -53.52 -40.26 65.31 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.938 -0.574 . . . . 71.329999999999998 111.568 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -107.03 25.12 11.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.256 0.551 . . . . 63.409999999999997 111.152 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.568 ' OG ' ' HA ' ' A' ' 4' ' ' ASP . 46.9 p -144.85 43.89 1.35 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.74 -0.664 . . . . 71.400000000000006 109.762 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -78.77 1.88 21.67 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.807 -0.633 . . . . 74.239999999999995 111.07 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.8 p -88.16 86.56 7.11 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.841 -0.8 . . . . 51.100000000000001 108.841 168.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' A' ' 60' ' ' GLU . 1.7 pt? -146.52 -177.28 5.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.548 . . . . 74.209999999999994 110.739 -173.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -126.03 146.16 50.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.019 -0.363 . . . . 73.120000000000005 110.019 -176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -108.41 115.09 29.46 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.098 0.475 . . . . 75.239999999999995 110.088 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -111.13 142.9 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.159 0.504 . . . . 72.510000000000005 111.274 -172.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -93.85 121.89 35.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.807 -0.633 . . . . 74.400000000000006 109.781 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.72 140.0 6.34 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.555 -0.831 . . . . 73.349999999999994 112.292 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 56' ' ' ARG . . . -85.74 152.57 22.95 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.712 0.291 . . . . 64.299999999999997 110.536 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 28' ' ' VAL . 9.8 p -67.75 142.5 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.35 -0.386 . . . . 75.409999999999997 110.363 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 1.067 ' HB ' ' HD2' ' A' ' 29' ' ' LYS . 12.6 t -111.97 -33.59 6.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.668 0.27 . . . . 75.540000000000006 110.551 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -161.72 168.6 22.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 75.540000000000006 110.256 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -147.6 156.0 42.37 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.032 0.444 . . . . 73.420000000000002 110.851 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 25' ' ' GLU . 37.1 tp -119.09 129.86 25.16 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 108.204 -1.036 . . . . 73.329999999999998 108.204 174.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.44 22.22 0.08 OUTLIER 'Trans proline' 0 N--CA 1.476 0.485 0 C-N-CA 123.363 2.708 . . . . 74.540000000000006 113.333 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 21' ' ' LEU . . . -105.19 25.82 10.12 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.35 -0.611 . . . . 75.140000000000001 109.35 175.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 71.42 27.89 3.01 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.07 -0.968 . . . . 63.030000000000001 111.069 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.748 ' HB3' ' HB3' ' A' ' 21' ' ' LEU . 34.5 tt0 -111.28 136.06 50.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.728 -0.669 . . . . 74.120000000000005 110.274 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.512 ' HB2' HG21 ' A' ' 73' ' ' ILE . 92.0 m-85 -131.29 125.76 33.64 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.616 -0.513 . . . . 75.239999999999995 109.616 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -110.33 114.96 28.83 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.101 0.477 . . . . 61.32 110.897 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 33.3 m -105.54 156.0 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.818 -0.628 . . . . 72.329999999999998 109.602 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 1.067 ' HD2' ' HB ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -122.98 131.38 53.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.471 0.653 . . . . 73.329999999999998 110.921 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.62 ' HG ' ' H ' ' A' ' 32' ' ' ASN . 64.4 tp -74.85 144.76 43.27 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.074 -1.084 . . . . 64.299999999999997 108.074 170.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -59.79 -20.09 54.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.906 0.384 . . . . 53.43 111.048 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.62 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 8.7 t30 -86.91 30.85 0.72 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.189 -0.46 . . . . 73.129999999999995 110.963 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 28.7 tt0 67.43 38.87 3.06 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.405 0.622 . . . . 52.210000000000001 111.293 170.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -129.63 118.53 22.09 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.634 -0.666 . . . . 65.450000000000003 110.33 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -106.19 132.11 52.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.957 -0.386 . . . . 70.329999999999998 109.957 -176.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.2 mt -121.03 136.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.401 -0.363 . . . . 72.420000000000002 111.205 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 73.8 mt -79.75 109.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.352 0.596 . . . . 64.510000000000005 110.214 177.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 55.7 m -114.11 168.03 10.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 70.420000000000002 110.488 -177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -155.93 172.81 17.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.122 -0.49 . . . . 65.450000000000003 109.957 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -84.97 118.99 32.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.184 0.516 . . . . 73.109999999999999 110.583 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.1 p -165.98 60.47 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.899 -0.591 . . . . 74.409999999999997 110.064 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.15 -140.35 2.85 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.806 -0.711 . . . . 24.34 111.669 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.03 -30.49 71.64 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.797 0.332 . . . . 54.109999999999999 110.453 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.759 HG23 ' HB ' ' A' ' 49' ' ' ILE . 7.7 p -57.56 -29.61 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 115.985 -0.552 . . . . 63.219999999999999 111.468 178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.441 ' C ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -69.57 -48.75 59.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.241 -0.436 . . . . 70.200000000000003 110.866 -177.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 46' ' ' ARG . 3.6 ptt180 -88.91 -21.38 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.509 0.559 . . . . 71.049999999999997 112.509 -176.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.6 t -93.17 -14.29 27.34 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.848 -0.341 . . . . 72.120000000000005 110.879 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt 58.69 83.81 0.12 Allowed 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.663 0.602 . . . . 52.329999999999998 111.24 178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.759 ' HB ' HG23 ' A' ' 44' ' ' VAL . 50.9 mm -114.26 141.97 28.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.112 -0.494 . . . . 75.219999999999999 110.197 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -91.84 118.14 30.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.562 -0.29 . . . . 74.5 110.642 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 74' ' ' ILE . 4.0 mp -81.73 122.29 36.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.097 -0.502 . . . . 62.0 109.674 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.752 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -112.39 146.28 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.942 0.401 . . . . 73.209999999999994 110.821 179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.446 ' HA ' HG11 ' A' ' 17' ' ' VAL . 45.6 mm -79.9 129.51 37.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.011 -0.541 . . . . 74.25 110.677 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.76 10.83 26.0 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.709 -0.757 . . . . 75.209999999999994 112.212 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -111.92 139.94 46.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.071 -0.344 . . . . 65.340000000000003 110.071 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 32.0 mtt180 -86.33 116.86 24.77 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.222 -0.658 . . . . 72.409999999999997 109.222 178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.02 -178.04 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.186 0.517 . . . . 65.530000000000001 111.354 -171.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 42.5 tp -112.77 122.49 47.82 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.463 -0.789 . . . . 74.150000000000006 109.518 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.37 128.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.318 0.58 . . . . 51.130000000000003 110.16 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.726 ' HG2' HD11 ' A' ' 10' ' ' LEU . 37.0 tt0 -113.56 109.38 18.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.717 -0.674 . . . . 73.230000000000004 110.376 -176.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -152.19 165.06 36.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.32 -0.4 . . . . 71.310000000000002 110.124 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 31.2 t -99.94 161.76 13.41 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.833 0.349 . . . . 73.349999999999994 110.534 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.8 mm -80.43 -7.89 10.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 111.325 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -69.8 -93.38 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.678 0.992 . . . . 64.209999999999994 113.678 -168.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 66' ' ' ARG . 17.8 p-10 -146.18 -71.04 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.064 0.764 . . . . 64.420000000000002 113.064 -172.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.589 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -79.72 -27.28 40.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.248 0.547 . . . . 65.120000000000005 110.429 -174.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.672 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 65.4 t30 -98.43 17.13 19.64 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.625 -0.716 . . . . 71.150000000000006 109.08 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 62' ' ' SER . . . -101.55 -49.91 3.88 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.056 -0.52 . . . . 71.140000000000001 111.716 -176.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.488 ' H ' ' HG3' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -94.11 21.5 6.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.255 0.55 . . . . 75.420000000000002 111.378 -177.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.672 ' HE3' ' HA ' ' A' ' 67' ' ' ASN . 0.1 OUTLIER -147.57 142.15 26.55 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.721 -0.844 . . . . 65.310000000000002 108.721 172.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.42 163.86 25.41 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.116 -1.04 . . . . 53.100000000000001 112.559 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.6 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 2.1 ptp180 -96.72 120.42 37.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.906 0.384 . . . . 74.150000000000006 110.131 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.512 HG21 ' HB2' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -114.25 137.27 48.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.047 -0.524 . . . . 75.530000000000001 109.617 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.663 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.3 tt -129.0 -66.14 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.358 -0.383 . . . . 65.109999999999999 110.809 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.663 ' H ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER 175.19 172.98 0.26 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.127 -1.064 . . . . 73.299999999999997 108.127 177.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 56' ' ' ARG . 74.2 ttt-85 -70.52 131.15 43.57 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.93 -0.396 . . . . 75.019999999999996 109.93 174.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 77' ' ' LEU . 2.1 pt? -66.35 140.48 58.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.173 -0.467 . . . . 71.040000000000006 109.82 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 78' ' ' LYS . 3.6 mppt? -88.06 110.21 20.45 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.497 -0.557 . . . . 65.239999999999995 109.497 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 120.1 103.42 1.97 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.749 -0.659 . . . . 33.520000000000003 111.754 -175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 t -112.71 125.59 54.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.29 0.567 . . . . 71.430000000000007 110.256 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.2 m -146.71 47.29 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.19 -0.459 . . . . 62.409999999999997 110.613 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -50.53 -60.3 3.16 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.767 -0.651 . . . . 73.510000000000005 110.283 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -150.06 -74.75 0.16 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.438 -0.801 . . . . 55.310000000000002 109.172 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.3 t -165.68 95.22 0.62 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.825 0.822 . . . . 53.539999999999999 109.948 174.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.7 pt -133.39 128.79 55.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.398 -0.819 . . . . 53.100000000000001 110.712 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -108.12 0.13 21.42 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.776 -0.647 . . . . 52.409999999999997 109.994 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 87' ' ' LYS . 34.1 ttpt . . . . . 0 C--O 1.244 0.787 0 CA-C-N 115.325 -0.852 . . . . 72.140000000000001 109.256 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.703 0.287 . . . . 60.229999999999997 110.428 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.9 m -98.82 -43.93 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.682 0.277 . . . . 63.520000000000003 111.233 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -131.21 94.3 3.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.935 0.397 . . . . 74.450000000000003 109.939 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -94.2 -40.94 9.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.674 -0.693 . . . . 71.25 109.594 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 6' ' ' LYS . 11.9 mt-10 -59.93 -58.3 9.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.017 -0.992 . . . . 74.109999999999999 109.722 177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.604 ' HD2' ' HB2' ' A' ' 5' ' ' GLU . 11.9 mptt -84.82 94.38 8.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.032 -0.986 . . . . 73.420000000000002 108.545 177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.7 m -70.27 96.94 1.16 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.479 -0.782 . . . . 72.239999999999995 112.522 -170.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -91.35 -22.53 20.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.247 -0.649 . . . . 42.219999999999999 109.247 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -84.7 69.27 10.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.348 -0.842 . . . . 74.129999999999995 111.003 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 10' ' ' LEU . 2.7 pt? -127.23 161.17 29.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.619 -0.719 . . . . 70.200000000000003 109.167 176.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.696 ' HB2' HD11 ' A' ' 63' ' ' ILE . 9.1 t80 -92.68 123.97 36.35 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.484 -0.561 . . . . 74.299999999999997 109.484 -177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -128.07 104.82 7.99 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.818 -0.628 . . . . 73.400000000000006 109.502 -176.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.455 ' O ' HD12 ' A' ' 58' ' ' LEU . 14.3 m -143.16 170.47 10.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.844 0.354 . . . . 73.109999999999999 111.829 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -93.05 138.54 31.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.535 -0.757 . . . . 63.340000000000003 109.963 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.2 -175.93 15.19 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.058 -0.591 . . . . 41.340000000000003 112.045 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.481 ' HB2' ' NH1' ' A' ' 56' ' ' ARG . . . -121.84 123.78 42.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.697 0.285 . . . . 71.200000000000003 110.588 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 28' ' ' VAL . 3.0 p -73.17 123.35 27.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.109 0.48 . . . . 74.040000000000006 109.799 175.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 29' ' ' LYS . 14.6 t -100.57 -32.49 10.74 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.1 -0.5 . . . . 73.400000000000006 111.081 -175.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -165.26 168.17 17.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.996 0.427 . . . . 63.520000000000003 111.311 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.499 ' HG ' HD11 ' A' ' 53' ' ' ILE . 4.1 pp -133.84 155.61 49.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.58 -0.736 . . . . 71.349999999999994 109.757 174.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.35 143.87 36.88 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 116.386 -0.37 . . . . 72.120000000000005 110.108 -179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.67 59.91 2.12 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.176 2.584 . . . . 74.140000000000001 112.639 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.24 25.67 0.47 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.732 -0.667 . . . . 25.32 109.614 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.07 30.46 19.92 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.515 -0.766 . . . . 64.219999999999999 109.988 -173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -118.19 136.33 53.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 75.319999999999993 110.197 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 91.1 m-85 -122.78 158.75 29.52 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.628 -0.508 . . . . 73.140000000000001 109.628 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 27' ' ' ARG . 24.2 mtt85 -133.64 116.12 15.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.466 0.651 . . . . 73.230000000000004 110.521 173.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 17' ' ' VAL . 31.0 m -116.61 156.12 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.136 -0.938 . . . . 54.219999999999999 109.543 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.832 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -125.59 140.8 52.43 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.049 0.452 . . . . 72.319999999999993 110.988 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.0 tp -66.31 148.43 51.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.945 -1.131 . . . . 73.109999999999999 107.945 169.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -61.36 -17.48 54.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.093 0.473 . . . . 74.329999999999998 111.087 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -84.44 19.26 1.98 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.051 -0.522 . . . . 74.340000000000003 110.379 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 68.83 50.98 0.6 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.714 0.806 . . . . 73.150000000000006 112.725 172.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -129.75 118.12 21.34 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.922 -0.399 . . . . 72.5 109.922 171.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.832 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 45.5 mt-10 -97.74 134.58 40.72 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.123 0.264 . . . . 71.329999999999998 110.778 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 59' ' ' VAL . 31.2 pt -129.3 170.1 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.886 0.374 . . . . 70.209999999999994 111.315 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 66.9 mt -89.35 140.1 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.997 -0.547 . . . . 70.420000000000002 110.432 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 17.1 t -126.44 142.0 51.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.018 0.437 . . . . 73.310000000000002 111.144 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -143.8 160.78 40.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.661 -0.7 . . . . 75.530000000000001 109.58 174.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.3 m -72.31 130.56 35.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.12 0.486 . . . . 55.450000000000003 110.406 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.7 t -112.9 -175.85 2.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.236 -0.438 . . . . 75.0 110.122 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -30.15 -92.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.622 0 O-C-N 124.588 1.18 . . . . 54.299999999999997 115.108 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.63 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 38.9 ttpt -48.75 -45.22 39.38 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.373 0.508 . . . . 73.239999999999995 112.373 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.66 -40.76 77.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.302 . . . . 74.310000000000002 111.48 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -62.17 -45.84 91.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 61.420000000000002 111.043 -176.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.63 ' HD3' ' HA ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -87.08 -17.71 32.23 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.493 -0.483 . . . . 73.230000000000004 111.495 -175.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.7 t -84.15 -23.38 30.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.898 -0.137 . . . . 70.109999999999999 111.062 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt 60.59 87.34 0.09 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 123.528 0.518 . . . . 62.130000000000003 110.931 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.536 HG21 HG13 ' A' ' 74' ' ' ILE . 44.2 mm -107.83 141.38 23.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 71.129999999999995 110.342 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -89.74 106.33 18.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.367 -0.379 . . . . 62.539999999999999 110.667 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.2 mt -98.55 113.85 34.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.258 -0.428 . . . . 70.150000000000006 109.87 177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.506 ' O ' HG11 ' A' ' 17' ' ' VAL . 36.1 pt -110.82 150.38 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.398 -0.364 . . . . 73.129999999999995 110.827 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 20' ' ' LEU . 54.5 mt -77.56 137.46 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.501 -0.318 . . . . 63.210000000000001 110.725 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' H ' HG13 ' A' ' 17' ' ' VAL . . . 89.06 17.41 56.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.884 -0.674 . . . . 72.349999999999994 112.807 176.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -121.2 158.14 28.69 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.902 -0.407 . . . . 73.420000000000002 109.902 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.481 ' NH1' ' HB2' ' A' ' 16' ' ' ALA . 34.9 mmt180 -75.38 130.87 39.7 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.938 0.399 . . . . 72.239999999999995 109.987 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.642 ' HB ' HG23 ' A' ' 73' ' ' ILE . 15.9 m -132.12 154.71 40.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.475 . . . . 74.519999999999996 111.255 -175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 13' ' ' VAL . 35.6 tp -105.86 122.53 46.29 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.424 -0.584 . . . . 64.219999999999999 109.424 -178.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.546 HG21 HD11 ' A' ' 36' ' ' ILE . 7.5 p -104.25 131.36 53.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.308 0.575 . . . . 72.209999999999994 111.113 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -120.15 110.05 16.16 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.323 -0.853 . . . . 64.299999999999997 109.123 176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 4.1 ppp? -131.29 159.35 38.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.823 0.344 . . . . 72.349999999999994 111.226 -178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.748 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 10.0 m -99.0 136.62 38.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.179 -0.464 . . . . 44.020000000000003 111.341 -175.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.696 HD11 ' HB2' ' A' ' 11' ' ' PHE . 18.9 mm -76.97 3.56 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 121.181 0.515 . . . . 70.519999999999996 111.139 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -74.54 -92.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.794 0.664 . . . . 74.319999999999993 112.794 -173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -140.02 -69.94 0.4 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.083 0.401 . . . . 75.530000000000001 112.083 -171.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.765 ' HD2' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -70.65 -41.13 72.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.395 -0.366 . . . . 70.099999999999994 111.523 -175.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.748 ' HB2' ' HB2' ' A' ' 62' ' ' SER . 83.3 m-20 -90.57 15.47 10.82 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.877 0.37 . . . . 70.109999999999999 110.449 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.2 -20.59 47.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.103 0.478 . . . . 72.329999999999998 110.455 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.92 17.83 5.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.522 0.677 . . . . 71.129999999999995 110.29 177.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -147.1 134.11 20.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.31 -0.859 . . . . 75.019999999999996 108.805 177.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.67 -178.9 16.4 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.299 -0.953 . . . . 40.229999999999997 112.354 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -111.87 139.58 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.57 -0.53 . . . . 73.329999999999998 109.57 176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.642 HG23 ' HB ' ' A' ' 57' ' ' VAL . 18.6 mm -114.07 134.1 58.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.976 -0.556 . . . . 64.310000000000002 110.438 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.756 HG23 ' H ' ' A' ' 75' ' ' ARG . 4.8 tt -112.81 -69.58 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.409 -0.516 . . . . 74.219999999999999 109.97 170.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.756 ' H ' HG23 ' A' ' 74' ' ' ILE . 60.8 ttt180 172.57 172.48 0.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.34 -0.985 . . . . 74.010000000000005 108.34 172.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.45 ' HD3' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -70.02 124.55 24.35 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.263 -1.014 . . . . 71.349999999999994 108.263 174.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 77' ' ' LEU . 2.6 pt? -63.49 145.85 54.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.972 0.415 . . . . 73.040000000000006 110.722 -178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 78' ' ' LYS . 3.9 mppt? -82.06 113.01 19.65 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.057 0.456 . . . . 70.200000000000003 109.823 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 101.79 100.37 2.48 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.624 -0.798 . . . . 42.229999999999997 111.199 -174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.2 t -76.81 73.1 3.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.768 0.794 . . . . 71.109999999999999 111.38 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -104.16 83.07 2.03 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.594 -0.73 . . . . 73.230000000000004 110.351 177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' OD2' ' HD3' ' A' ' 83' ' ' ARG . 1.0 OUTLIER -92.7 -73.82 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.797 -0.638 . . . . 73.310000000000002 110.35 179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.629 ' HD3' ' OD2' ' A' ' 82' ' ' ASP . 0.2 OUTLIER 164.93 -31.08 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 O-C-N 124.3 1.0 . . . . 72.230000000000004 109.742 174.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.433 ' OG1' ' HG2' ' A' ' 83' ' ' ARG . 33.4 m -146.73 -32.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.577 0.954 . . . . 72.310000000000002 113.577 -175.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 82' ' ' ASP . 36.0 pt -47.04 94.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 113.77 1.026 . . . . 75.450000000000003 113.77 -167.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 60.6 m -158.63 7.19 0.12 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.042 -0.981 . . . . 70.439999999999998 109.843 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.859 ' HA ' ' HE3' ' A' ' 87' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.876 0 CA-C-N 115.493 -0.776 . . . . 63.340000000000003 109.5 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 109.814 -0.439 . . . . 73.209999999999994 109.814 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.2 t -67.77 -41.4 85.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 109.6 -0.519 . . . . 74.329999999999998 109.6 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -82.46 64.01 6.9 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 108.805 -0.813 . . . . 74.150000000000006 108.805 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.426 ' HA ' HH12 ' A' ' 72' ' ' ARG . 34.7 m-20 -169.79 -60.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.217 -1.401 . . . . 64.140000000000001 107.217 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.704 ' HA ' ' HE3' ' A' ' 8' ' ' LYS . 25.7 mm-40 -58.16 -57.83 11.15 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 114.079 -1.419 . . . . 64.5 111.575 178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 6' ' ' LYS . 10.9 mptt -87.5 29.2 0.89 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.349 0.595 . . . . 72.409999999999997 110.63 -175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.5 m -141.16 22.89 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.533 -0.758 . . . . 72.409999999999997 110.055 176.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.704 ' HE3' ' HA ' ' A' ' 5' ' ' GLU . 96.3 mttt -72.01 -37.12 69.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.251 -0.431 . . . . 73.549999999999997 110.731 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.4 m -96.99 102.05 13.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.747 -0.464 . . . . 75.540000000000006 109.747 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -150.76 -178.84 6.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.059 -0.518 . . . . 40.399999999999999 109.971 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.42 124.64 43.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.011 0.434 . . . . 75.329999999999998 109.855 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.599 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 15.9 mt-10 -112.13 113.66 26.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.827 -0.624 . . . . 71.150000000000006 110.412 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.543 ' HB ' HD13 ' A' ' 30' ' ' LEU . 17.3 m -119.63 157.72 21.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.108 0.48 . . . . 74.530000000000001 111.089 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -112.71 117.49 32.39 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.956 -0.565 . . . . 51.049999999999997 109.629 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.82 -170.29 11.89 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.68 -0.772 . . . . 45.210000000000001 111.905 -175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.643 ' HB2' ' HD3' ' A' ' 56' ' ' ARG . . . -123.96 143.83 50.16 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.884 0.342 . . . . 72.409999999999997 110.722 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.695 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.3 p -71.25 139.93 19.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.233 -0.439 . . . . 73.400000000000006 110.364 176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -102.35 -46.84 4.68 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.227 0.537 . . . . 62.530000000000001 110.548 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.6 168.45 21.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.298 -0.864 . . . . 63.399999999999999 109.789 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 53' ' ' ILE . 2.6 pt? -127.29 155.54 43.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.126 0.489 . . . . 70.340000000000003 110.707 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 21' ' ' LEU . 5.5 mp -108.04 149.32 38.97 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.478 -0.783 . . . . 73.400000000000006 109.516 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -69.93 12.98 0.32 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.301 2.667 . . . . 71.420000000000002 113.362 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -105.47 23.96 12.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.47 -0.332 . . . . 74.519999999999996 110.345 178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.98 32.98 19.92 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.813 0.816 . . . . 65.540000000000006 109.473 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -121.29 144.0 48.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.564 -1.198 . . . . 65.25 109.344 -173.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.83 ' HB2' ' HB3' ' A' ' 38' ' ' CYS . 97.0 m-85 -119.43 162.93 18.01 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.921 0.391 . . . . 72.439999999999998 111.073 -176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -134.83 115.84 14.12 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.853 -0.612 . . . . 50.350000000000001 109.987 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG12 ' HA ' ' A' ' 17' ' ' VAL . 15.2 m -122.79 156.25 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.887 -0.597 . . . . 74.349999999999994 110.571 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.862 ' HB3' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -125.66 141.28 52.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.924 0.393 . . . . 73.439999999999998 110.541 177.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 13' ' ' VAL . 56.3 tp -62.48 159.78 14.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.425 -0.954 . . . . 25.109999999999999 108.425 169.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.06 -9.68 41.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.101 0.41 . . . . 63.32 112.071 -177.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -91.21 4.58 51.9 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 121.857 0.837 . . . . 63.200000000000003 109.623 173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 65.17 68.41 0.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.81 -1.086 . . . . 62.340000000000003 112.772 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -130.1 119.07 22.47 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.843 -1.169 . . . . 70.549999999999997 107.843 164.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.862 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 32.5 mt-10 -97.58 137.4 36.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.132 0.491 . . . . 74.310000000000002 111.967 -172.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.64 167.78 25.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.466 -0.788 . . . . 73.430000000000007 109.951 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 56.3 mt -82.34 150.3 4.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.225 -0.443 . . . . 60.109999999999999 109.936 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.83 ' HB3' ' HB2' ' A' ' 26' ' ' PHE . 34.9 t -126.78 140.45 52.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.786 0.327 . . . . 73.230000000000004 110.677 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.68 155.58 31.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.407 -0.59 . . . . 71.239999999999995 109.407 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.6 m -71.66 130.86 35.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.212 0.53 . . . . 61.240000000000002 110.751 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.4 m -118.72 -165.19 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.926 -0.579 . . . . 53.130000000000003 109.969 178.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -38.68 -92.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.615 0 O-C-N 124.191 0.932 . . . . 52.520000000000003 114.814 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -44.51 -39.71 5.06 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.786 0.661 . . . . 63.140000000000001 112.786 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.11 -39.61 86.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 111.624 0.231 . . . . 54.229999999999997 111.624 -176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.492 ' C ' ' HD3' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -58.37 -52.53 65.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.386 -0.37 . . . . 74.430000000000007 111.62 -172.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.35 -5.94 58.94 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.35 -0.54 . . . . 74.25 111.305 -173.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 27.1 t -86.42 -20.65 27.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.527 -0.306 . . . . 70.230000000000004 110.614 -178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.6 mttt 58.77 79.67 0.21 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.41 0.624 . . . . 75.519999999999996 110.235 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 74' ' ' ILE . 35.8 mm -105.74 138.38 31.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.343 -0.844 . . . . 62.009999999999998 111.173 -174.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -108.78 107.55 18.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.631 . . . . 74.109999999999999 110.11 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.89 111.71 23.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.465 -0.568 . . . . 72.019999999999996 109.465 177.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.847 HD13 ' H ' ' A' ' 52' ' ' ILE . 0.2 OUTLIER -100.58 151.21 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.038 0.447 . . . . 65.299999999999997 111.988 -172.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.585 ' HA ' HG11 ' A' ' 17' ' ' VAL . 60.0 mt -78.5 128.02 38.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.697 -0.683 . . . . 34.450000000000003 111.407 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.0 -31.22 7.15 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.973 -0.632 . . . . 52.32 112.783 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -85.5 150.83 24.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.6 0.238 . . . . 75.120000000000005 110.834 -175.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.643 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 70.9 mmt-85 -75.23 137.51 41.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.718 -0.475 . . . . 54.039999999999999 109.718 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.9 m -124.34 165.13 21.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.041 0.448 . . . . 52.119999999999997 111.05 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 68.4 tp -107.14 113.89 27.6 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.844 -0.616 . . . . 64.299999999999997 109.496 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.561 ' HB ' HG12 ' A' ' 73' ' ' ILE . 2.8 p -116.35 116.05 51.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.366 0.603 . . . . 52.439999999999998 110.582 -178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.599 ' HB3' ' HG2' ' A' ' 12' ' ' GLU . 10.7 pt-20 -108.73 117.8 35.12 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.637 -0.711 . . . . 74.340000000000003 109.546 175.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.62 156.28 48.15 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.791 -0.641 . . . . 63.210000000000001 110.382 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 67' ' ' ASN . 7.8 m -99.91 118.79 37.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.577 -0.527 . . . . 64.099999999999994 109.577 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.6 mt -73.61 3.22 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.455 0.645 . . . . 73.310000000000002 110.897 -175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -69.98 -74.53 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 72.450000000000003 111.95 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -148.48 -70.79 0.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 113.555 0.946 . . . . 33.539999999999999 113.555 -174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -80.18 -50.54 10.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.186 0.439 . . . . 54.409999999999997 112.186 -171.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 62' ' ' SER . 58.2 t30 -81.33 26.2 0.47 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.971 0.415 . . . . 64.010000000000005 110.068 -178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.13 -41.58 7.85 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.868 -0.606 . . . . 51.43 111.401 -176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 69' ' ' LYS . 9.5 mptt -65.46 -43.16 91.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.237 0.541 . . . . 72.430000000000007 110.152 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -124.55 152.33 43.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.428 -0.806 . . . . 72.409999999999997 110.312 -178.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -118.0 159.1 14.37 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.798 -0.715 . . . . 63.109999999999999 111.331 176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.426 HH12 ' HA ' ' A' ' 4' ' ' ASP . 30.8 ptt180 -93.99 107.89 19.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.412 0.625 . . . . 74.439999999999998 109.69 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.561 HG12 ' HB ' ' A' ' 59' ' ' VAL . 57.5 mt -105.36 134.68 46.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.695 -0.684 . . . . 70.329999999999998 111.192 -175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.709 HG23 ' H ' ' A' ' 75' ' ' ARG . 3.5 tt -108.58 -67.54 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.029 -0.532 . . . . 63.200000000000003 109.695 171.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.709 ' H ' HG23 ' A' ' 74' ' ' ILE . 1.0 OUTLIER 174.73 164.53 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.521 -0.918 . . . . 75.420000000000002 108.521 174.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.488 ' O ' ' HD3' ' A' ' 75' ' ' ARG . 6.3 tpt180 -71.29 129.52 39.07 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.585 -0.524 . . . . 70.310000000000002 109.585 174.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 pp -58.69 140.31 54.87 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.599 -0.519 . . . . 44.420000000000002 109.599 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -47.23 135.52 10.11 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.741 0.651 . . . . 71.430000000000007 112.183 -169.505 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.7 133.83 52.61 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.914 -1.039 . . . . 72.120000000000005 114.221 -169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.5 t -85.6 -37.53 19.44 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.143 -0.528 . . . . 70.049999999999997 109.88 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -150.15 143.85 25.31 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.498 -0.556 . . . . 72.200000000000003 109.498 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.66 -24.88 18.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.456 0.169 . . . . 72.099999999999994 111.01 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 69.43 -67.6 0.22 Allowed 'General case' 0 N--CA 1.467 0.419 0 O-C-N 123.67 0.606 . . . . 72.040000000000006 111.018 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.7 t -174.61 -41.01 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.387 -0.37 . . . . 71.209999999999994 110.073 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 26.0 pt 35.83 44.78 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.381 1.072 . . . . 44.329999999999998 113.387 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.5 m -110.69 18.53 19.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.233 0.54 . . . . 52.25 109.966 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.594 -0.73 . . . . 62.43 110.318 -176.574 . . . . . . . . 0 0 . 1 stop_ save_